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Bacteriophage life cycle 
Bacteriophages (phages) were discovered by Frederick Twort and Félix d’Hérelle in the beginning of the 20th 
century. d’Hérelle coined the term bacteriophage (derived from "bacteria" and the Greek: φαγεῖν (phagein), 
"to eat") for these ‘invisible antagonists’ (D’Herelle, 1917). Phages are the most abundant biological entities in 
earth, outnumbering their hosts in most ecosystems, up to 150 fold (Wigington et al., 2016). Phages consist of 
nucleic acid genomes encapsulated by a proteinaceous capsid and can have a wide range of morphologies. 
Most known phages have a polyhedral morphology, but others are filamentous, or pleomorphic (Ackermann, 
2003). Most phage genomes consist of dsDNA, but others contain ssDNA, ssRNA, or dsRNA. Bacteriophages are 
metabolically inert and require a host for replication. The process of phage infections starts with adsorption of 
the virus to the cell surface. Phage adsorption is usually accomplished via binding of the phage particle to cell-
surface receptors, membrane proteins, or lipopolysaccharides (LPS). Subsequent to successful adsorption, the 
viral DNA is injected into the host cell. Penetration of the bacterial cell wall is sometimes aided by phage-
encoded lysozymes bound to the phage tail that partially degrades the peptidoglycan layer (Arisaka et al., 
2003). The genomic DNA of the phage is then replicated and copy numbers can reach up to 200 (Demerec and 
Fano, 1945). Transcription and translation of viral DNA is followed by protein assembly and viral particle 
formation. The last step of the viral life cycle is lysis of the host cells, usually performed by viral enzymes, such 
as porins, that perforate the cell wall. Generally, there are two ways a viral infection can spread, namely lytic 
and lysogenic infection. In a lytic infection, which is considered the main lifestyle of phages, the phage directly 
takes over the metabolic activities of the host in order to replicate and release new phages. Unlike lytic 
infection, lysogenic infection is followed by integration of the viral genome into the bacterial genome. The 
integrated viral genome (prophage) turns the bacterial cell into a lysogen. Prophages can be activated upon 
cellular stress such as DNA damage which initiates the SOS response of the cell (Nanda et al., 2014). 
Interestingly, some phages show yet another lifestyle, that of a chronic infection. In this life cycle, there is a 
continues production of phage particles that are released from the cell without lysis of the cell (Clokie et al., 
2011).  
Biotechnological applications of phages 
Phages are present in all ecosystems where bacteria are found, which can include industrial fermentation 
reactors. Although phages can cause problems in bacterial fermentation processes in food, feed, chemical, and 
pharmaceutical industries, phage related problems probably are best documented in dairy related 
fermentations (Garneau and Moineau, 2011). In a dairy fermentation process, lactic acid bacteria (LAB) 
produce lactic acid via lactose fermentation, which acidifies the milk. The decreased pH is a crucial factor for 
avoiding contamination by pathogenic and spoilage microorganisms. Phage infection of LAB starter cultures is 
the primary cause of slow fermentation or even culture collapse in industrial fermentation processes. The 
relevance and implications of phage infections are enormous, considering that the dairy industry is a multi-
billion dollar industry. A better understanding of phage-host interactions is expected to contribute to the 
development of more effective anti-phage measures (Horvath and Barrangou, 2010).  
 
Figure 1. Schematic overview of the life cycle of Escherichia coli phage T4. (A) A single tail fiber binds to the outer 
membrane receptors OmpC or LPS. (B) Multiple long tail fibers unwrap from the tail sheath and bind to the 
outer membrane. Also the baseplate binds the membrane. (C) The tail sheath contracts and internal tube 
penetrates the outer membrane and DNA is injected into the cytoplasm. (D) Degradation of the host DNA and 
replication of viral DNA. (E) Synthesis of phage proteins followed by assembly of complete phage particles. (F) 
Holin proteins form pores in the bacterial cell membrane and the cell bursts to release phage progeny.  
Box1. The quintessence of bacteriophages / War against the machines 
Bacteriophages are by common definition not alive nor organisms. The lack of a universal definition of life 
indicates that the question whether something is alive might be a more philosophical than a physical question. 
Life definitions shift towards ‘context-dependent’ definitions to include entities that are argued to be alive but 
do not satisfy technical definitions (Schrödinger, 1967). Some biologists argue that the living part of a 
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bacteriophage is not the viral particle, but the viral factory within the infected cell with all its associated 
biosynthetic activity (Brüssow, 2009). The manner in which inanimate bacteriophages are being transmitted 
could ground one’s argument for considering them as ‘memes’. A meme, as introduced in Richard Dawkins’ 
book The Selfish Gene (Dawkins, 1976), is a discrete unit that is replicated, mutated and responsive to selective 
pressure (Stotz, 2004). These philosophical ideas might not give a satisfactory distinction between life or 
inanimacy for scientists who are used to thinking in well-defined categories. The question whether 
bacteriophages are alive might forever stay controversial.  
Anti-viral defense mechanisms 
The parasitic nature of bacteriophages poses an incredible selective pressure on micro-organisms to develop 
anti-viral defense mechanisms. The competitive interactions between hosts and parasites forces a continuous 
arms-race to prevent extinction. This evolutionary law was postulated as the Red Queen Hypothesis (van Valen, 
1973). Originally describing extinction biology of eukaryotes, this hypothesis is most applicable on the co-
evolution of prokaryotes and their viruses largely due to the fast mutation rates of phage genomes (Paez-Espino 
et al., 2015).  
Recently, new types of defense mechanisms have been discovered, of which the CRISPR-Cas mechanisms have 
had a large impact on the field of genome engineering (Doudna and Charpentier, 2014). Anti-viral defense 
mechanisms can be divided into two categories: prevention of phage infection and prevention of phage 
replication. In the following section examples are described for several anti-viral defense mechanisms and 
escape mechanisms used by bacteriophages are explained.  
Inhibition of phage adsorption 
Bacteriophage adsorption is initiated by interaction between cell surface receptors and bacteriophage 
components. With a distinct composition of cell wall and surface structures, gram-negative and gram-positive 
bacteria have different receptors available for phage adsorption (Figure 2). Adsorption inhibition strategies 
include blocking of phage receptors, production of extracellular matrix, and production of competitive 
inhibitors.  
In gram-negative bacteria, lipopolysaccharides (LPS) represent the most common receptor for phage 
attachment. LPS is composed of fatty acids and monosaccharides typically organized into three sub-structures: 
lipid A, core polysaccharide and O-chain (i.e. O-antigen). LPS with such organization is known as smooth LPS; 
rough LPS lacking the O-antigen can also be found in many gram-negative bacteria (Pupo et al., 2013). Phages 
targeting the O-antigen (smooth LPS) are expected to reveal a narrower host range due to the high variability 
of the O-antigen chain among species and strains (Alicja Niewiadomska et al., 2005). Conversely, phages 
recognizing elements of the LPS core may demonstrate a broader host range as the core structure (exposed in 
rough LPS and less accessible in smooth LPS) is highly conserved in a number of species and genera of gram-
negative bacteria. Production of a structured extracellular matrix such as LPS can provide bacteria with a 
physical barrier between phages and their receptors. In response these extracellular matrices have become 
receptors themselves, as described above. Antithetically, phages have evolved polysaccharide degrading 
enzymes, such as lysozymes (reviewed by Sutherland, 1995). These viral proteins are either bound to the phage 
particle or released in the environment when cells lyse.  
 
 
Figure 2. Representation of Gram-positive and Gram-negative bacterial receptors used by bacteriophages for 
adsorption.  
Membrane proteins, such transport proteins and efflux pumps, can also serve as phage receptors. Outer 
membrane proteins OmpC and OmpF in gram-negative bacteria are used by bacteriophages as receptor for 
tail-fiber attachment (Hantke, 1978; Ho and Slauch, 2001; Marti et al., 2013). Maltose transport protein LamB, 
vitamin B12 transporter BtuB, and efflux pump TolC are used as receptors by phage λ, BF23, and ST29 
respectively (Meyer et al., 2012; Mondigler et al., 2006; Ricci and Piddock, 2010). A common mechanism of 
bacteria to block phage infection is mutation of receptors. In response phages can evolve the ability to 
recognize new receptors. Phage T4 has developed an OmpC-dependent and OmpC-independent/LPS-
dependent adsorption mode to circumvent adsorption block by OmpC mutation (Washizaki et al., 2016). 
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Another example is the adaptation of phage λ to recognize a new receptor upon reduced expression of outer-
membrane receptor LamB (Meyer et al., 2012). While LamB is its preferred receptor, phage λ was able to 
change the receptor specificity by minor mutations of its tail attachment protein J.  
In gram-positive bacteria the main component of the cell wall is peptidoglycan, a heteropolymer composed of 
N-acetylglucosamine and N-acetylmuramic acid. A tetrapeptide is covalently attached to the N-acetylmuramic 
acid. The other vital component of gram-positive bacteria cell wall are teichoic acids, polyol phosphate 
polymers with either ribitol or glycerol linked by phosphodiester bonds. The substituent groups on the polyol 
chains (D-alanine, N-acetylglucosamine, N- acetylgalactosamine, and glucose) are characteristic of a particular 
bacterial species and thus can act as a specific antigenic determinant. For example, Staphylococcus aureus and 
Bacillus subtilis have similar peptidoglycan and teichoic acids structure, so phages specific for S. aureus may 
also adsorb on the surface of B. subtilis (Rakieten and Rakieten, 1937). Conversely, the specific distinction of 
the teichoic acid substituent between these species (D-glucose for Bacillus and N-acetylglucosamine for S. 
aureus) is key for the specific adsorption of phages to B. subtilis (e.g. phages Ø1, SP3 and Sp02)(Glacer, L., 
Lonesco, H. & Shaefer, 1966; Young, 1967). Proteins of gram-positive bacteria may also serve as receptors for 
phage adsorption. Examples include GamR of the Bacillus anthracis cell wall which is involved in the adsorption 
of phage γ 63, and the extra-membrane domain YueB of Bacillus subtilis to which phage SPP1 irreversibly binds 
(São-José et al., 2006). As some of the receptors used by phages are not essential for the host, phage resistance 
frequently occurs by random mutation.  
Super infection exclusion / DNA injection blocking 
Shortly after phage adsorption the viral DNA is injected into the cell via a syringe-like mechanism and within a 
few minutes the first phage-encoded proteins are synthesized (Molineux, 2008). In the case of T-even phages, 
these include superinfection exclusion (Sie) proteins. Sie systems were discovered by Dubecco in the 1950s, 
who observed that infection with a mix of two different phages was inefficient unless infection occurred 
simultaneously. Sie systems are typically encoded by phages or prophages and protect bacteria from secondary 
infections by the same or closely related phages. Membrane-associated proteins imm and sp were later 
characterized as responsible for Sie in T4 (Dulbecco, 1952; Lu and Henning, 1994). Imm inhibits DNA transfer 
across the cytoplasmic membrane and Sp inhibits local degradation of the murein layer by phage lysozyme (Lu 
and Henning, 1994).  
Restriction-Modification 
Bacterial Restriction-Modification (R-M) systems can provide protection from mobile genetic elements by 
degradation of foreign DNA. R-M systems are active against phage DNA but also strongly involved in the 
regulation of plasmid immigration, illustrated by the fact that R-M systems are over-represented in naturally 
competent organisms (Oliveira et al., 2014). This phenomenon was first discovered when Arber and Dussoix 
found that phage λ isolated from E. coli B strains could not infect E. coli K strains and vice versa (Kühnlein and 
Arber, 1972). This inability to infect was due to DNA restriction by EcoKI and EcoBI restriction systems 
respectively. Typically, R-M systems have enzymes responsible for recognition and cleavage of specific DNA 
sequences and a cognate methyltransferase that confers protection from cleavage by methylation of the same 
DNA sequence. Typically, specific DNA sequences of the host are methylated whereas invading DNA usually 
does not contain these methylation patterns. A multitude of DNA base modifications is known that allows hosts 
to distinguish between their own and phage DNA. The most prominent DNA modifications are nucleobase 
methylations of either adenine or cytosine.  
R-M systems can be divided into four different classes (Roberts et al., 2003). Type I R-M systems are 
characterized by a multisubunit protein complex that usually contains two restriction endonuclease (REase) 
subunits, two methyltransferase (MTase) subunits, and one specificity (S) subunit. The S subunit determines 
the DNA sequence that is recognized. When the recognized DNA sequence does not contain methylated 
adenosine bases (m6A) the REase subunits of the protein complex cleave the DNA in an ATP-dependent 
manner. When the recognized DNA sequence is hemimethylated, in which one of the strands is methylated, 
the MTase subunit uses S-adenosylmethionine (SAM) as methyl donor for methylation of the unmethylated 
strand. The best known example of a Type I R-M system is the EcoKI system in E. coli K-strains that recognizes 
the ACC(N6)GTGC sequence (Murray, 2000; Sain and Murray, 1980) 
Type II R-M systems are a widely diverse class subdivided into 11 subclasses (Roberts et al., 2003). REase 
subunits and MTase subunits function separately and recognize short palindromic sequences. A monomeric or 
homodimeric REase cleaves in or close to that sequence producing 5’-phosphates and 3’-hydroxyls. Type II R-
M enzymes, such as EcoRI, are commonly used in recombinant DNA technologies and more than 3500 REases 
have been characterized (Pingoud and Jeltsch, 2001; Roberts et al., 2015).  
Type III R-M systems are similar to Type I systems as they form a protein complex containing two REase subunits 
and two MTase subunits. Cleavage occurs when two inversely oriented copies of unmethylated recognition 
sequences are bound to the R-M complex (Meisel et al., 1992). Recognition sequences are typically 5-6 bp 
asymmetric, exemplified by the EcoP1 enzyme that recognizes AGACC, and cleavage only requires Mg2+ as a 
cofactor (Bickle and Kruger, 1993) 
Unlike other R-M systems that recognize methylated DNA as host DNA, Type IV R-M systems will only cleave 
bases that have been modified (Loenen and Raleigh, 2014). The first Type IV restriction enzymes characterized 
were rglA and rglB (restrict glucoseless) which were later renamed to McrA and McrBC (modified cytosine 
restriction). The structural organization of modification dependent systems (MDS) suggests that they have 
emerged multiple times independently of each other (Loenen and Raleigh, 2014). Sequence specificity is usually 
very low for Type IV restriction enzymes.  
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aureus) is key for the specific adsorption of phages to B. subtilis (e.g. phages Ø1, SP3 and Sp02)(Glacer, L., 
Lonesco, H. & Shaefer, 1966; Young, 1967). Proteins of gram-positive bacteria may also serve as receptors for 
phage adsorption. Examples include GamR of the Bacillus anthracis cell wall which is involved in the adsorption 
of phage γ 63, and the extra-membrane domain YueB of Bacillus subtilis to which phage SPP1 irreversibly binds 
(São-José et al., 2006). As some of the receptors used by phages are not essential for the host, phage resistance 
frequently occurs by random mutation.  
Super infection exclusion / DNA injection blocking 
Shortly after phage adsorption the viral DNA is injected into the cell via a syringe-like mechanism and within a 
few minutes the first phage-encoded proteins are synthesized (Molineux, 2008). In the case of T-even phages, 
these include superinfection exclusion (Sie) proteins. Sie systems were discovered by Dubecco in the 1950s, 
who observed that infection with a mix of two different phages was inefficient unless infection occurred 
simultaneously. Sie systems are typically encoded by phages or prophages and protect bacteria from secondary 
infections by the same or closely related phages. Membrane-associated proteins imm and sp were later 
characterized as responsible for Sie in T4 (Dulbecco, 1952; Lu and Henning, 1994). Imm inhibits DNA transfer 
across the cytoplasmic membrane and Sp inhibits local degradation of the murein layer by phage lysozyme (Lu 
and Henning, 1994).  
Restriction-Modification 
Bacterial Restriction-Modification (R-M) systems can provide protection from mobile genetic elements by 
degradation of foreign DNA. R-M systems are active against phage DNA but also strongly involved in the 
regulation of plasmid immigration, illustrated by the fact that R-M systems are over-represented in naturally 
competent organisms (Oliveira et al., 2014). This phenomenon was first discovered when Arber and Dussoix 
found that phage λ isolated from E. coli B strains could not infect E. coli K strains and vice versa (Kühnlein and 
Arber, 1972). This inability to infect was due to DNA restriction by EcoKI and EcoBI restriction systems 
respectively. Typically, R-M systems have enzymes responsible for recognition and cleavage of specific DNA 
sequences and a cognate methyltransferase that confers protection from cleavage by methylation of the same 
DNA sequence. Typically, specific DNA sequences of the host are methylated whereas invading DNA usually 
does not contain these methylation patterns. A multitude of DNA base modifications is known that allows hosts 
to distinguish between their own and phage DNA. The most prominent DNA modifications are nucleobase 
methylations of either adenine or cytosine.  
R-M systems can be divided into four different classes (Roberts et al., 2003). Type I R-M systems are 
characterized by a multisubunit protein complex that usually contains two restriction endonuclease (REase) 
subunits, two methyltransferase (MTase) subunits, and one specificity (S) subunit. The S subunit determines 
the DNA sequence that is recognized. When the recognized DNA sequence does not contain methylated 
adenosine bases (m6A) the REase subunits of the protein complex cleave the DNA in an ATP-dependent 
manner. When the recognized DNA sequence is hemimethylated, in which one of the strands is methylated, 
the MTase subunit uses S-adenosylmethionine (SAM) as methyl donor for methylation of the unmethylated 
strand. The best known example of a Type I R-M system is the EcoKI system in E. coli K-strains that recognizes 
the ACC(N6)GTGC sequence (Murray, 2000; Sain and Murray, 1980) 
Type II R-M systems are a widely diverse class subdivided into 11 subclasses (Roberts et al., 2003). REase 
subunits and MTase subunits function separately and recognize short palindromic sequences. A monomeric or 
homodimeric REase cleaves in or close to that sequence producing 5’-phosphates and 3’-hydroxyls. Type II R-
M enzymes, such as EcoRI, are commonly used in recombinant DNA technologies and more than 3500 REases 
have been characterized (Pingoud and Jeltsch, 2001; Roberts et al., 2015).  
Type III R-M systems are similar to Type I systems as they form a protein complex containing two REase subunits 
and two MTase subunits. Cleavage occurs when two inversely oriented copies of unmethylated recognition 
sequences are bound to the R-M complex (Meisel et al., 1992). Recognition sequences are typically 5-6 bp 
asymmetric, exemplified by the EcoP1 enzyme that recognizes AGACC, and cleavage only requires Mg2+ as a 
cofactor (Bickle and Kruger, 1993) 
Unlike other R-M systems that recognize methylated DNA as host DNA, Type IV R-M systems will only cleave 
bases that have been modified (Loenen and Raleigh, 2014). The first Type IV restriction enzymes characterized 
were rglA and rglB (restrict glucoseless) which were later renamed to McrA and McrBC (modified cytosine 
restriction). The structural organization of modification dependent systems (MDS) suggests that they have 
emerged multiple times independently of each other (Loenen and Raleigh, 2014). Sequence specificity is usually 
very low for Type IV restriction enzymes.  
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Anti-restriction systems 
In response to the selective pressure of R-M systems bacteriophages have developed several different 
mechanisms to subvert these defense systems (Tock and Dryden, 2005). One classic example of R-M diversion 
is the production of Ocr (overcome restriction) protein encoded by gene 0.3 of bacteriophage T7 (Walkinshaw 
et al., 2002). This anti-restriction protein contains a characteristic sequence of negatively charged Asp and Glu 
residues. Dimers of Ocr mimic approximately 24 base pairs of bent B-form DNA making it an efficient inhibitor 
of all known Type I R-M systems (Walkinshaw et al., 2002). The inhibitory activity of Ocr has been exploited to 
improve transformation efficiencies by blocking Type I R-M systems in various organisms by electroporation of 
Ocr proteins along with transforming DNA (Hoffman et al., 2002). Upon injection of the bacteriophage DNA it 
is directly vulnerable to attack by restriction enzymes. Therefore, in order to provide protection from restriction 
it is cardinal significance that anti-restriction proteins are synthesized directly after DNA injection. In the case 
of T7, the ocr gene is the first to be transcribed and translated (Atanasiu et al., 2001; Walkinshaw et al., 2002). 
To prevent belated protection by phage-encoded anti-restriction proteins that have to be transcribed and 
translated, anti-restriction proteins can also be co-injected with the phage DNA. Anti-restriction proteins DarA 
and DarB from bacteriophage P1 are packaged in the phage head and injected into the recipient cell along with 
the DNA and bind to restriction sites in the phage genome, protecting from attack by Type I R-M systems (Iida 
et al., 1987).  
Similar to the Ocr protein from T7, phage T4 also encodes a DNA mimicking protein; Arn (anti-restriction 
nuclease) (Goldberg and Dharmalingam, 1976, 1979). Besides binding to restriction enzyme McrBC, Arn also 
binds to bacterial histone-like protein H-NS. H-NS plays a regulatory role in host defense and by disruption of 
the H-NS-DNA binding Arn neutralizes the gene silencing effect of H-NS (Ho et al., 2014). The identification of 
this dual function of Arn may suggest that anti-restriction proteins play more important role in overcoming 
host defense systems than previously anticipated.  
Other mechanisms to overcome host defense systems include methylation of phage DNA, loss of restriction 
sites or by hiding restriction sites in a non-recognizable conformation. E .coli phage T3 evades the Type II-E 
restriction enzyme EcoRII by keeping copies of the pseudo-palindromic restriction sites genomically distant 
from each other (H.Kruger et al., 1979). Similarly, T7 evades EcoP15 by using inverse orientation of recognition 
sites (Meisel et al., 1992).  
BREX and DISARM 
Recently Sorek and colleagues have discovered two novel phage resistance systems that are widespread in 
microbial genomes (Goldfarb et al., 2015; Ofir et al., 2017). The Bacteriophage Exclusion (BREX) system is a 
novel system that allows phage adsorption but blocks phage DNA replication. Unlike R-M systems, BREX 
proteins do not cleave or degrade phage DNA. BREX systems are found in approximately 10% of all sequenced 
microbial genomes. The BREX system characterized in Bacillus cereus includes a methylase that methylates the 
non-palindromic 5’-TAGGAG-3’ sequence, providing bases of discrimination between self and non-self DNA. A 
putative Lon-like protease, a protein containing an alkaline phosphatase domain, a putative RNA- binding 
protein, and a protein containing an ATPase-domain, and a protein of unknown function together with the DNA 
methylase confer resistance to both virulent and temperate phages (Goldfarb et al., 2015). Interestingly, 
infection by several Lambda-like phages is not blocked by BREX. This could indicate that this phage family has 
evolved strategies to evade the BREX defense.  
The Defense Islands System Associated with Restriction-Modification (DISARM) system is yet another variation 
on the theme of inhibition of phage replication. DISARM systems are found in approximately 3% of all 
sequenced genomes. Similar to R-M systems, the DISARM system also prevents phage DNA replication by 
restriction but distinguishes itself from R-M systems by the multi-gene restriction-modification module. The 
DISARM system in Bacillus paralicheniformis 9945A includes a methylase that methylates the palindromic 
CCWGG sequence. A protein with a helicase domain, a protein with a DUF1998 domain, a protein with a 
catalytic nuclease PLD domain, and a protein of unknown function (Ofir et al., 2017). The DISARM system in B. 
paralicheniformis 9945A provides protection against diverse phages. 
CRISPR-Cas systems 
The anti-viral defense mechanisms described above are robust and generic systems but not adaptive. Clustered 
regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) systems were the first 
adaptive and heritable immunity systems found in prokaryotes. CRISPR-Cas systems provide prokaryotes with 
resistance against mobile genetic elements (MGEs), such as plasmids and bacteriophages (Barrangou et al., 
2007; Brouns et al., 2008; Marraffini and Sontheimer, 2008). CRISPR-Cas systems are found in most bacterial 
and almost all archaeal genomes (Westra et al., 2012). CRISPR-Cas systems can be classified into two classes, 
six types, and multiple subtypes (Makarova et al., 2015; Shmakov et al., 2017). The mechanisms of CRISPR-Cas 
interference differs among different classes, types, and sub-types.  
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Figure 3. Schematic overview of the three stages of the CRISRP-Cas type I-E system in E. coli. In the acquisition 
phase Cas1 and Cas2 are involved in the expansion of the CRISPR by addition of short fragments of foreign DNA. 
In the expression stage Cas genes are transcribed and translated and form CRISPR-Cas complexes. The CRISPR 
array is transcribed into long pre-crRNAs. Processing and loading of crRNAs result in the formation of crRNA-
guided CRISPR complexes. In the intereference stage previously encountered DNA is recognized and boudn by 
the crRNA-guided complexes. The nuclease Cas3 is recruited and degrades the foreign DNA.  
CRISPR-Cas systems function in three stages; adaptation, expression, and interference. In the adaptation 
process invader DNA sequences are incorporated into a CRISPR array. Incorporation is mediated by Cas1 and 
Cas2 which are conserved in most CRISPR-Cas systems (Koonin and Makarova, 2013). In the expression stage 
CRISPR arrays are transcribed into pre-crRNA (pre-CRISPR RNA) and further processed into crRNAs (CRISPR 
RNAs). In the interference stage CRISPR-Cas effector complexes loaded with crRNA bind their cognate foreign 
DNA targets (termed “protospacers”) when flanked by a protospacer-adjacent motif (PAM) (Barrangou; 
Marraffini and Sontheimer, 2010; Sorek et al., 2013; Wiedenheft et al., 2012) followed by degradation of target 
DNA.  
Escherichia coli K12 contains a type I-E CRISPR-Cas hallmarked by the Cascade crRNA-effector complex encoded 
by Cas8e, Cas11, Cas7, Cas5, and Cas6. The crRNA guides Cascade to dsDNA target sequences by forming base 
pairs with the complementary DNA strand. Binding affinity between crRNA-Cascade and target DNA is within 
the nanomolar range (Beloglazova et al., 2015). Target binding induces displacement of the noncomplementary 
strand to form an R-loop (Jore et al., 2011; Thomas et al., 1976). R-loop formation marks the target DNA for 
degradation by the CRISPR-associated helicase-nuclease Cas3. Cas3 degrades the DNA in a processive manner 
and hereby generating fragments of about 30-100 nucleotides (Kunne et al., 2016).  
New spacers from not previously encountered MGEs can be acquired in a process called naïve acquisition. The 
naïve acquisition process solely requires Cas1 and Cas2 for successful incorporation of new spacers in the 
CRISPR array. New spacers are usually inserted a the leader proximal end (Yosef et al., 2012). This feature of 
leader proximal insertion of new spacers provides a molecular chronological record of previously encountered 
MGEs. Interestingly, this attribute of the CRISPR array was recently used to lay the foundations of a multimodal 
intracellular recording device (Shipman et al., 2016).  
Invaders are capable of avoiding immunity by introduction of mutations that prevent recognition by the CRISPR-
Cas system. Mutated protospacers are often not capable of initiating direct interference; nevertheless, 
immunity can be restored due to a positive feedback mechanism termed priming (Datsenko et al., 2012; 
Savitskaya et al., 2013; Swarts et al., 2012). The priming process requires all CRISPR-Cas components for 
increased acquisition of spacers primed by a partially matching protospacer. Recent studies show that DNA 
degradation products produced by Cas3 are enriched for thymine-stretches in their 3’ ends. These degradation 
fragments form the ideal substrate for the Cas1-2 complex and are efficiently integrated in the CRISPR array 
(Kunne et al., 2016).  
Previous work by Fineran and colleagues revealed that direct interference tolerates mutations mostly at 
specific positions and can cope with a number of mutations in the non-seed region of the protospacer. The 
priming process is much more robust and can facilitate spacer acquisition of target containing up to 11 
mismatches (Fineran et al., 2014). Major findings by Fineran and colleagues include identification of new PAMs, 
determination of protospacer locations that promote priming. Further studies by Xue and colleagues showed 
that differences in CRISPR activity depend on PAM and seed sequences (Xue et al., 2015).  
Both the naïve and priming acquisition expand the spacer diversity within a population. As a result of this 
increased diversity, bacteriophages can no longer escape CRISPR-Cas interference by point mutations. Rapid 
acquisition of a highly diverse set of spacers constrains phage evolution and can even lead to phage extinction 
(Houte et al., 2016; Paez-Espino et al., 2015). This incredibly strong selection drives phages to adapt new 
strategies of CRISPR-Cas evasion. One of these strategies employed by phages infecting Streptococcus 
thermophilus is recombination-based formation of chimeric phages in which sequences targeted by spacers 
were replaced (Paez-Espino et al., 2015). The presence of multiple phages that infect the same host increases 
phage genome mosaicism and can prevent phage extinction. Increased rates of recombination events 
demonstrate that recombination is a mechanism that is specifically used by phages to escape CRISPR 
interference (Paez-Espino et al., 2015).  
General introduction and thesis outline
17
1
 
Figure 3. Schematic overview of the three stages of the CRISRP-Cas type I-E system in E. coli. In the acquisition 
phase Cas1 and Cas2 are involved in the expansion of the CRISPR by addition of short fragments of foreign DNA. 
In the expression stage Cas genes are transcribed and translated and form CRISPR-Cas complexes. The CRISPR 
array is transcribed into long pre-crRNAs. Processing and loading of crRNAs result in the formation of crRNA-
guided CRISPR complexes. In the intereference stage previously encountered DNA is recognized and boudn by 
the crRNA-guided complexes. The nuclease Cas3 is recruited and degrades the foreign DNA.  
CRISPR-Cas systems function in three stages; adaptation, expression, and interference. In the adaptation 
process invader DNA sequences are incorporated into a CRISPR array. Incorporation is mediated by Cas1 and 
Cas2 which are conserved in most CRISPR-Cas systems (Koonin and Makarova, 2013). In the expression stage 
CRISPR arrays are transcribed into pre-crRNA (pre-CRISPR RNA) and further processed into crRNAs (CRISPR 
RNAs). In the interference stage CRISPR-Cas effector complexes loaded with crRNA bind their cognate foreign 
DNA targets (termed “protospacers”) when flanked by a protospacer-adjacent motif (PAM) (Barrangou; 
Marraffini and Sontheimer, 2010; Sorek et al., 2013; Wiedenheft et al., 2012) followed by degradation of target 
DNA.  
Escherichia coli K12 contains a type I-E CRISPR-Cas hallmarked by the Cascade crRNA-effector complex encoded 
by Cas8e, Cas11, Cas7, Cas5, and Cas6. The crRNA guides Cascade to dsDNA target sequences by forming base 
pairs with the complementary DNA strand. Binding affinity between crRNA-Cascade and target DNA is within 
the nanomolar range (Beloglazova et al., 2015). Target binding induces displacement of the noncomplementary 
strand to form an R-loop (Jore et al., 2011; Thomas et al., 1976). R-loop formation marks the target DNA for 
degradation by the CRISPR-associated helicase-nuclease Cas3. Cas3 degrades the DNA in a processive manner 
and hereby generating fragments of about 30-100 nucleotides (Kunne et al., 2016).  
New spacers from not previously encountered MGEs can be acquired in a process called naïve acquisition. The 
naïve acquisition process solely requires Cas1 and Cas2 for successful incorporation of new spacers in the 
CRISPR array. New spacers are usually inserted a the leader proximal end (Yosef et al., 2012). This feature of 
leader proximal insertion of new spacers provides a molecular chronological record of previously encountered 
MGEs. Interestingly, this attribute of the CRISPR array was recently used to lay the foundations of a multimodal 
intracellular recording device (Shipman et al., 2016).  
Invaders are capable of avoiding immunity by introduction of mutations that prevent recognition by the CRISPR-
Cas system. Mutated protospacers are often not capable of initiating direct interference; nevertheless, 
immunity can be restored due to a positive feedback mechanism termed priming (Datsenko et al., 2012; 
Savitskaya et al., 2013; Swarts et al., 2012). The priming process requires all CRISPR-Cas components for 
increased acquisition of spacers primed by a partially matching protospacer. Recent studies show that DNA 
degradation products produced by Cas3 are enriched for thymine-stretches in their 3’ ends. These degradation 
fragments form the ideal substrate for the Cas1-2 complex and are efficiently integrated in the CRISPR array 
(Kunne et al., 2016).  
Previous work by Fineran and colleagues revealed that direct interference tolerates mutations mostly at 
specific positions and can cope with a number of mutations in the non-seed region of the protospacer. The 
priming process is much more robust and can facilitate spacer acquisition of target containing up to 11 
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Recently, several families of phage-encoded proteins that inhibit CRISPR-Cas systems have been identified 
(Bondy-Denomy et al., 2013; Pawluk et al., 2016a). These viral anti-CRISPR (Acr) proteins were discovered in 
lysogens of Pseudomonas aeroginosa strains containing a CRISPR-Cas Type I-F system when these systems 
appeared to be inactivated by small phage-encoded proteins. It was recently demonstrated that different 
families of Acrs exhibit distinct modes of inhibition (Bondy-Denomy et al., 2015). AcrF1 and AcrF2 bind to the 
Type I-F Csy complex thereby preventing crRNA binding or crRNA-DNA binding respectively. AcrF3 binds 
specifically to the Cas3 helicase-nuclease preventing DNA degradation, essentially converting AcrF3 into a gene 
regulator (Bondy-Denomy et al., 2015). Analogous to AcrF3 proteins, AcrIIC1-3 proteins encoded by mobile 
elements in Neisseria meningitidis bind to Cas9 thereby inhibiting target recognition of Cas9. These Acrs can 
potentially be used as ‘off-switch’ for genome editing by conditional control of Cas9 activity (Pawluk et al., 
2016b) ACR proteins AcrIIA1-4 encoded by Listeria monocytogenes prophages prevent Cas9 binding and can 
be used to regulate the genome engineering activity of Cas9 (Rauch et al., 2017). 
Abortive infection and Toxin-Antitoxin systems 
Abortive infection (Abi) systems block phage replication by altruistic death of the host cell. Most Abis have been 
found in Lactococcus lactis. Large scale milk fermentation by L. lactis is highly susceptible to phage infection 
involving economic consequences (Forde and Fitzgerald, 1999; Whitehead and Cox, 1935). Although the 
mechanism of many Abis remains unknown, the general theme involves activation of dormant enzymes which 
cleave essential components of the cellular translational apparatus. Protein synthesis is arrested by inactivation 
of the translational machinery and phage infections is aborted (Chopin et al., 2005). One of the best 
characterized examples of abortive infection is the cleavage of translation elongation factor Tu (EF-Tu) in 
Escherichia coli K12 strains. Transcription and translation of gol region of T4 infecting phage DNA activates 
proteolysis of EF-Tu by e14-encoded Lit protein. Cleavage of EF-Tu blocks translation and multiplication of the 
infecting phage (Georgiou et al., 1998) Mutations of the gol peptide partially overcome EF-Tu proteolysis.  
Lactococcus lactis strains that contain the abortive infection gene abiD1 prevent growth of phage bIL66 
(Bidnenko et al., 1995). Expression of abiD1 is tightly controlled but induced by phage-encoded Orf1 (Bidnenko 
et al., 2002). AbiD1 is proposed to decrease the activity of phage-encoded RuvC nuclease, a protein required 
for resolution of phage DNA structures (Bidnenko et al., 1995).  
Toxin-antitoxin (TA) systems are known to stabilize plasmids. TA systems act as a programmed cell death 
mechanism by post-segregational killing (Gerdes et al., 1985; Ogura and Hiraga, 1983). Typically, a plasmid 
encoded toxin and antitoxin are continuously produced. Antitoxins usually have a shorter half-life than their 
cognate toxin leading to addiction to the TA system. Cells that lose the plasmids during cell division will not 
survive because of the lack of the antitoxin .Although most TA systems identified have a role in plasmid 
maintenance, several systems have been shown to abort phage infection. Escherichia coli K38 strains contain 
the chromosomal addictive toxin-antitoxin module mazEF (Aizenman et al., 1996). Continuous production of 
the unstable MazE protein is required to inhibit the activity of MazF, a stable toxin that cleaves specific sites of 
translated mRNAs (Christensen et al., 2003) The mazEF module protects bacterial cultures against the spreads 
of P1 phages (Hazan and Engelberg-Kulka, 2004). Some TA systems to fulfill dual roles, a role in plasmid 
maintenance and a role in anti-viral defense. The hok (host killing) and sok (suppressor of killing) genes encoded 
on plasmid R1 in E. coli was first identified as a post-segregational killer system (Gerdes et al., 1990) but was 
later shown to exhibit inhibition of infection by phage T4 (Pecota and Wood, 1996). Short-lived Shok mRNA is 
antisense to Hok mRNA and prevents translation of Hok protein. Upon infection of T4, host mRNA production 
is halted, allowing translation of the more stable Hok mRNA. The gene product of hok is a membrane associated 
polypeptide that results in a loss of cell membrane potential followed by cessation of respiration leading to cell 
death (Gerdes et al., 1986). 
Modified DNA bases  
Nucleic acids are not boring long polymers of only four types of nucleotides (Grosjean, 2009). Until halfway the 
20th century, it was thought that nucleic acid polymers (DNA or RNA) only contain four canonical nucleosides: 
guanosine, adenosine, thymidine, and cytosine. The first report of modified nucleobases was published in 1925, 
when Johnson and Coghill detected small amounts of methylated cytosine in DNA of avian tubercule bacilli 
(Johnson and Coghill, 1925). A few decades later, N6-methyl adenine was detected in the DNA of E. coli 
although its function remained unknown (Dunn and Smith, 1958). Unlike methylation in prokaryotes, which is 
a post-replicative enzymatic process, pre-replicative modifications of bases was discovered in bacteriophages. 
Replacement of thymine by 5-hydroxymethyluracil was detected in the DNA of phages for Bacillus subtilis 
(Kallen et al., 1962). Since the discovery of modified DNA of phages, many other types of modifications have 
been found. The most common modifications are simple methylations of cytosine or adenine (Grosjean, 2009). 
Although less abundant, many exotic nucleobase modifications have been identified in bacteriophages and 
viruses (Gommers-Ampt and Borst, 1995; Warren, 1980). From biosynthesis to biological functions, modified 
bases have surprising features. It is well established that DNA modifications affect a wide range of biological 
processes. DNA modifications in prokaryotes are mainly used by R-M systems as a manner to distinguish 
between foreign or non-foreign DNA. Sinuously, bacteriophages use elaborate DNA modifications to evade 
prokaryotic defense mechanisms, such as R-M systems.  
DNA modifications in eukaryotes 
DNA modifications in eukaryotes play important roles in genetic regulations and have functions that vary from 
early development in embryonic cells to cellular maintenance pathways in adults. During cellular development 
the DNA methylation patterns change as a result of dynamic processes involving de novo methylation and 
demethylation. As a result, differentiated cells establish a unique and stable DNA methylation pattern that 
regulates tissue-specific gene transcription (Moore et al., 2013). 5-methylcytosine formation is catalyzed by a 
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Recently, several families of phage-encoded proteins that inhibit CRISPR-Cas systems have been identified 
(Bondy-Denomy et al., 2013; Pawluk et al., 2016a). These viral anti-CRISPR (Acr) proteins were discovered in 
lysogens of Pseudomonas aeroginosa strains containing a CRISPR-Cas Type I-F system when these systems 
appeared to be inactivated by small phage-encoded proteins. It was recently demonstrated that different 
families of Acrs exhibit distinct modes of inhibition (Bondy-Denomy et al., 2015). AcrF1 and AcrF2 bind to the 
Type I-F Csy complex thereby preventing crRNA binding or crRNA-DNA binding respectively. AcrF3 binds 
specifically to the Cas3 helicase-nuclease preventing DNA degradation, essentially converting AcrF3 into a gene 
regulator (Bondy-Denomy et al., 2015). Analogous to AcrF3 proteins, AcrIIC1-3 proteins encoded by mobile 
elements in Neisseria meningitidis bind to Cas9 thereby inhibiting target recognition of Cas9. These Acrs can 
potentially be used as ‘off-switch’ for genome editing by conditional control of Cas9 activity (Pawluk et al., 
2016b) ACR proteins AcrIIA1-4 encoded by Listeria monocytogenes prophages prevent Cas9 binding and can 
be used to regulate the genome engineering activity of Cas9 (Rauch et al., 2017). 
Abortive infection and Toxin-Antitoxin systems 
Abortive infection (Abi) systems block phage replication by altruistic death of the host cell. Most Abis have been 
found in Lactococcus lactis. Large scale milk fermentation by L. lactis is highly susceptible to phage infection 
involving economic consequences (Forde and Fitzgerald, 1999; Whitehead and Cox, 1935). Although the 
mechanism of many Abis remains unknown, the general theme involves activation of dormant enzymes which 
cleave essential components of the cellular translational apparatus. Protein synthesis is arrested by inactivation 
of the translational machinery and phage infections is aborted (Chopin et al., 2005). One of the best 
characterized examples of abortive infection is the cleavage of translation elongation factor Tu (EF-Tu) in 
Escherichia coli K12 strains. Transcription and translation of gol region of T4 infecting phage DNA activates 
proteolysis of EF-Tu by e14-encoded Lit protein. Cleavage of EF-Tu blocks translation and multiplication of the 
infecting phage (Georgiou et al., 1998) Mutations of the gol peptide partially overcome EF-Tu proteolysis.  
Lactococcus lactis strains that contain the abortive infection gene abiD1 prevent growth of phage bIL66 
(Bidnenko et al., 1995). Expression of abiD1 is tightly controlled but induced by phage-encoded Orf1 (Bidnenko 
et al., 2002). AbiD1 is proposed to decrease the activity of phage-encoded RuvC nuclease, a protein required 
for resolution of phage DNA structures (Bidnenko et al., 1995).  
Toxin-antitoxin (TA) systems are known to stabilize plasmids. TA systems act as a programmed cell death 
mechanism by post-segregational killing (Gerdes et al., 1985; Ogura and Hiraga, 1983). Typically, a plasmid 
encoded toxin and antitoxin are continuously produced. Antitoxins usually have a shorter half-life than their 
cognate toxin leading to addiction to the TA system. Cells that lose the plasmids during cell division will not 
survive because of the lack of the antitoxin .Although most TA systems identified have a role in plasmid 
maintenance, several systems have been shown to abort phage infection. Escherichia coli K38 strains contain 
the chromosomal addictive toxin-antitoxin module mazEF (Aizenman et al., 1996). Continuous production of 
the unstable MazE protein is required to inhibit the activity of MazF, a stable toxin that cleaves specific sites of 
translated mRNAs (Christensen et al., 2003) The mazEF module protects bacterial cultures against the spreads 
of P1 phages (Hazan and Engelberg-Kulka, 2004). Some TA systems to fulfill dual roles, a role in plasmid 
maintenance and a role in anti-viral defense. The hok (host killing) and sok (suppressor of killing) genes encoded 
on plasmid R1 in E. coli was first identified as a post-segregational killer system (Gerdes et al., 1990) but was 
later shown to exhibit inhibition of infection by phage T4 (Pecota and Wood, 1996). Short-lived Shok mRNA is 
antisense to Hok mRNA and prevents translation of Hok protein. Upon infection of T4, host mRNA production 
is halted, allowing translation of the more stable Hok mRNA. The gene product of hok is a membrane associated 
polypeptide that results in a loss of cell membrane potential followed by cessation of respiration leading to cell 
death (Gerdes et al., 1986). 
Modified DNA bases  
Nucleic acids are not boring long polymers of only four types of nucleotides (Grosjean, 2009). Until halfway the 
20th century, it was thought that nucleic acid polymers (DNA or RNA) only contain four canonical nucleosides: 
guanosine, adenosine, thymidine, and cytosine. The first report of modified nucleobases was published in 1925, 
when Johnson and Coghill detected small amounts of methylated cytosine in DNA of avian tubercule bacilli 
(Johnson and Coghill, 1925). A few decades later, N6-methyl adenine was detected in the DNA of E. coli 
although its function remained unknown (Dunn and Smith, 1958). Unlike methylation in prokaryotes, which is 
a post-replicative enzymatic process, pre-replicative modifications of bases was discovered in bacteriophages. 
Replacement of thymine by 5-hydroxymethyluracil was detected in the DNA of phages for Bacillus subtilis 
(Kallen et al., 1962). Since the discovery of modified DNA of phages, many other types of modifications have 
been found. The most common modifications are simple methylations of cytosine or adenine (Grosjean, 2009). 
Although less abundant, many exotic nucleobase modifications have been identified in bacteriophages and 
viruses (Gommers-Ampt and Borst, 1995; Warren, 1980). From biosynthesis to biological functions, modified 
bases have surprising features. It is well established that DNA modifications affect a wide range of biological 
processes. DNA modifications in prokaryotes are mainly used by R-M systems as a manner to distinguish 
between foreign or non-foreign DNA. Sinuously, bacteriophages use elaborate DNA modifications to evade 
prokaryotic defense mechanisms, such as R-M systems.  
DNA modifications in eukaryotes 
DNA modifications in eukaryotes play important roles in genetic regulations and have functions that vary from 
early development in embryonic cells to cellular maintenance pathways in adults. During cellular development 
the DNA methylation patterns change as a result of dynamic processes involving de novo methylation and 
demethylation. As a result, differentiated cells establish a unique and stable DNA methylation pattern that 
regulates tissue-specific gene transcription (Moore et al., 2013). 5-methylcytosine formation is catalyzed by a 
Chapter 1
20
family of DNA methyl transferases (DNMTs) that transfer a methyl group from S-adenyl methionine to the fifth 
carbon of cytosine in a post-replicative process and is regarded as a stable, highly heritable mark. Methylation 
of cytosines predominantly occurs in the dinucleotide CpG, often localized in so-called CpG islands, and is used 
as a transcriptional silencing mechanism (Bonasio et al., 2010; Jones, 2001). Differences in gene expression are 
highly correlated with alteration in the epigenetic landscape. The dynamic nature of methylation patterns is 
realized by both active methylation and demethylation however no enzymes are known that can cleave a 
methyl group from 5-mC. The recent discovery of 5-hydroxymethylcytosine (5-hmC) in eukaryotes has led to 
the hypothesis that 5-hmC serves as an intermediate in the demethylation of 5mC in a pathway that involves 
further oxidation from 5-hmC to 5-formylcytosine (5fC) and 5-carboxylcytosine (5-caC) (Branco et al., 2011). 
Oxidation of 5mC to 5-hmC is catalyzed by ten-eleven translocation (Tet) enzymes (Tahiliani et al., 2009). 5-
hmC can be further oxidized to 5fC and then to 5caC by Tet enzymes or alternatively 5-hmC can be deaminated 
by activation-induced cytidine deaminase (AID)/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-
like (APOBEC) enzyme complexes to 5-hydroxymethyluracil (5-hmU) (Guo et al., 2011). Resulting modified 
residues can be cleaved off by thymine DNA glycosylase (TDG) in the base excision repair (BER) pathway 
(Cortellino et al., 2011; He et al., 2011). Efforts to quantify the levels of 5-hmC have resulted in several 
extremely sensitive methods to detect low levels in various tissues (Chen et al., 2017; Shahal et al., 2014; Yuan 
et al., 2016). It is not fully understood whether 5-hmC merely acts as an intermediate in demethylation 
pathways or has a distinct regulatory role but its importance in epigenetics made 5-hmC to be considered as 
the sixth base in higher eukaryotes (Münzel et al., 2011).  
DNA modifications in prokaryotes 
Modified bases were first identified in the DNA of bacteria and for a few decades the only known functional 
roles were in host defense against bacteriophages. Later additional roles of DNA methylation were identified 
when inactivation of the methyl-directed mismatch repair system in E. coli was shown to cause a strong 
mutator phenotype (Modrich and Lahue, 1996). Multiple adenine methylation-dependent regulatory systems 
were later identified in various bacterial species(Casadesus and Low, 2006; Wion and Casadesús, 2006). 
Extensive analysis of the genomes of 230 diverse bacterial and archaeal species revealed that DNA methylation 
is observed in 93% of analyzed genomes but strikingly 48% of organisms harbor active MTases with no apparent 
cognate restriction enzyme (Blow et al., 2016). Interestingly, these ‘orphan’ MTase are more strictly conserved 
across prokaryotic phyla than R-M system-associated MTases (Blow et al., 2016). A well-studied example of an 
orphan MTase that plays an essential role in regulating epigenetic circuits is the DNA adenine methylase (Dam) 
in E. coli. Dam moves along the genomic DNA by linear diffusion and specifically methylates 5’-GATC-3’ 
sequences by transferring a methyl group to the exocyclic N6 nitrogen of adenine (Urig et al., 2002). 5’-GATC-
3’ sequences that are methylated on both strands are converted into two hemimethylated DNA duplexes after 
DNA replication which provides a signal that DNA replication just has occurred and plays a role in diverse cellular 
processes (Casadesus and Low, 2006; Marinus and Casadesus, 2009). It has remained unknown how common 
methylation-associated regulatory pathways are and also it is unknown if R-M-associated methylases can play 
a regulatory role.  
DNA modifications in bacteriophages 
Modifications of nucleobases are not only found in eukaryotes but also in prokaryotes and their viruses. While 
the functional roles of DNA modifications in eukaryotes is mostly attributed to genetic regulation, DNA 
modifications in prokaryotes and viruses are primarily related to processes the differentiate DNA between self 
and non-self. One well-studied DNA modification is β-glucosyl-5-hydroxymethylcytosine (5ghmC), a base 
modification that is found in T4. T-even bacteriophages were instrumental in the first formulations of many 
fundamental biological concepts, however early efforts to clone T4 genes were largely thwarted by the inability 
of most restriction endonucleases to cleave 5-ghmC containing DNA (Miller et al., 2003). T4 mutants that 
contain cytosine instead of 5-ghmC were constructed (Snyder et al., 1976)which allowed the construction of 
an detailed restriction map of T4 and further advancing of the field of molecular biology (Carlson and 
Nicolaisen, 1979; Snyder et al., 1976). Already in the 1950s it was discovered that T4 degrades the host genome 
and shuttles free dCTP though a protein complex that produces 5-hydroxymethyl-deoxycytidine triphosphate 
(5-hmdCTP). This complex, named dNTP synthesis complex (DSC) consists of at least 8 phage encoded proteins 
and 2 host encoded proteins. 5-hmdCTP is used by the DNA polymerase and other proteins involved in DNA 
synthesis and is further glucosylated by T4 glucosyltransferases. Approximately 30% of 5-hmC is glucosylated 
by α-glucosyltransferases and the remaining 70% is glucosylated by β-glucosyltransferases. Interestingly, 
glucosylation seems to be not completely sequence independent and α-glucosylation is hindered by 
neighboring 5-hmC residues (de Waard et al., 1967). Although glucosylation is a post-replicative process, it is 
shown to be tightly coupled to replication (McNicol and Goldberg, 1973).  
Substitution of thymine by 5-hydroxymethyluracil (5hmU) is found in phage φe of Bacillus subtilis (Warren, 
1980). Like 5-hmC synthesis in T4, the route of biosynthesis of 5hmU in φe ensures the exclusion of thymine 
from the DNA. Unlike T4, φe does not degrade the host DNA in order to shuttle breakdown products to 5hmU, 
meaning that deoxyribonucleotides in φe DNA are synthesized purely de novo. To limit incorporation of 
thymine in the DNA, Φe encodes a protein inhibitor of the host thymidylate synthase to channel dUMP towards 
5hmdUMP, which is further phosphorylated to 5hmdUTP (Roscoe and Tucker, 1966). Substitution of thymine 
by 5-hmU confers resistance to the restriction enzymes produced by the bacterial host (Samson et al., 2013).  
Some bacteriophages that substitute nucleobases by modified bases further modify them through secondary 
modification, a feature commonly referred to as hypermodification. One example of a bacteriophage with 
hypermodified DNA is Bacillus subtilis phage SP10 in which 15-20 % of thymine is substituted by α-
glutamylthymine (Gommers-Ampt and Borst, 1995; Witmer and Wiatr, 1985). Upon infection by SP10, host 
thymidylate synthase activity is reduced by 70% and is replaced by deoxyuridylate hydroxymethyltransferase 
activity followed by incorporation of 5-hmU in the DNA (Witmer and Dosmar, 1978). In a presumably post-
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mutator phenotype (Modrich and Lahue, 1996). Multiple adenine methylation-dependent regulatory systems 
were later identified in various bacterial species(Casadesus and Low, 2006; Wion and Casadesús, 2006). 
Extensive analysis of the genomes of 230 diverse bacterial and archaeal species revealed that DNA methylation 
is observed in 93% of analyzed genomes but strikingly 48% of organisms harbor active MTases with no apparent 
cognate restriction enzyme (Blow et al., 2016). Interestingly, these ‘orphan’ MTase are more strictly conserved 
across prokaryotic phyla than R-M system-associated MTases (Blow et al., 2016). A well-studied example of an 
orphan MTase that plays an essential role in regulating epigenetic circuits is the DNA adenine methylase (Dam) 
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3’ sequences that are methylated on both strands are converted into two hemimethylated DNA duplexes after 
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(5-hmdCTP). This complex, named dNTP synthesis complex (DSC) consists of at least 8 phage encoded proteins 
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synthesis and is further glucosylated by T4 glucosyltransferases. Approximately 30% of 5-hmC is glucosylated 
by α-glucosyltransferases and the remaining 70% is glucosylated by β-glucosyltransferases. Interestingly, 
glucosylation seems to be not completely sequence independent and α-glucosylation is hindered by 
neighboring 5-hmC residues (de Waard et al., 1967). Although glucosylation is a post-replicative process, it is 
shown to be tightly coupled to replication (McNicol and Goldberg, 1973).  
Substitution of thymine by 5-hydroxymethyluracil (5hmU) is found in phage φe of Bacillus subtilis (Warren, 
1980). Like 5-hmC synthesis in T4, the route of biosynthesis of 5hmU in φe ensures the exclusion of thymine 
from the DNA. Unlike T4, φe does not degrade the host DNA in order to shuttle breakdown products to 5hmU, 
meaning that deoxyribonucleotides in φe DNA are synthesized purely de novo. To limit incorporation of 
thymine in the DNA, Φe encodes a protein inhibitor of the host thymidylate synthase to channel dUMP towards 
5hmdUMP, which is further phosphorylated to 5hmdUTP (Roscoe and Tucker, 1966). Substitution of thymine 
by 5-hmU confers resistance to the restriction enzymes produced by the bacterial host (Samson et al., 2013).  
Some bacteriophages that substitute nucleobases by modified bases further modify them through secondary 
modification, a feature commonly referred to as hypermodification. One example of a bacteriophage with 
hypermodified DNA is Bacillus subtilis phage SP10 in which 15-20 % of thymine is substituted by α-
glutamylthymine (Gommers-Ampt and Borst, 1995; Witmer and Wiatr, 1985). Upon infection by SP10, host 
thymidylate synthase activity is reduced by 70% and is replaced by deoxyuridylate hydroxymethyltransferase 
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replicative process 5hmU is further modified to α-glutamylthymine. In Delftia acidovorans phage ɸW14, 
thymine is for 50% substituted by the hypermodified base 5-(4-aminobutylaminomethyl)uracil, also called α-
putrescinylthymine (Miller et al., 1983, 1985) 
 
Figure 4. Modified bases of bacteriophages. Modifications are highlighted.  
Roles of DNA modifications in bacteriophage DNA 
The primary role of DNA modifications of bacteriophage DNA is to escape anti-viral defense systems in their 
hosts. Base modifications in virulent phages can serve two purposes. Firstly, base modifications prevent site 
specific recognition of DNA by restriction enzymes, thereby preventing cleavage. Secondly, base modifications 
serve to protect from phage-encoded nucleases that attack the unmodified host DNA. T4 encodes nucleases 
EndoII and EndoIV (gene product of denA and denB) that initiated degradation of cytosine-containing host DNA. 
EndoII is a sequence specific endonuclease that restricts 5’-CCGC-3’ motifs by sequential nicking of both bottom 
and top-strands (Carlson and Kosturko, 1999). DNA fragments are further degraded to single nucleotides by 3’-
5’ exonuclease DexA and shuttled to the DSC (Warner et al., 1972). Not all bacteriophages that degrade host 
DNA protect their own DNA using base modifications: E. coli phages T5, T7, and L. lactis phage c6A all degrade 
host DNA but do not contain base modifications (Mitsunobu et al., 2014; Powell et al., 1992; Warner et al., 
1975).  
Beside the roles of DNA modifications in the arms race between prokaryotes and their viruses, base 
modifications also play key roles in packaging of DNA into the viral capsid. The hypermodified bases in the DNA 
of Delftia acidovorans phage ɸW14 facilitate the exceptionally high density of packaged DNA in the capsid 
(Benbasat, 1984). The hypermodified bases (α-putrescinylthymine) exhibit a decreased linear charge density 
compared to B-form DNA, resulting in compression of the DNA double helix. By increasing the packable length, 
ɸW14 base modifications allow more information to be carried on the genome. Besides influencing packaged 
DNA densities base modifications can have a role in the initiation of DNA packaging. Packaging of E. coli phage 
P1 is initiated after cleavage of the phage packaging site (pac) (Sternberg and Coulby, 1987). Cleavage of 
unmethylated pac is blocked and stalls initiation of DNA packaging and shows that the phage life cycle is 
regulated by base modifications (Sternberg and Coulby, 1988).  
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Single Molecule Localization Microscopy 
Microscopy has provided the biological sciences with many insights in the inner workings of living organisms. 
From the time that Antoni van Leeuwenhoek and Robert Hooke started using a single lens to study simple 
biological samples, to current state of the art microscopy techniques, the field of microscopy has seen large 
progression. Most notable was the development of fluorescence microscopy. Already in 1852, Stokes 
discovered that substance specific fluorescence could be used to identify compounds (Stokes, 1852). This 
molecular feature could be captured using the first fluorescence microscopes, developed by Carl Zeiss in the 
20th century. Not all biological components of interest have fluorescent properties. For this reason, biological 
substances, such as proteins and DNA, are often labeled with specific fluorophores. Intracellular distribution, 
and the biological processes in which they are involved, of fluorescently labeled molecules can be studied.  
Förster resonance energy transfer 
 
Figure 5. Energy transitions of FRET pairs. Excitation light can cause transition of a donor from the non-
fluorescent ground state into an excited state. The excited donor can return to the ground state by either 
fluorescent emmission or by resonance energy transfer to the acceptor molecule.  
Förster resonance energy transfer (FRET) is a technique to measure distances between two fluorescent 
molecules. A donor fluorophore that is excited by laser light may transfer its excitation energy to a nearby 
acceptor fluorophore in a non-radiative fashion. Non-radiative energy transfer occurs through long-range 
dipole-dipole interactions (Förster, 1959). Energy transfer decreases the lifetime of the excited state of the 
donor fluorophore but increases the fluorescence intensity of the donor fluorophore. The efficiency of this 
transfer (FRET efficiency) is dependent on the distance between the donor and acceptor fluorophores. FRET is 
a useful tool in molecular biology  and provides an ideal probe of inter- and intramolecular distances in a range 
of 10-100Å. Conventional FRET measurements involve high concentrations of donor and acceptor pairs, 
resulting in average values in which it is difficult to distinguish subpopulations. Recent developments in single 
molecule FRET (smFRET) have made it possible to single fluorophores under biological relevant conditions (Ha, 
2001). Usually, molecules of interest are immobilized on a surface and acquired trajectories are analyzed using 
high throughput data analysis software (Rahul et al., 2008). smFRET can thus be used to resolve heterogeneous 
populations providing association and dissociation kinetics on binding constants.  
PALM and STORM 
Technical advances have greatly increased the resolution of microscopy images. However, achievable 
resolutions are limited by the diffraction limit (also called Abbe-limit) of the imaging light. Because of this 
diffraction limit, molecules with an inter-particle distance of less than 250 nm cannot be differentiated and 
thus are observed as one. The diffraction limit was considered an unbreakable rule for more than a century. In 
1994, Hell and Wichmann introduced the stimulated emission depletion (STED) technique (Hell and Wichmann, 
1994). By stimulating a small spot on the surface of a sample and depleting everything around that spot, Hell 
was able to excite individual fluorophores 65 nm apart from each other, thereby overcoming the diffraction 
limit. Similar techniques providing an even higher resolution, such as photo activated localization microscopy 
(PALM) and stochastic optical reconstruction microscopy (STORM) were later developed (Hess et al., 2006; Rust 
et al., 2006). Both PALM and STORM techniques use the particular ability of some fluorescent molecules to 
switch between a fluorescent ‘’on-state’’ and dark ‘’off-state’’. Fluorophores reside in a non-fluorescent dark 
state and can be stochastically activated using low intensity laser light. During that excitation, the molecule has 
a certain probability to switch back into the dark state or bleach, thereby losing its ability to fluoresce. 
Fluorophores in the dark state can be recovered to its ground state using short wavelength light. Photons 
emitted during the fluorescent phase are observed with a camera and a super resolution image can be fitted. 
STORM originally made use of fluorophore pairs but improvements enabled to directly switch only the 
fluorophore of interest (van de Linde et al., 2011). Later improvements involved alterations of the switching 
properties of dyes by changing the concentrations of reducing compounds and oxygen in the solution and 
thereby reducing the number of visible molecules, a technique called direct STORM (dSTORM) (Ehmann et al., 
2014) Figure 6. PALM techniques use a similar imaging procedure as STORM, but instead of photo-switchable 
dyes they use photo-switchable proteins (Betzig et al., 2006; Hess et al., 2006).  
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20th century. Not all biological components of interest have fluorescent properties. For this reason, biological 
substances, such as proteins and DNA, are often labeled with specific fluorophores. Intracellular distribution, 
and the biological processes in which they are involved, of fluorescently labeled molecules can be studied.  
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Figure 5. Energy transitions of FRET pairs. Excitation light can cause transition of a donor from the non-
fluorescent ground state into an excited state. The excited donor can return to the ground state by either 
fluorescent emmission or by resonance energy transfer to the acceptor molecule.  
Förster resonance energy transfer (FRET) is a technique to measure distances between two fluorescent 
molecules. A donor fluorophore that is excited by laser light may transfer its excitation energy to a nearby 
acceptor fluorophore in a non-radiative fashion. Non-radiative energy transfer occurs through long-range 
dipole-dipole interactions (Förster, 1959). Energy transfer decreases the lifetime of the excited state of the 
donor fluorophore but increases the fluorescence intensity of the donor fluorophore. The efficiency of this 
transfer (FRET efficiency) is dependent on the distance between the donor and acceptor fluorophores. FRET is 
a useful tool in molecular biology  and provides an ideal probe of inter- and intramolecular distances in a range 
of 10-100Å. Conventional FRET measurements involve high concentrations of donor and acceptor pairs, 
resulting in average values in which it is difficult to distinguish subpopulations. Recent developments in single 
molecule FRET (smFRET) have made it possible to single fluorophores under biological relevant conditions (Ha, 
2001). Usually, molecules of interest are immobilized on a surface and acquired trajectories are analyzed using 
high throughput data analysis software (Rahul et al., 2008). smFRET can thus be used to resolve heterogeneous 
populations providing association and dissociation kinetics on binding constants.  
PALM and STORM 
Technical advances have greatly increased the resolution of microscopy images. However, achievable 
resolutions are limited by the diffraction limit (also called Abbe-limit) of the imaging light. Because of this 
diffraction limit, molecules with an inter-particle distance of less than 250 nm cannot be differentiated and 
thus are observed as one. The diffraction limit was considered an unbreakable rule for more than a century. In 
1994, Hell and Wichmann introduced the stimulated emission depletion (STED) technique (Hell and Wichmann, 
1994). By stimulating a small spot on the surface of a sample and depleting everything around that spot, Hell 
was able to excite individual fluorophores 65 nm apart from each other, thereby overcoming the diffraction 
limit. Similar techniques providing an even higher resolution, such as photo activated localization microscopy 
(PALM) and stochastic optical reconstruction microscopy (STORM) were later developed (Hess et al., 2006; Rust 
et al., 2006). Both PALM and STORM techniques use the particular ability of some fluorescent molecules to 
switch between a fluorescent ‘’on-state’’ and dark ‘’off-state’’. Fluorophores reside in a non-fluorescent dark 
state and can be stochastically activated using low intensity laser light. During that excitation, the molecule has 
a certain probability to switch back into the dark state or bleach, thereby losing its ability to fluoresce. 
Fluorophores in the dark state can be recovered to its ground state using short wavelength light. Photons 
emitted during the fluorescent phase are observed with a camera and a super resolution image can be fitted. 
STORM originally made use of fluorophore pairs but improvements enabled to directly switch only the 
fluorophore of interest (van de Linde et al., 2011). Later improvements involved alterations of the switching 
properties of dyes by changing the concentrations of reducing compounds and oxygen in the solution and 
thereby reducing the number of visible molecules, a technique called direct STORM (dSTORM) (Ehmann et al., 
2014) Figure 6. PALM techniques use a similar imaging procedure as STORM, but instead of photo-switchable 
dyes they use photo-switchable proteins (Betzig et al., 2006; Hess et al., 2006).  
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Figure 6. The dSTORM concept. (van de Linde et al., 2011) 
Single molecule localization microscopy (SMLM) provides incredible possibilities to study in vivo behavior of 
proteins and other cellular components. Next to information on diffusion, single-particle tracking reveals 
cellular localization patterns that cannot be identified using conventional microscopy and can reconcile 
molecular models with seemingly contradictory observations. For example, single-particle tracking of ribosomal 
subunits indicated that free subunit precursors are not excluded from the E. coli nucleoid, allowing for direct 
translation after transcription. This finding allowed reconciliation of the requirements of several gene-
regulation mechanisms with previous observations that ribosomes are excluded from the nucleoid (Sanamrad 
et al., 2014). The unique opportunities of SMLM to provide insights in protein stoichiometry and spatial 
relations at a nanoscopic resolution have also been harnessed to study the molecular mechanisms of CRISPR-
Cas systems. In a study on DNA targeting by crRNA-Cas9 complexes, proteins labeled with Q-dots were 
observed to find their target by a three-dimensional diffusion binding mechanism (Sternberg et al., 2014).  
 
  
Thesis Outline 
This thesis is about the interaction of bacteriophages and their hosts and aims to explore mechanistic details 
of host defense by CRISPR-Cas systems. The described studies address questions concerning physical 
phenomena of target search and binding by CRISPR complexes. Besides exploring the surveillance behavior of 
CRISPR-Cas components we investigated defense evasion mechanisms employed by bacteriophages. We found 
opportunity to exploit one of the discovered features of defense evasion and developed a widely customizable 
method for labeling macromolecular DNA.  
In chapter 2 we describe the mechanism of probing for targets by the Cascade complex in E. coli. The CRISPR-
Cas type I-E system in E. coli encodes several Cas proteins of which five different proteins for a surveillance 
complex that binds target DNA based on complementarity with its crRNA. Using single molecule FRET binding, 
events of bona fide targets and mutated targets were visualized. We characterized the binding modes by 
analysis of FRET states and binding times. We developed a model explaining that the binding mode of Cascade 
leads to different functional outcomes. 
In chapter 3 we provide a perspective of target search by crRNA-effector complexes in a cellular environment. 
We describe how we have used single-particle tracking methods to analyze the surveillance behavior of CRISPR 
complexes and give insight in how these systems are able to provide protection from invaders in molecular 
crowded cellular environments. We show that these complexes are obligate ribonucleoprotein complexes that 
spend their time scanning the host nucleoid for PAM sites. Surprisingly, we found that type I-E Cascade 
complexes expel the large Cas8e subunit when encountering CRISPR arrays in order to avoid self-targeting, 
while type I-F Cascade complexes are oblivious to CRISPR arrays.  
As described in the introduction, bacteriophages have developed diverse strategies to escape bacterial defense 
systems of which the production of anti-CRISPR proteins is one example. In an effort to identify novel anti-
CRISPR proteins we isolated a number of E. coli phages and screened them for anti-CRISPR activity. In chapter 
4 we describe the isolation and genome sequencing of one of the screened phages, phage Ayreon. Even though 
anti-CRISPR activity could not be confirmed, the characterization of phage Ayreon is a valuable addition to the 
body of knowledge about bacteriophage biology.  
In order to broaden our search for escape strategies employed by bacteriophages we investigated the effect 
of bacteriophage DNA modifications on CRISPR-Cas interference. In chapter 5 we show that glucosyl-5-
hydroxymethylation of cytosine in the DNA of T4 inhibits interference by both type I-E and type II-A CRISPR 
systems. CRISPR-Cas interference of a type V system is not affected by glucosyl-5-hydroxymethylation of DNA. 
Our results suggest that CRISPR-Cas systems have contributed to the selective pressure on phages to develop 
more generic solutions to escape sequence specific host defense systems. 
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The finding that glucosyl-5-hydroxymethylcytosine inhibits CRISPR-Cas interference raised the question if this 
feature could be used for analytical or biotechnological purposes. In chapter 6 we demonstrate that 
introduction of several T4 genes into E. coli results in synthesis of modified DNA. We show that modified 
plasmid DNA can be specifically labeled with groups of interest, such as fluorophores. We demonstrate that 
single particle tracking of plasmid DNA can be used to study plasmid uptake and stability after transformation. 
We demonstrate that this method can be used to identify bottlenecks in efforts of genetic transformation of 
bacterial species 
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Chapter 2
Abstract 
Small RNA-guided protein complexes play an essential role in CRISPR-mediated immunity in prokaryotes. While 
these complexes initiate interference by flagging cognate invader DNA for destruction, recent evidence has 
implicated their involvement in new CRISPR memory formation, called priming, against mutated invader 
sequences. The mechanism by which the target recognition complex mediates these disparate responses—
interference and priming—remains poorly understood. Using single-molecule FRET, we visualize how bona fide 
and mutated targets are differentially probed by E. coli Cascade. We observe that the recognition of bona fide 
targets is an ordered process that is tightly controlled for high fidelity. Mutated targets are recognized with low 
fidelity, which is featured by short-lived and PAM- and seed-independent binding by any segment of the crRNA. 
These dual roles of Cascade in immunity with distinct fidelities underpin CRISPR- Cas robustness, allowing for 
efficient degradation of bona fide targets and priming of mutated DNA targets 
  
Introduction 
Clustered regularly interspaced short palindromic repeat (CRISPR) loci are widely spread throughout 
prokaryotic genomes and provide an inheritable RNA-guided adaptive immune system against bacteriophages 
and mobile genetic elements (Barrangou and Van der Oost, 2013; Charpentier and Marraffini, 2014; Fineran 
and Charpentier, 2012; Reeks et al., 2013; Samson et al., 2013; Sorek et al., 2013; Westra et al., 2014) In 
response to invading phages or mobile genetic elements, CRISPR-associated (Cas) proteins integrate small 
fragments of foreign DNA into the CRISPR array, which are subsequently processed into mature CRISPR RNAs 
(crRNAs). crRNAs form a complex with one Cas protein (Cas9 from type II) or multiple Cas proteins (types I and 
III), which utilizes the crRNA as a guide to trigger degradation of cognate invading nucleic acids. While it is DNA 
that is targeted in types I and II (van der Oost et al., 2014), recent studies suggest that both DNA and RNA are 
targeted in type III (Goldberg et al., 2014; Hale et al., 2014; Rouillon et al., 2013; Staals et al., 2013; Tamulaitis 
et al., 2014). Among the target recognition complexes, Cas9 has been widely applied as a versatile tool for 
genome engineering in a broad spectrum of organisms (Hsu et al., 2014; Terns and Terns, 2014). In the CRISPR-
Cas/I-E system of Escherichia coli, mature crRNAs are incorporated into CRISPR-associated complex for antiviral 
defense (Cascade), an 11-subunit complex comprised of five different Cas proteins (Cse11, Cse22, Cas76, 
Cas51, and Cas61)(Jore et al., 2011)(Figure 1A). In the CRISPR interference pathway, Cascade generates an R-
loop between the crRNA and its double-stranded DNA (dsDNA) target (protospacer), which subsequently leads 
to target degradation by the nuclease-helicase Cas3 (Mulepati and Bailey, 2013; Sinkunas et al., 2013; Westra 
et al., 2012a). The first 8 nt (with exception of the sixth nucleotide) of the protospacer, or ‘‘seed’’ region, must 
be a perfect match for efficient R-loop formation (Künne et al., 2014). Additionally, R-loop formation requires 
an immediately neighboring trinucleotide protospacer adjacent motif (PAM). This conserved PAM sequence at 
the seed end of the proto- spacer is recognized by the Cse1 subunit and is essential for the discrimination 
between targets and non-targets (Sashital et al., 2012; Westra et al., 2013). The mechanism by which Cascade 
finds its target among the vast amount of DNA in the cell remains elusive. It has been hypothesized that Cascade 
transiently associates with PAM sequences, interrogating neighboring sequences for a complementary seed, 
followed by directional R-loop formation (Künne et al., 2014). A recent single-molecule study has visualized the 
transient interactions of Cas9 with PAM-rich sequences in real time (Sternberg et al., 2014). Another study with 
Cascade and Cas9 has shown directional R-loop formation and how PAM and protospacer complementarity 
influences its stability (Szczelkun et al., 2014). However, it is yet to be shown how the stepwise interaction 
between PAM, seed, and protospacer is coordinated and how off-targeting is avoided during target recognition. 
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Abstract 
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sequences. The mechanism by which the target recognition complex mediates these disparate responses—
interference and priming—remains poorly understood. Using single-molecule FRET, we visualize how bona fide 
and mutated targets are differentially probed by E. coli Cascade. We observe that the recognition of bona fide 
targets is an ordered process that is tightly controlled for high fidelity. Mutated targets are recognized with low 
fidelity, which is featured by short-lived and PAM- and seed-independent binding by any segment of the crRNA. 
These dual roles of Cascade in immunity with distinct fidelities underpin CRISPR- Cas robustness, allowing for 
efficient degradation of bona fide targets and priming of mutated DNA targets 
  
Introduction 
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Figure 1. Two Binding Modes of Cascade Revealed by a Single-Molecule FRET Assay. (A) Schematic of a single-
molecule FRET experiment used to monitor binding of Cascade to target DNA substrates. (B) The bona fide 
target construct consists of a 15 bp flank (black), a PAM(orange), and a protospacer (green), with its seed 
highlighted in blue. Cy7 (red star) was attached to position +9 of the target strand and Cy3 (green star) to 
position +17 of the nontarget strand. (C) A representative time trace of donor (Cy3, green) and acceptor (Cy7, 
red) fluorescence and corresponding FRET (blue) exhibiting the long-lived binding of the bona fide target. High 
FRET (~0.84, named EI for FRET efficiency of an intermediate state) exhibited upon binding is followed by low 
FRET (~0.44, named EO for FRET efficiency of an open state). DNA was added at time = 10 s. (D) A representative 
time trace exhibiting the short-lived binding of the bona fide target exhibits two FRET states (EO~0.44 and 
EC~0.65; EC is for FRET efficiency of a closed state). The duration of each state is measured as the dwell time 
(Δτ). DNA was added at time = 10 s. (E) The FRET distribution of the bona fide target DNA alone (light blue) or 
after equilibration with immobilized Cascade (purple) with peaks at EC (0.65) and EO (0.44), respectively (derived 
from Gaussian fit, black line). Data were obtained from five fields of view each. (F) A histogram of the initial 
FRET upon binding (average of first 1.5 s of each event) of the bona fide target exhibits three peaks at FRET = 
EO (0.44), EC (0.65), EI (0.84) (derived from Gaussian fit, black line). (G) The survival rate of events that start at 
EI (0.84) was fitted using a single (light blue color) and a double (black color) exponential curve. The double 
exponential fit resulted in two characteristic times (25.9 and 1040 s). (H) The dwell time distribution of EI (0.84) 
state of bona fide target binding with mean Δτ0.84 (derived from single exponential fit, black line). Error 
represents standard deviation (three individual data sets).  
Recent in vivo studies have revealed an additional functionality of CRISPR-Cas immunity. When facing ‘‘escape 
mutants,’’ previously targeted sequences that bear mutations in their PAM and/or protospacer, Cascade 
initiates a response called priming wherein the CRISPR-Cas system acquires new spacer sequences from the 
mutant at an elevated rate to restore immunity (Datsenko et al., 2012; Fineran et al., 2014; Li et al., 2014; 
Richter et al., 2014). High-throughput plasmid loss assays of a randomized PAM and protospacer library have 
revealed that priming is a robust process, tolerating up to 13 mutations in the PAM and protospacer sequence 
(Fineran et al., 2014). Even though Cascade is essential for priming, its role in this process is poorly understood. 
Intriguingly, biochemical studies have shown that a single-point mutation in the PAM or seed sequence leads 
to a drastic decrease in the binding affinity of Cascade (Semenova et al., 2011). Therefore, it is puzzling how 
Cascade is able to associate with these mutated substrates despite its low affinity and, further, how it 
distinguishes these mutated substrates from bona fide targets to initiate priming.  
Single-molecule fluorescence is a powerful tool for elucidating the intricate mechanistic details of complex 
protein-nucleic acid interactions (Ha, 2014; Joo et al., 2013; Juette et al., 2014; Robinson and van Oijen, 2013; 
Schuler and Hofmann, 2013). To dissect Cascade’s two distinct functional roles, we developed a single-molecule 
FRET assay to monitor the interaction of Cascade with bona fide and mutated substrates. Real-time observation 
of Cascade-target interactions revealed that an initial recognition complex proceeds to a stable R-loop only if 
the crRNA makes an extensive match with the target. In addition to this ‘‘canonical binding mode,’’ we 
identified an alternative binding mode of Cascade that is triggered by partial complementarity to a target. Using 
an in vivo assay, we validated that this binding mode enables Cascade to probe mutated DNA substrates and 
consequently initiate priming. 
Results 
Single-Molecule Observation of Cascade Target Binding 
For single-molecule measurements, Cascade was labeled with a biotin on the N terminus of its Cse1 subunit 
and immobilized to the surface of a microscope slide via a biotin-streptavidin linkage (Figure 1A). Dye-labeled 
dsDNA targets were added to the slide, and individual binding events were imaged in real time with a total 
internal reflection fluorescence (TIRF) microscope (Figure 1A). DNA constructs consisted of a protospacer, a 
PAM, and an additional 15 base pair flank (Figure 1B). The target strand (complementary to the crRNA) was 
labeled with an acceptor dye (Cy7) at protospacer position +9, whereas the nontarget strand was labeled with 
a donor dye (Cy3) at protospacer position +17. These labeling positions yielded a FRET value of ~0.65 (named 
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EC for a FRET state which represents a closed conformation of dsDNA between nt 9 and 17) (Figure 1E) as 
measured by immobilization of the DNA alone (see Experimental Procedures and Table S1). Control 
experiments showed that dye labeling of the DNA at protospacer positions +9 and +17 did not appreciably 
affect the target binding reaction of Cascade (Figure S1F). We first explored Cascade’s interaction with a bona 
fide target DNA, a substrate that triggers interference in vivo. This substrate contains a protospacer with perfect 
complementarity to the crRNA and an interference-permissive PAM (named ‘‘interfering PAM’’) (Figure 1B) 
(Fineran et al., 2014; Westra et al., 2012a). After equilibration of the DNA with the immobilized Cascade, the 
measured FRET distribution exhibited one major peak centered at 0.44 (named EO for a FRET state which 
represents an open conformation of dsDNA between nucleotides 9 and 17), a decrease from the starting value 
of EC (0.65) (Figure 1E). This decrease in FRET is consistent with the expected open DNA conformation resulting 
from R-loop formation upon Cascade binding. A similar decrease in FRET was observed upon exchanging the 
position of the donor and acceptor dyes (Figure S1C) or when Cascade was prebound to the DNA prior to 
immobilization (Figure S1D), indicating that the observed decrease in FRET was not due to a protein- or surface-
induced photophysical effect. 
Two Distinct Binding Modes of Cascade 
Next we characterized the kinetics and structural dynamics of Cascade binding in real time by adding a bona 
fide target substrate to immobilized Cascade during data acquisition. Interestingly, time trajectories exhibited 
disparate binding events that varied in their dwell time and FRET value. The dwell time distribution followed a 
double-exponential decay curve (Figure 1G, a fit in black), suggesting heterogeneity in binding. A histogram of 
the initial FRET of binding events exhibited three distinct peaks (centered at EO [0.44], EC [0.65], and 0.84) 
(Figure 1F), which, combined with dwell time analysis, led us to divide the events into two distinct types. The 
first type of binding event initiated at a FRET of 0.84, persisted over the entire duration of our observation time 
(30 min) (Figure 1C), and was therefore considered to be irreversible over the timescale of our experiment 
(Figure 1G). Interestingly, events of this type did not remain at their initial FRET of 0.84, but exhibited a 
transition after 1.6 ± 0.4 s (Figure 1H) to a final FRET of 0.44 (Figure 1C). This observation is consistent with the 
single FRET peak centered at 0.44 (EO) observed at equilibrium (Figure 1E). The initial transient state (0.84, 
named EI for an initial transient state) may represent a target-recognition complex wherein the crRNA interacts 
with the dsDNA before full displacement of the nontarget strand (schematic, Figure 1C). Notably, the FRET of 
the initial state is higher than that of the DNA alone (EC, 0.65, Figure 1E), likely arising from a subtle 
conformational change of the dsDNA upon target recognition (e.g., twisting or bending) (Hochstrasser et al., 
2014; Westra et al., 2012a). The observed transition (EI/EO) may represent a previously hypothesized locking 
process, wherein Cascade slides its Cse2 dimer toward its Cse1 subunit upon target recognition (Szczelkun et 
al., 2014; Wiedenheft et al., 2011a), ultimately resulting in the displacement of the nontarget strand and stable 
R-loop formation (schematic, Figure 1C). Taken together, considering Cascade’s strong target association and 
observed conformational change (Semenova et al., 2011; Szczelkun et al., 2014; Wiedenheft et al., 2011a), we 
interpret the first type of binding event to correspond to Cascade’s canonical mode of target binding that leads 
to interference in vivo. We therefore refer to this event type as Cascade’s interference mode of binding. Unlike 
the interference mode, the second type of binding event was short-lived (25.9 s, Figure 1G) and exhibited an 
initial FRET of either EO or EC (Figure 1D). These states were further distinguished from the interference mode, 
as they did not exhibit any kinetic intermediates, nor did they show transitions to other FRET states. As a 
substrate containing no complementarity (Mut[S1-6]) to the crRNA showed negligible binding (Figure S1E), we 
speculate that these short binding events (named ‘‘noncanonical mode’’) arise from sequence-specific 
interactions wherein the probed region of the target DNA is either opened up in a locally formed R-loop (EO) 
or remains closed (EC). To explore the origin of Cascade’s disparate binding interactions, we first focused on 
the role of the PAM. We repeated our assay with a DNA substrate containing a point mutation in the PAM 
(Mut[PAM], Table S2) that represents one of the dominant mutant phenotypes of bacteriophages that escape 
CRISPR interference (Semenova et al., 2011) and subsequently trigger priming in vivo (Datsenko et al., 2012; 
Fineran et al., 2014). Notably, while Cascade was still able to interact with Mut[PAM], only binding events 
characteristic of its noncanonical mode were observed (Figure 2A). A histogram of the initial FRET of each event 
exhibited only two peaks, centered at EC and EO (Figure 2B), identical to the peak positions observed for the 
noncanonical binding mode (Figure 1F). In addition, the binding events observed for Mut[PAM] were short-
lived, exhibiting a dwell time of 24.8 ± 8.9 s (Figure 2C), similar to that of the noncanonical binding mode (Figure 
1G). These results indicate that Cascade’s interaction with target substrates through its noncanonical binding 
mode does not require an interfering PAM. Given the results above, we hypothesize that the observed binding 
states represent two functional modes of Cascade. The first is the interference mode, in which Cascade binds 
a bona fide DNA target (i.e., interfering PAM and complementary protospacer) and triggers Cas3-mediated 
target degradation. The second is the priming mode (noncanonical mode), in which Cascade is able to associate 
with targets harboring a PAM mutation to initiate primed spacer acquisition. 
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Figure 2. Short Binding of Cascade to PAM-Mutated Targets. (A) A representative time trace exhibiting the short-
lived binding of the PAM- mutated target exhibits two FRET states, EO (0.44) and EO (0.65). The duration of each 
state is measured as the dwell time (Δτ).DNA was added at time = 10 s. (B) A histogram of the initial FRET upon 
binding (average of first 1.5 s of each event) of Mut[PAM] exhibits peaks at EO (0.44) and EC (0.65) (derived 
from Gaussian fit, black line). (C) The dwell time distribution of Mut[PAM] binding events with mean Δτt 
(derived from single exponential fit, black line). Error represents SD (three individual data sets). 
Structural Elements of Two Distinct Binding Modes 
To investigate the structural elements of Cascade’s two different binding modes, we employed a series of target 
DNA substrates bearing mutations in their PAM and/or protospacer sequence(s). Recent studies have reported 
that base pairing between Cas- cade’s crRNA and the protospacer occurs over five segments of 5 nt (segments 
1–5) and one segment of 2 nt (segment 6) (Fineran et al., 2014; Jackson et al., 2014; Mulepati et al., 2014; Zhao 
et al., 2014) We therefore chose to systematically mutate the protospacer in segments, starting from either 
the PAM-proximal or PAM-distal end of the protospacer (Figures 3 and S2; Table S2). Upon mutation of the first 
segment of the protospacer (Mut[S1], Figure 3A), which comprises the majority of the seed region, the 
noncanonical binding mode persisted as binding events exhibited nearly identical FRET values and dwell times 
to the Mut[PAM] targets (Figures 3B and 3C). The same was observed for a DNA substrate containing both the 
PAM and seed mutations (Mut[PAM+S1], Figures 3A–3C), indicating that the noncanonical binding mode is 
largely insensitive to the PAM and seed sequence. This observation is in stark contrast to the canonical binding 
mode, which requires both an intact seed sequence and an interfering PAM. Remarkably, when the first two 
PAM-proximal segments, including the entire seed, were mutated (Mut[S1-2]), the noncanonical binding mode 
was still evident, with initial FRET values centered at EO or EC and an average dwell time of 19.6 ± 0.4 s (Figures 
3B, 3C, and S2A). 
Intriguingly, when the first three (Mut[S1-3], Figure 3A) PAM- proximal segments were mutated, the binding 
events exhibited only one major initial FRET population centered at EC, with an average dwell time of 10.5 ± 1.9 
s (Figures 3B, 3C, and S2A), indicating that these events arise from sequence-specific interactions confined 
outside of the probed region of the protospacer (segments 4–6, Figure 3A). Removal of complementarity in the 
first four segments (Mut[S1-4], Figures 3A and 3B) or all segments (Mut[S1-6], Figure S1E) disrupted binding to 
background levels. Taken together, the series of PAM-proximal mutations indicate that the noncanonical 
binding mode of Cascade comprises sequence-specific interactions with a minimum requirement of three full 
segments for target recognition. The PAM-distal mutation series showed complementary behavior, consistent 
with the structural features of the non- canonical binding mode observed above (Figures 3D–3F). Upon 
mutation of the last two segments of the protospacer (Mut[S5-6]), the noncanonical binding mode persisted 
with two peaks centered at EO and EC. When three segments (Mut [S4-6]) were mutated, the noncanonical 
binding mode exhibited only one peak centered at EO, indicating that these interactions are confined within 
the probed region (segments 1–3). Further removal of complementarity disrupted binding to background 
levels, confirming that a minimum of three consecutive segments are required for noncanonical binding. 
Besides the noncanonical mode, a fraction of binding events in the PAM-distal mutation series exhibited the 
signature initial FRET of the interference mode (EI, left column, Figure 3E). Even though this initial FRET was 
identical to that of the canonical binding mode, binding events were transient and did not exhibit any FRET 
transitions until dissociation after 24.8 ± 7.3 s (Figures 3F and S2C). This state reports on the formation of an 
interference-like target-recognition complex that cannot be locked and is in line with a previous observation 
that the PAM- distal region is required for stable R-loop formation in the interference model (Szczelkun et al., 
2014). Finally, to evaluate the role of the PAM in Cascade’s noncanonical binding mode, we repeated both 
series of protospacer mutations in the presence of the escape mutant PAM (named ‘‘priming PAM,’’ Figures 3 
and S2). Overall, mutation of the PAM substantially reduced the number of binding events for each mutant 
compared to its interfering PAM counterpart (compare columns, Figures 3B and 3E), indicating that the PAM is 
not strictly required for, but rather facilitates, noncanonical binding. In addition, the EI state observed in 
Mut[S5-6] and Mut[S4-6] was completely abrogated upon PAM mutation, suggesting that this intermediate 
requires the coordinated ternary interaction of Cascade with the PAM and the seed. In summary, our single-
molecule results show that the noncanonical binding mode of Cascade is much more robust than its canonical 
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Figure 2. Short Binding of Cascade to PAM-Mutated Targets. (A) A representative time trace exhibiting the short-
lived binding of the PAM- mutated target exhibits two FRET states, EO (0.44) and EO (0.65). The duration of each 
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binding (average of first 1.5 s of each event) of Mut[PAM] exhibits peaks at EO (0.44) and EC (0.65) (derived 
from Gaussian fit, black line). (C) The dwell time distribution of Mut[PAM] binding events with mean Δτt 
(derived from single exponential fit, black line). Error represents SD (three individual data sets). 
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the PAM-proximal or PAM-distal end of the protospacer (Figures 3 and S2; Table S2). Upon mutation of the first 
segment of the protospacer (Mut[S1], Figure 3A), which comprises the majority of the seed region, the 
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3B, 3C, and S2A). 
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outside of the probed region of the protospacer (segments 4–6, Figure 3A). Removal of complementarity in the 
first four segments (Mut[S1-4], Figures 3A and 3B) or all segments (Mut[S1-6], Figure S1E) disrupted binding to 
background levels. Taken together, the series of PAM-proximal mutations indicate that the noncanonical 
binding mode of Cascade comprises sequence-specific interactions with a minimum requirement of three full 
segments for target recognition. The PAM-distal mutation series showed complementary behavior, consistent 
with the structural features of the non- canonical binding mode observed above (Figures 3D–3F). Upon 
mutation of the last two segments of the protospacer (Mut[S5-6]), the noncanonical binding mode persisted 
with two peaks centered at EO and EC. When three segments (Mut [S4-6]) were mutated, the noncanonical 
binding mode exhibited only one peak centered at EO, indicating that these interactions are confined within 
the probed region (segments 1–3). Further removal of complementarity disrupted binding to background 
levels, confirming that a minimum of three consecutive segments are required for noncanonical binding. 
Besides the noncanonical mode, a fraction of binding events in the PAM-distal mutation series exhibited the 
signature initial FRET of the interference mode (EI, left column, Figure 3E). Even though this initial FRET was 
identical to that of the canonical binding mode, binding events were transient and did not exhibit any FRET 
transitions until dissociation after 24.8 ± 7.3 s (Figures 3F and S2C). This state reports on the formation of an 
interference-like target-recognition complex that cannot be locked and is in line with a previous observation 
that the PAM- distal region is required for stable R-loop formation in the interference model (Szczelkun et al., 
2014). Finally, to evaluate the role of the PAM in Cascade’s noncanonical binding mode, we repeated both 
series of protospacer mutations in the presence of the escape mutant PAM (named ‘‘priming PAM,’’ Figures 3 
and S2). Overall, mutation of the PAM substantially reduced the number of binding events for each mutant 
compared to its interfering PAM counterpart (compare columns, Figures 3B and 3E), indicating that the PAM is 
not strictly required for, but rather facilitates, noncanonical binding. In addition, the EI state observed in 
Mut[S5-6] and Mut[S4-6] was completely abrogated upon PAM mutation, suggesting that this intermediate 
requires the coordinated ternary interaction of Cascade with the PAM and the seed. In summary, our single-
molecule results show that the noncanonical binding mode of Cascade is much more robust than its canonical 
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mode, capable of binding a wide variety of mutated targets, yet still exhibiting sequence specificity. Such 
versatility could facilitate primed spacer acquisition, in which invading DNA variants that harbor mutations in 
their PAM or protospacer can still be detected by the CRISPR-Cas immune system. 
 
Figure 3. Cascade Exhibits Noncanonical Binding to Protospacers with PAM-Proximal or PAM-Distal Segmented 
Mutations. (A) Schematics of DNA targets in the PAM-proximal mutation series illustrating mutated (white) or 
unmutated (green) segments (S1–S6) of the protospacer. Mut [S1], Mut[S1-2], Mut[S1-3], and Mut[S1-4] have 
segments 1, 1-2, 1-3, and 1-4 mutated, respectively. (B) Histograms of the initial FRET upon binding (average 
of first 1.5 s of each event) of each PAM-proximal mutant from (A) bearing either an interfering (purple bars, 
left column) or priming (light blue bars, right column) PAM exhibit peaks (Gaussian fits, black lines) positioned 
similar to that of the bona fide and Mut[PAM] targets (top row, same as Figures 1F and 2B) at EO (0.44), EC 
(0.65), or EI (0.84) (dashed black lines). The recorded events are from one field of view of the detector. (C) 
Mean binding dwell time of each PAM-proximal mutant from (A) bearing either an interfering (purple bars) or 
a priming (light blue bars)PAM(derived from dwell time distributions, see Figure S2A). Error represents SD 
(three individual data sets). The dwell time of the bona fide target could not be measured accurately due to 
the photobleaching and thus we arbitrarily set 1,040 s to represent the longer characteristic timescale in Figure 
1G. (D) Schematics of DNA targets in the PAM-distal mutation series illustrated as in (A). Mut[S5-6], Mut[S4-6], 
and Mut[S3-6] have segments 5-6, 4-6, and 3-6 mutated, respectively. (E) Histograms of the initial FRET upon 
binding of each PAM-distal mutant from (D) displayed in a similar fashion to that in (B). (F) Mean binding dwell 
of each PAM-distal mutant from (D) bearing either an interfering (purple bars) or a priming (light blue bars) 
PAM (derived from dwell time distributions, see Figure S2A). Error represents SD (three individual data sets). 
N.D., ‘‘not determined.’’ See also Table S2. 
 
Figure 4. Noncanonical Binding Leads to Primed Spacer Acquisition. (A) Cartoon representation of the in vivo 
assay used to determine primed plasmid loss and spacer acquisition. (B) Transformation efficiencies of plasmids 
harboring different target sequences (see schematics) with an interfering (purple bar) or a priming (light blue 
bar) PAM. CFU, ‘‘colony-forming unit.’’ Error is SD of three individual measurements. (C) A two-dimensional 
bubble plot showing the fraction of forward-oriented spacers acquired versus the percentage of plasmid loss 
for those targets in (B) that exhibited spacer integration. Circle size represents the total number of spacers that 
were acquired, and circle color represents an interfering (purple) or a priming (light blue) PAM. Asterisk 
indicates a forward directional bias (relative to random) with a p value < 1 x 10-5 based on binomial statistics. 
The numbers of 1, 2, 3, and 4 indicate data points from constructs Mut[PAM+S5-6], Mut[PAM+S1], Mut[S4-6], 
and Mut[PAM+S4-6], respectively. See also Figure S3, Table S1, and Table S3. 
Functional Roles of Two Distinct Binding Modes  
To investigate whether the canonical and noncanonical binding modes of Cascade lead to different functional 
outcomes, we reconstituted CRISPR interference in vitro. We cloned the segmented mutants that showed 
binding in our single-molecule experiments into plasmids (Table S3) and tested the plasmids for Cascade-
directed degradation by Cas3. Our assay revealed that only the plasmid with a perfectly complementary 
protospacer accompanied by an interfering PAM led to target degradation, whereas target plasmids containing 
either an escape PAM mutation and/or segmented mutations proximal or distal to the PAM were unaffected 
by Cas3 (Figure S3). These results suggest that only Cascade’s canonical binding mode (EI / EO) generates an R-
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mode, capable of binding a wide variety of mutated targets, yet still exhibiting sequence specificity. Such 
versatility could facilitate primed spacer acquisition, in which invading DNA variants that harbor mutations in 
their PAM or protospacer can still be detected by the CRISPR-Cas immune system. 
 
Figure 3. Cascade Exhibits Noncanonical Binding to Protospacers with PAM-Proximal or PAM-Distal Segmented 
Mutations. (A) Schematics of DNA targets in the PAM-proximal mutation series illustrating mutated (white) or 
unmutated (green) segments (S1–S6) of the protospacer. Mut [S1], Mut[S1-2], Mut[S1-3], and Mut[S1-4] have 
segments 1, 1-2, 1-3, and 1-4 mutated, respectively. (B) Histograms of the initial FRET upon binding (average 
of first 1.5 s of each event) of each PAM-proximal mutant from (A) bearing either an interfering (purple bars, 
left column) or priming (light blue bars, right column) PAM exhibit peaks (Gaussian fits, black lines) positioned 
similar to that of the bona fide and Mut[PAM] targets (top row, same as Figures 1F and 2B) at EO (0.44), EC 
(0.65), or EI (0.84) (dashed black lines). The recorded events are from one field of view of the detector. (C) 
Mean binding dwell time of each PAM-proximal mutant from (A) bearing either an interfering (purple bars) or 
a priming (light blue bars)PAM(derived from dwell time distributions, see Figure S2A). Error represents SD 
(three individual data sets). The dwell time of the bona fide target could not be measured accurately due to 
the photobleaching and thus we arbitrarily set 1,040 s to represent the longer characteristic timescale in Figure 
1G. (D) Schematics of DNA targets in the PAM-distal mutation series illustrated as in (A). Mut[S5-6], Mut[S4-6], 
and Mut[S3-6] have segments 5-6, 4-6, and 3-6 mutated, respectively. (E) Histograms of the initial FRET upon 
binding of each PAM-distal mutant from (D) displayed in a similar fashion to that in (B). (F) Mean binding dwell 
of each PAM-distal mutant from (D) bearing either an interfering (purple bars) or a priming (light blue bars) 
PAM (derived from dwell time distributions, see Figure S2A). Error represents SD (three individual data sets). 
N.D., ‘‘not determined.’’ See also Table S2. 
 
Figure 4. Noncanonical Binding Leads to Primed Spacer Acquisition. (A) Cartoon representation of the in vivo 
assay used to determine primed plasmid loss and spacer acquisition. (B) Transformation efficiencies of plasmids 
harboring different target sequences (see schematics) with an interfering (purple bar) or a priming (light blue 
bar) PAM. CFU, ‘‘colony-forming unit.’’ Error is SD of three individual measurements. (C) A two-dimensional 
bubble plot showing the fraction of forward-oriented spacers acquired versus the percentage of plasmid loss 
for those targets in (B) that exhibited spacer integration. Circle size represents the total number of spacers that 
were acquired, and circle color represents an interfering (purple) or a priming (light blue) PAM. Asterisk 
indicates a forward directional bias (relative to random) with a p value < 1 x 10-5 based on binomial statistics. 
The numbers of 1, 2, 3, and 4 indicate data points from constructs Mut[PAM+S5-6], Mut[PAM+S1], Mut[S4-6], 
and Mut[PAM+S4-6], respectively. See also Figure S3, Table S1, and Table S3. 
Functional Roles of Two Distinct Binding Modes  
To investigate whether the canonical and noncanonical binding modes of Cascade lead to different functional 
outcomes, we reconstituted CRISPR interference in vitro. We cloned the segmented mutants that showed 
binding in our single-molecule experiments into plasmids (Table S3) and tested the plasmids for Cascade-
directed degradation by Cas3. Our assay revealed that only the plasmid with a perfectly complementary 
protospacer accompanied by an interfering PAM led to target degradation, whereas target plasmids containing 
either an escape PAM mutation and/or segmented mutations proximal or distal to the PAM were unaffected 
by Cas3 (Figure S3). These results suggest that only Cascade’s canonical binding mode (EI / EO) generates an R-
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loop structure that supports target degradation by Cas3. Next, we sought to determine if the noncanonical 
binding mode of Cascade results in primed spacer acquisition in vivo. To assess primed spacer acquisition, we 
first transformed the target plasmids with segmented mutations into E. coli containing a targeting CRISPR array 
plasmid (Figure 4A). Notably, only the target with a perfectly complementary protospacer and interfering PAM 
led to a reduced transformation efficiency (Figure 4B), confirming that the CRISPR-Cas system exclusively 
targets the R-loops generated through the canonical binding mode of Cascade. Next, transformants were 
transferred to nonselective media, which allowed the CRISPR-Cas system to mount a primed response. After 2 
days of cell growth, three mutant constructs (Mut[PAM], Mut[S5-6], and Mut[PAM+S1-2]) showed a higher 
degree of plasmid loss than the negative control construct Mut[S1-6] did (Figure 4C). To identify if these 
plasmids were lost through primed spacer acquisition, the genomic CRISPR- array was amplified by PCR, and 
amplicons with increased size were sequenced (Figure 4A). In total, 23, 26, and 20 new spacers were obtained 
that originated from the target plasmids Mut[PAM], Mut[S5-6], and Mut[PAM+S1-2], respectively. Sequencing 
of the genomic CRISPR array also allowed us to determine whether the acquired spacers showed any strand 
bias that is typical of the priming process in type I-E systems (Datsenko et al., 2012; Fineran et al., 2014; Swarts 
et al., 2012). Among the three constructs, Mut[PAM] and Mut[S5-6] exhibited bias in spacer acquisition toward 
the target strand (p value < 1 x 10-5, Figure 4C), suggesting that these spacers were obtained by primed spacer 
acquisition. Taken together, the high frequency of plasmid loss and strand bias in the acquired spacers suggests 
that the noncanonical binding mode acts as a gateway to priming in vivo. 
 
Figure 5. Two Binding Modes of Cascade Lead to Different Functional Outcomes. Cascade employs two distinct 
target-DNA binding modes that trigger (A) interference or (B) priming. (A) In the interference pathway, target 
recognition initiates from the PAM and PAM-proximal region. R-loop formation then propagates toward the 
PAM- distal region. When Cascade senses the fully paired structure, it brings this complex into a lower energy 
state (‘‘locking’’) that displaces the nontarget strand out of Cascade. This exposed strand is then cleaved by 
Cas3. (B) In the priming pathway, DNA is probed through brief interactions. PAM recognition facilitates this 
priming pathway but is not required. The brief interactions may initiate from the PAM-proximal (left), the PAM-
distal region (right), or the middle of the protospacer (middle), which becomes stable when paired over three 
or more segments. This noncanonical (‘‘unlocked’’) binding mode leads to a unique conformation of the R-loop 
and signals for primed spacer acquisition. 
Discussion 
Adaptive immune systems are found in both vertebrates and prokaryotes and provide specific defense against 
invading pathogens. The high specificity of this immunity is important for distinguishing self from nonself 
(Gandon and Vale, 2014), yet it brings a downside that it can be readily overcome by rapidly evolving pathogens 
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loop structure that supports target degradation by Cas3. Next, we sought to determine if the noncanonical 
binding mode of Cascade results in primed spacer acquisition in vivo. To assess primed spacer acquisition, we 
first transformed the target plasmids with segmented mutations into E. coli containing a targeting CRISPR array 
plasmid (Figure 4A). Notably, only the target with a perfectly complementary protospacer and interfering PAM 
led to a reduced transformation efficiency (Figure 4B), confirming that the CRISPR-Cas system exclusively 
targets the R-loops generated through the canonical binding mode of Cascade. Next, transformants were 
transferred to nonselective media, which allowed the CRISPR-Cas system to mount a primed response. After 2 
days of cell growth, three mutant constructs (Mut[PAM], Mut[S5-6], and Mut[PAM+S1-2]) showed a higher 
degree of plasmid loss than the negative control construct Mut[S1-6] did (Figure 4C). To identify if these 
plasmids were lost through primed spacer acquisition, the genomic CRISPR- array was amplified by PCR, and 
amplicons with increased size were sequenced (Figure 4A). In total, 23, 26, and 20 new spacers were obtained 
that originated from the target plasmids Mut[PAM], Mut[S5-6], and Mut[PAM+S1-2], respectively. Sequencing 
of the genomic CRISPR array also allowed us to determine whether the acquired spacers showed any strand 
bias that is typical of the priming process in type I-E systems (Datsenko et al., 2012; Fineran et al., 2014; Swarts 
et al., 2012). Among the three constructs, Mut[PAM] and Mut[S5-6] exhibited bias in spacer acquisition toward 
the target strand (p value < 1 x 10-5, Figure 4C), suggesting that these spacers were obtained by primed spacer 
acquisition. Taken together, the high frequency of plasmid loss and strand bias in the acquired spacers suggests 
that the noncanonical binding mode acts as a gateway to priming in vivo. 
 
Figure 5. Two Binding Modes of Cascade Lead to Different Functional Outcomes. Cascade employs two distinct 
target-DNA binding modes that trigger (A) interference or (B) priming. (A) In the interference pathway, target 
recognition initiates from the PAM and PAM-proximal region. R-loop formation then propagates toward the 
PAM- distal region. When Cascade senses the fully paired structure, it brings this complex into a lower energy 
state (‘‘locking’’) that displaces the nontarget strand out of Cascade. This exposed strand is then cleaved by 
Cas3. (B) In the priming pathway, DNA is probed through brief interactions. PAM recognition facilitates this 
priming pathway but is not required. The brief interactions may initiate from the PAM-proximal (left), the PAM-
distal region (right), or the middle of the protospacer (middle), which becomes stable when paired over three 
or more segments. This noncanonical (‘‘unlocked’’) binding mode leads to a unique conformation of the R-loop 
and signals for primed spacer acquisition. 
Discussion 
Adaptive immune systems are found in both vertebrates and prokaryotes and provide specific defense against 
invading pathogens. The high specificity of this immunity is important for distinguishing self from nonself 
(Gandon and Vale, 2014), yet it brings a downside that it can be readily overcome by rapidly evolving pathogens 
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(Koel et al., 2013). However, both vertebrates and prokaryotes have developed sophisticated fail-safe 
mechanisms to target these pathogens. For example, when vertebrates face invaders bearing mutated 
antigens, they may still be recognized by a pool of polyclonal antibodies (Purtha et al., 2011). The resulting 
secondary response proceeds more quickly and efficiently than the primary response, which allows vertebrate 
hosts to keep pace with their evolving pathogens (Tarlinton and Good-Jacobson, 2013). The prokaryotic 
adaptive immune system faces similar challenges. Rapidly evolving pathogens readily overcome sequence- 
specific CRISPR-Cas-mediated host defense (Deveau et al., 2010; Semenova et al., 2011), exposing a major 
limitation to prokaryotic adaptive immunity (Weinberger et al., 2012). However, analogous to vertebrate 
adaptive immunity, once pre-exposed to an ancestral invader, CRISPR-Cas responds more rapidly and efficiently 
to future variants than it can to a novel invader (Datsenko et al., 2012; Fineran et al., 2014; Li et al., 2014; 
Richter et al., 2014; Samson et al., 2013; Tamulaitis et al., 2014; Westra et al., 2012b). Although Cascade was 
shown to be essential for this ‘‘primed’’ response (Datsenko et al., 2012), the underlying mechanism has 
remained enigmatic. Here we provide in- sights into this puzzle by showing that Cascade binds mutated targets 
through a distinct noncanonical mode with low-fidelity compared to the high-fidelity binding mode used for 
unmutated targets. We show that the canonical, high-fidelity binding mode is a stepwise process that locks, 
triggering recruitment of nuclease/helicase Cas3 only when all criteria are met, including an interfering PAM, a 
matching seed, and pairing of all segments of the crRNA guide. In contrast, the noncanonical, low-fidelity 
binding mode initiates a downstream pathway that results in rapid spacer acquisition through the priming 
process (Figure 5). 
Protein-Mediated High-Fidelity Target Recognition 
Our single-molecule data demonstrate in real time that high- fidelity target-DNA binding is a multistep process 
and occurs in a directional manner from the PAM-proximal to PAM-distal end of the protospacer. Previous 
studies have shown that the recognition process is initiated when the Cse1 subunit recognizes the PAM 
(Sashital et al., 2012) and the crRNA hybridizes with the seed sequence. After this initial recognition complex is 
formed, the R-loop propagates toward the PAM-distal region of the protospacer (Semenova et al., 2011; 
Szczelkun et al., 2014; Wiedenheft et al., 2011b). When the pairing of the crRNA reaches the PAM distal-end 
of the protospacer, Cascade senses the fully paired structure and stabilizes this complex into a lower energy 
state (‘‘locking’’) (Szczelkun et al., 2014). This state acts as a flag for the destruction of the target DNA by Cas3 
(Mulepati and Bailey, 2013; Sinkunas et al., 2013; Westra et al., 2012a). This stepwise mechanism involves both 
protein-nucleic acid interactions (Cse1-PAM) and progressive crRNA-DNA base pairing, ensuring efficient and 
high-fidelity recognition, and degradation of targeted DNA. Our study shows how Cascade maintains a strict 
regime to prevent nonspecific cleavage by controlling the pathway toward the proposed locking process 
(Szczelkun et al., 2014). When Cascade encounters a target with mismatches (e.g., Mut [S5-6], Figure 3F), the 
initial recognition complex forms, but the R-loop does not propagate throughout the full protospacer (absence 
of a transition of EI to EO)(Figure S2C). As a result, Cascade will not lock the R-loop, and the initiation complex 
can disassemble using thermal energy. This process cannot be explained by the thermodynamic properties of 
base pairing alone, since a target with mismatches often forms a far larger number of consecutive base pairs 
than seven (e.g., Mut[S5- 6]), which has been shown to be the minimal number of base pairs required for stable 
binding (Cisse et al., 2012). Instead, the last step of stepwise recognition (locking) must involve protein-nucleic 
acid interactions that verify base pairing over the entire protospacer. This model is analogous to the stepwise 
conformational change observed with Argonaute proteins during its target search process (Schirle et al., 2014; 
Wang et al., 2009) and contrasts with the low-fidelity RecA-mediated target search that does not seem to use 
protein-nucleic acid interaction in promoting specificity (Chen et al., 2008). 
Structural View of the Priming Mode  
The structure of Cascade supports our finding that low-fidelity target-DNA interactions can initiate from any 
segment of the crRNA (Figure 5B). Cascade is composed of five different Cas protein subunits assembled into 
a highly interlocked, crRNA- containing protein complex (Jackson et al., 2014; Mulepati et al., 2014; Zhao et al., 
2014). The backbone of the complex consists of six Cas7 subunits with a hand-like architecture. Each hand uses 
its thumb to hold and position the crRNA at 6 nt intervals. As a consequence, every sixth base is flipped out of 
the plane and is unable to interact with the target DNA. This unusual configuration permits the crRNA to pair 
with a target in segments of five nucleotides in an underwound, ribbon-like structure (Mulepati et al., 2014). 
Interestingly, individual segments of the crRNA in the apo-Cascade structure are already preordered in a 
pseudo A-form helix with their nucleobases facing the solvent (Jackson et al., 2014; Zhao et al., 2014). Structural 
preordering is a common strategy to facilitate target binding of nucleic acid guided complexes (e.g., Argonaute 
and RecA) (Chen et al., 2008; Künne et al., 2014; Wang et al., 2009), and thus the preordered segments of 
crRNA of Cascade are in line with the idea that low-fidelity interactions can nucleate from any crRNA segment 
(Figure 5B). Although the low-fidelity binding mode leads to relatively short-lived R-loops, it is their distinct 
conformation that likely signals for a primed spacer acquisition response in the cell. The DNA recognition 
mechanism of Cascade contrasts that of Cas9, which has recently been shown to be strictly dependent on the 
PAM (Sternberg et al., 2014). Furthermore, Cas9 does not base pair its crRNA in segments to the target DNA 
(Nishimasu et al., 2014) but rather forms a contiguous double helix, making it more difficult to imagine that 
PAM-distal regions of Cas9’s crRNA can initiate an interaction with the target DNA. Off-target cleavage analysis 
of Cas9 during genome editing clearly indicates that Cas9 also tolerates mutations (Kuscu et al., 2014), but 
whether this leads to a priming response in bacteria with Type II CRISPR-Cas systems remains to be shown. 
Mechanisms of the Priming Mode  
Although the interference response of CRISPR immunity is a relatively well-characterized phenomenon, the 
molecular mechanism of priming remains poorly understood. First, our data show that Cascade distinguishes 
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(Koel et al., 2013). However, both vertebrates and prokaryotes have developed sophisticated fail-safe 
mechanisms to target these pathogens. For example, when vertebrates face invaders bearing mutated 
antigens, they may still be recognized by a pool of polyclonal antibodies (Purtha et al., 2011). The resulting 
secondary response proceeds more quickly and efficiently than the primary response, which allows vertebrate 
hosts to keep pace with their evolving pathogens (Tarlinton and Good-Jacobson, 2013). The prokaryotic 
adaptive immune system faces similar challenges. Rapidly evolving pathogens readily overcome sequence- 
specific CRISPR-Cas-mediated host defense (Deveau et al., 2010; Semenova et al., 2011), exposing a major 
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shown to be essential for this ‘‘primed’’ response (Datsenko et al., 2012), the underlying mechanism has 
remained enigmatic. Here we provide in- sights into this puzzle by showing that Cascade binds mutated targets 
through a distinct noncanonical mode with low-fidelity compared to the high-fidelity binding mode used for 
unmutated targets. We show that the canonical, high-fidelity binding mode is a stepwise process that locks, 
triggering recruitment of nuclease/helicase Cas3 only when all criteria are met, including an interfering PAM, a 
matching seed, and pairing of all segments of the crRNA guide. In contrast, the noncanonical, low-fidelity 
binding mode initiates a downstream pathway that results in rapid spacer acquisition through the priming 
process (Figure 5). 
Protein-Mediated High-Fidelity Target Recognition 
Our single-molecule data demonstrate in real time that high- fidelity target-DNA binding is a multistep process 
and occurs in a directional manner from the PAM-proximal to PAM-distal end of the protospacer. Previous 
studies have shown that the recognition process is initiated when the Cse1 subunit recognizes the PAM 
(Sashital et al., 2012) and the crRNA hybridizes with the seed sequence. After this initial recognition complex is 
formed, the R-loop propagates toward the PAM-distal region of the protospacer (Semenova et al., 2011; 
Szczelkun et al., 2014; Wiedenheft et al., 2011b). When the pairing of the crRNA reaches the PAM distal-end 
of the protospacer, Cascade senses the fully paired structure and stabilizes this complex into a lower energy 
state (‘‘locking’’) (Szczelkun et al., 2014). This state acts as a flag for the destruction of the target DNA by Cas3 
(Mulepati and Bailey, 2013; Sinkunas et al., 2013; Westra et al., 2012a). This stepwise mechanism involves both 
protein-nucleic acid interactions (Cse1-PAM) and progressive crRNA-DNA base pairing, ensuring efficient and 
high-fidelity recognition, and degradation of targeted DNA. Our study shows how Cascade maintains a strict 
regime to prevent nonspecific cleavage by controlling the pathway toward the proposed locking process 
(Szczelkun et al., 2014). When Cascade encounters a target with mismatches (e.g., Mut [S5-6], Figure 3F), the 
initial recognition complex forms, but the R-loop does not propagate throughout the full protospacer (absence 
of a transition of EI to EO)(Figure S2C). As a result, Cascade will not lock the R-loop, and the initiation complex 
can disassemble using thermal energy. This process cannot be explained by the thermodynamic properties of 
base pairing alone, since a target with mismatches often forms a far larger number of consecutive base pairs 
than seven (e.g., Mut[S5- 6]), which has been shown to be the minimal number of base pairs required for stable 
binding (Cisse et al., 2012). Instead, the last step of stepwise recognition (locking) must involve protein-nucleic 
acid interactions that verify base pairing over the entire protospacer. This model is analogous to the stepwise 
conformational change observed with Argonaute proteins during its target search process (Schirle et al., 2014; 
Wang et al., 2009) and contrasts with the low-fidelity RecA-mediated target search that does not seem to use 
protein-nucleic acid interaction in promoting specificity (Chen et al., 2008). 
Structural View of the Priming Mode  
The structure of Cascade supports our finding that low-fidelity target-DNA interactions can initiate from any 
segment of the crRNA (Figure 5B). Cascade is composed of five different Cas protein subunits assembled into 
a highly interlocked, crRNA- containing protein complex (Jackson et al., 2014; Mulepati et al., 2014; Zhao et al., 
2014). The backbone of the complex consists of six Cas7 subunits with a hand-like architecture. Each hand uses 
its thumb to hold and position the crRNA at 6 nt intervals. As a consequence, every sixth base is flipped out of 
the plane and is unable to interact with the target DNA. This unusual configuration permits the crRNA to pair 
with a target in segments of five nucleotides in an underwound, ribbon-like structure (Mulepati et al., 2014). 
Interestingly, individual segments of the crRNA in the apo-Cascade structure are already preordered in a 
pseudo A-form helix with their nucleobases facing the solvent (Jackson et al., 2014; Zhao et al., 2014). Structural 
preordering is a common strategy to facilitate target binding of nucleic acid guided complexes (e.g., Argonaute 
and RecA) (Chen et al., 2008; Künne et al., 2014; Wang et al., 2009), and thus the preordered segments of 
crRNA of Cascade are in line with the idea that low-fidelity interactions can nucleate from any crRNA segment 
(Figure 5B). Although the low-fidelity binding mode leads to relatively short-lived R-loops, it is their distinct 
conformation that likely signals for a primed spacer acquisition response in the cell. The DNA recognition 
mechanism of Cascade contrasts that of Cas9, which has recently been shown to be strictly dependent on the 
PAM (Sternberg et al., 2014). Furthermore, Cas9 does not base pair its crRNA in segments to the target DNA 
(Nishimasu et al., 2014) but rather forms a contiguous double helix, making it more difficult to imagine that 
PAM-distal regions of Cas9’s crRNA can initiate an interaction with the target DNA. Off-target cleavage analysis 
of Cas9 during genome editing clearly indicates that Cas9 also tolerates mutations (Kuscu et al., 2014), but 
whether this leads to a priming response in bacteria with Type II CRISPR-Cas systems remains to be shown. 
Mechanisms of the Priming Mode  
Although the interference response of CRISPR immunity is a relatively well-characterized phenomenon, the 
molecular mechanism of priming remains poorly understood. First, our data show that Cascade distinguishes 
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mutated targets from bona fide targets using a low-fidelity binding mode that can initiate priming. A recent 
study showed that priming in E. coli is robust, tolerating up to 13 mutations throughout the 32 nt protospacer 
and 3 nt PAM (Fineran et al., 2014). Even when mutations were clustered in any of the crRNA defined segments, 
priming was not abolished. The low-fidelity binding mode of Cascade, in which individual segments may initiate 
pairing with a target, can explain the reported high tolerance for distributed and clustered mutations in a target 
during priming. In this mode, Cascade can probe DNA for complementarity to any of its crRNA segments, and 
extend such an interaction in either direction, thereby achieving sequence-specific detection of targets with 
limited base complementarity. However, the minimal number of base pairs required for priming (Fineran et al., 
2014) ensures that detrimental self-priming of the bacterial genome at random sites is unlikely. Second, we 
observed that the noncanonical binding mode occurs even for substrates containing an interfering PAM and 
an intact seed, suggesting that direct interference and priming may occur simultaneously. Indeed, we have 
previously observed that E. coli is cured from high copy number plasmids by using existing spacers to expand 
the CRISPR array with a range of new spacers against the same target (Fineran and Charpentier, 2012; Swarts 
et al., 2012). For a host this is a highly advantageous strategy; by simultaneously using interference and priming, 
the CRISPR interference effect is amplified while the chance that invaders evade immunity through point 
mutations in their protospacers is reduced. Even though it remains to be seen how priming is coordinated in 
the presence of the remaining Cas protein machinery (Cas1, Cas2, and Cas3), the relatively short time that 
Cascade spends on a target in the priming mode suggests that other factors might stabilize this relatively weak 
interaction. Finally, in CRISPR-Cas/I-E systems priming is a DNA strand- dependent process in which 
approximately 90% of new spacers are integrated from the same strand as the spacer triggering priming 
(Shmakov et al., 2014). Our results with Mut[PAM] and Mut[S5-6] in Figure 4 are consistent with this strand 
bias. In contrast, primed spacer acquisition in Type I-B and I-F systems does not exhibit such strand bias ((Li et 
al., 2014; Richter et al., 2014). Interestingly, for protospacers mutated in the PAM and segments 1 and 2 
(Mut[PAM+S1-2]), including the seed, we observed a higher degree of spacer acquisition without the typical 
strand bias, suggesting that these types of targets lead to a priming behavior in which strand specificity is lost. 
Conclusion 
Faithful copying and decoding of genetic information is central to the most important processes in the cell, 
including DNA replication (Kunkel, 2004), RNA transcription (Xu et al., 2014), and protein translation (Zaher and 
Green, 2009). But high fidelity always comes at the cost of reduced processing speed. Here we show how a 
crRNA guided complex solves this dilemma by employing both high- and low-fidelity target-DNA recognition 
modes. While the high-fidelity mode ensures destruction of only perfectly matching targets, the low-fidelity 
priming mode enables detection of a whole range of mutated invaders to initiate the priming process. The 
unique combination of these two properties in a single RNA-guided complex not only makes CRISPR immunity 
robust, but also reveals versatility of adaptive immunity against rapidly mutating pathogens. 
Experimental Procedures 
Preparation of Cascade, Biotinylated Cascade, and Cas3 Cascade and Cascade lacking subunit Cse1 were affinity 
purified from E. coli strain BL21(DE3) as described previously (Jore et al., 2011). For biotinylated Cascade, 
Cascade was site-specifically labeled at the N terminus of subunit Cse1 with an aldehyde moiety using the 
formylglycine-generating enzyme (FGE) method described previously (Rabuka et al., 2012), reacted with biotin-
hydrazide, and purified by size exclusion chromatography. Cas3 was purified by size-exclusion chromatography 
as described previously (Mulepati and Bailey, 2013) (see ‘‘Protein Preparation’’ in Supplemental Experimental 
Procedures). 
Single-Molecule FRET Biotinylated Cascade complexes were anchored to polyethylene glycol- coated quartz 
microscope slides by biotin-streptavidin linkage Dye-labeled (Cy3 and Cy7) dsDNA targets (see ‘‘DNA 
Preparation’’ in Supplemental Experimental Procedures) were added to the immobilized Cascade complexes 
and detected by a prism-type TIRF microscope. In a typical field of view, 200–300 molecules were detected. 
dsDNA targets were excited with a 532 nm laser and fluorescence emissions from Cy3 and Cy7 were separated 
by dichroic mirrors and imaged onto two halves of a CCD camera after passing through various filters. Imaging 
buffer consisted of Cascade buffer (50 mM HEPES [pH 7.5], 75 mM NaCl, 2 mM MgCl2), an oxygen-scavenging 
system (1% glucose [v/v], 0.1 mg/mL glucose oxidase [Sigma], 17 mg/mL Catalase [Roche]) to reduce 
photobleaching, and 1 mM Trolox (Sigma) to reduce photoblinking of the dyes (Rasnik et al., 2006). Imaging 
was performed at room temperature (23 C±2 C). Fluorescence time traces of individual binding events were 
identified in recorded movies and subsequently analyzed using custom software developed in IDL and MATLAB, 
respectively. The FRET value was defined as IA/(ID+IA), where ID and IA represent the fluorescence signals 
detected in the Cy3 and Cy7 channels, respectively. See ‘‘Single-Molecule Fluorescence’’ in Supplemental 
Experimental Procedures. 
Direct interference and priming Direct interference was assessed by determining the transformation efficiency 
of target plasmids to E. coli strain KD263 (Shmakov et al., 2014) containing pWUR564 (Table S3). Cas gene 
expression was induced 30 min prior to making cells chemically competent. Priming was assessed using plasmid 
loss assays as previously described (Fineran et al., 2014). Briefly, E. coli trans- formants containing the target 
plasmids (pWUR738-747) were grown in LB for 48 hr, plated on LB agar, and imaged under mild UV light. GFP-
negative colonies were screened for spacer integration by PCR. Newly acquired spacers were sequenced and 
were strand-specifically mapped onto the target plasmid sequence to verify priming (see ‘‘Direct Interference 
and Priming’’ in Supplemental Experimental Procedures). 
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mutated targets from bona fide targets using a low-fidelity binding mode that can initiate priming. A recent 
study showed that priming in E. coli is robust, tolerating up to 13 mutations throughout the 32 nt protospacer 
and 3 nt PAM (Fineran et al., 2014). Even when mutations were clustered in any of the crRNA defined segments, 
priming was not abolished. The low-fidelity binding mode of Cascade, in which individual segments may initiate 
pairing with a target, can explain the reported high tolerance for distributed and clustered mutations in a target 
during priming. In this mode, Cascade can probe DNA for complementarity to any of its crRNA segments, and 
extend such an interaction in either direction, thereby achieving sequence-specific detection of targets with 
limited base complementarity. However, the minimal number of base pairs required for priming (Fineran et al., 
2014) ensures that detrimental self-priming of the bacterial genome at random sites is unlikely. Second, we 
observed that the noncanonical binding mode occurs even for substrates containing an interfering PAM and 
an intact seed, suggesting that direct interference and priming may occur simultaneously. Indeed, we have 
previously observed that E. coli is cured from high copy number plasmids by using existing spacers to expand 
the CRISPR array with a range of new spacers against the same target (Fineran and Charpentier, 2012; Swarts 
et al., 2012). For a host this is a highly advantageous strategy; by simultaneously using interference and priming, 
the CRISPR interference effect is amplified while the chance that invaders evade immunity through point 
mutations in their protospacers is reduced. Even though it remains to be seen how priming is coordinated in 
the presence of the remaining Cas protein machinery (Cas1, Cas2, and Cas3), the relatively short time that 
Cascade spends on a target in the priming mode suggests that other factors might stabilize this relatively weak 
interaction. Finally, in CRISPR-Cas/I-E systems priming is a DNA strand- dependent process in which 
approximately 90% of new spacers are integrated from the same strand as the spacer triggering priming 
(Shmakov et al., 2014). Our results with Mut[PAM] and Mut[S5-6] in Figure 4 are consistent with this strand 
bias. In contrast, primed spacer acquisition in Type I-B and I-F systems does not exhibit such strand bias ((Li et 
al., 2014; Richter et al., 2014). Interestingly, for protospacers mutated in the PAM and segments 1 and 2 
(Mut[PAM+S1-2]), including the seed, we observed a higher degree of spacer acquisition without the typical 
strand bias, suggesting that these types of targets lead to a priming behavior in which strand specificity is lost. 
Conclusion 
Faithful copying and decoding of genetic information is central to the most important processes in the cell, 
including DNA replication (Kunkel, 2004), RNA transcription (Xu et al., 2014), and protein translation (Zaher and 
Green, 2009). But high fidelity always comes at the cost of reduced processing speed. Here we show how a 
crRNA guided complex solves this dilemma by employing both high- and low-fidelity target-DNA recognition 
modes. While the high-fidelity mode ensures destruction of only perfectly matching targets, the low-fidelity 
priming mode enables detection of a whole range of mutated invaders to initiate the priming process. The 
unique combination of these two properties in a single RNA-guided complex not only makes CRISPR immunity 
robust, but also reveals versatility of adaptive immunity against rapidly mutating pathogens. 
Experimental Procedures 
Preparation of Cascade, Biotinylated Cascade, and Cas3 Cascade and Cascade lacking subunit Cse1 were affinity 
purified from E. coli strain BL21(DE3) as described previously (Jore et al., 2011). For biotinylated Cascade, 
Cascade was site-specifically labeled at the N terminus of subunit Cse1 with an aldehyde moiety using the 
formylglycine-generating enzyme (FGE) method described previously (Rabuka et al., 2012), reacted with biotin-
hydrazide, and purified by size exclusion chromatography. Cas3 was purified by size-exclusion chromatography 
as described previously (Mulepati and Bailey, 2013) (see ‘‘Protein Preparation’’ in Supplemental Experimental 
Procedures). 
Single-Molecule FRET Biotinylated Cascade complexes were anchored to polyethylene glycol- coated quartz 
microscope slides by biotin-streptavidin linkage Dye-labeled (Cy3 and Cy7) dsDNA targets (see ‘‘DNA 
Preparation’’ in Supplemental Experimental Procedures) were added to the immobilized Cascade complexes 
and detected by a prism-type TIRF microscope. In a typical field of view, 200–300 molecules were detected. 
dsDNA targets were excited with a 532 nm laser and fluorescence emissions from Cy3 and Cy7 were separated 
by dichroic mirrors and imaged onto two halves of a CCD camera after passing through various filters. Imaging 
buffer consisted of Cascade buffer (50 mM HEPES [pH 7.5], 75 mM NaCl, 2 mM MgCl2), an oxygen-scavenging 
system (1% glucose [v/v], 0.1 mg/mL glucose oxidase [Sigma], 17 mg/mL Catalase [Roche]) to reduce 
photobleaching, and 1 mM Trolox (Sigma) to reduce photoblinking of the dyes (Rasnik et al., 2006). Imaging 
was performed at room temperature (23 C±2 C). Fluorescence time traces of individual binding events were 
identified in recorded movies and subsequently analyzed using custom software developed in IDL and MATLAB, 
respectively. The FRET value was defined as IA/(ID+IA), where ID and IA represent the fluorescence signals 
detected in the Cy3 and Cy7 channels, respectively. See ‘‘Single-Molecule Fluorescence’’ in Supplemental 
Experimental Procedures. 
Direct interference and priming Direct interference was assessed by determining the transformation efficiency 
of target plasmids to E. coli strain KD263 (Shmakov et al., 2014) containing pWUR564 (Table S3). Cas gene 
expression was induced 30 min prior to making cells chemically competent. Priming was assessed using plasmid 
loss assays as previously described (Fineran et al., 2014). Briefly, E. coli trans- formants containing the target 
plasmids (pWUR738-747) were grown in LB for 48 hr, plated on LB agar, and imaged under mild UV light. GFP-
negative colonies were screened for spacer integration by PCR. Newly acquired spacers were sequenced and 
were strand-specifically mapped onto the target plasmid sequence to verify priming (see ‘‘Direct Interference 
and Priming’’ in Supplemental Experimental Procedures). 
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Abstract  
CRISPR-Cas systems encode versatile machineries that have evolved to store, recognize and cleave specific DNA 
sequences in prokaryotic cells. We visualized a CRISPR-Cas system in its native bacterial host to understand 
how RNA-effector complexes find foreign DNA targets in a crowded, DNA-packed, cellular environment 
containing ~700,000 native PAMs. By tracking individual RNA-effector complexes in live cells, we show these 
complexes interrogate potential sites much faster than reported before, enabling 100 RNA-effector complexes 
to find a single invader DNA sequence within 20 minutes. We discovered that RNA-effector complexes are 
affected by the presence of CRISPR arrays which lead to the PAM-scanning subunit Cas8e being expelled from 
the Cascade complex after binding CRISPR arrays. Though this response avoids self-targeting, it affects the 
ability of Cascade to interfere with foreign targets and therefore exposes an inherent weakness of CRISPR-Cas 
systems. Our results reveal new links between target search kinetics, host self-avoidance and CRISPR-Cas 
interference in its natural environment.  
 
  
Introduction 
RNA-guided CRISPR-Cas surveillance complexes have evolved to specifically and rapidly recognize sequences of 
previously catalogued mobile genetic elements (MGEs ) (Marraffini, 2015). Target recognition depends on RNA-
DNA complementarity and, in many CRISPR-Cas systems, on the presence of a protospacer adjacent motif 
(PAM), a short (3-6 bp) nucleotide sequence flanking the target, that together determine whether interference, 
priming (accelerated acquisition) or target escape occurs (Fineran et al., 2014; Mojica et al., 2009). In natural 
environments, CRISPR-Cas complexes have to overcome two major challenges common to all immune systems 
to work effectively. Firstly, the complexes have to avoid self-targeting, which is complicated by the presence of 
target-like sequences in the host CRISPR array. Secondly, they need to find their targets fast enough to prevent 
becoming a bacteriophage factory (Hadas et al., 1997).  
Many CRISPR-Cas surveillance complexes use the PAM to overcome these challenges (Blosser et al., 2015; Xue 
et al., 2016). The absence of the PAM in the genomic CRISPR array allows the complex to differentiate self from 
foreign DNA, efficiently preventing self-targeting (Westra et al., 2013). PAM scanning has been suggested to 
speed up the search process (Van Erp et al., 2015), as it can circumvent the need of R-loop formation (strand 
separation) at every position to check for potential targets (Jore et al., 2011; Rutkauskas et al., 2015). Several 
studies have shown that CRISPR-Cas complexes spend more time on probing PAM rich regions, which is 
indicative of its function as the first recognition site (Cooper et al., 2017; Redding et al., 2015; Rollins et al., 
2015; Sternberg et al., 2014). Targets in the E. coli Type I-E system are most often recognized when flanked by 
one of six PAMs (Leenay et al., 2016) , but the E. coli K12 genome itself, residing in the central region of the cell 
called the nucleoid (Macvanin and Adhya, 2012), contains already 700,000 of these PAM motifs. Both in vitro 
and in vivo studies have suggested that interaction times with PAM motifs occurs on the time scale of seconds 
(Blosser et al., 2015; Knight et al., 2015; Sternberg et al., 2014), which would mean that it would take > 200 
hours for a single complex to probe the entire genome.  
Single-Particle Tracking set-up 
In this study, we investigate the search process of type I-E CRISPR-Cas surveillance complexes (Cascade) of E. 
coli in their cellular environment. The fusion of the Cascade complex to a photoactivatable red fluorescent 
protein (PATagRFP) enabled us to trace the paths of thousands of complexes during their search through the 
bacterial cell (Fig 1A). We minimized changes in the regulation of Cas expression by genomic integration of the 
red fluorescent protein gene as a fusion to the N-terminus of cas8e (Suppl. M&M). Transformation assays 
confirmed that the interference ability in this strain was retained (Fig. S1). We upregulated cas gene expression 
to an average copy number of approximately 300-600 Cascade complexes by overexpression of the positive 
regulator LeuO to minimize the influence of autofluorescent entities in our analysis (Fig. S2, M&M (Westra et 
al., 2010)). Cascade diffusion behaviour was extracted from the displacement of each fluorescent particle for 
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four consecutive steps, spanning a time interval of 80 ms, and fitted to a varying number of underlying states 
(Fig. 1B). This allowed us to investigate the abundance and behaviour of complexes and subunits in the cell.  
Complex formation of Cascade 
To distinguish associated motilities of the fluorescent Cascade complexes from monomeric Cas8e subunits, we 
first measured the diffusion of the PATagRFP-Cas8e fusion in strains lacking the other Cascade subunits 
(Δ(cas11-6e); Fig. 1C). We found that the majority of tracks in this strain were highly mobile (D3* = 2.55 μm2/s, 
83%) (2). In the WT strain, this fraction only accounted for 27% of all trajectories (Fig. 1D), the rest being slower 
showing that the majority of our signal comes from fully formed Cascade complexes. Interestingly, when we 
used the faster maturing, but less photostable PAmCherry (maturation time of 23 min; (Subach et al., 2009)) 
instead of PATagRFP (75 min; (Subach et al., 2010)) as a fluorescent tag, the percentage of the subunit Cas8e 
fraction increased (D* = 2.55 μm2/s, 40%), indicating that complex formation did not fully complete within the 
PAmCherry maturation time of 23 minutes (Fig. S3). 
It has been hypothesized that Cascade complexes are formed around a mature crRNA (24), although it is 
possible to isolate complexes without crRNA (25). We deleted both genomic CRISPR arrays (ΔCRISPR) to test 
whether complex formation is possible in the absence of crRNA. The diffusion behaviour of labeled Cas8e in 
the ΔCRISPR fusion strain was the same as in strains expressing only labeled Cas8e Δ(cas11-cas6e) (Fig. 1E), 
demonstrating that these complexes are obligatory ribonucleoprotein complexes that depend on crRNA for 
their formation. 
 
Figure 1. Experimental set-up and complex vs subunit diffusion. (A) Chromosomal locus of the Cascade subunits 
and integration site of the patagrfp gene upstream of cas8e. (B) Four subsequent theoretical displacements of 
particles with different mobility within a bacterial cell are used to infer the different diffusion states. (C) 
Diffusion states of the Cas8e subunit. (D) Diffusion states of the Cascade complex. (E) Relative fractions of the 
diffusion states for the Cas8e, Cascade and ΔCRISPR strains and their assignment to different fractions; D1 
represents longer DNA interactions, D2 represents short DNA interactions and D3 represents freely diffusing 
monomeric Cas8e proteins. 
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Cascade search in absence of targets 
The probing behavior of Cascade could be inferred from the remaining trajectories belonging to the fractions 
slower than monomeric Cas8e found in the Cascade strain. The immobile fraction (D1*= 0 μm2/s, 19%) 
represents molecules tightly bound to DNA for longer than our measured time window (80 ms), whereas the 
largest fraction (D2*= 0.85 μm2/s, 50%) represent mobile Cascade complexes (Fig. 1E). To assess the 
contribution of PAM interactions of Cascade with DNA, we introduced a G160A mutation in the Cas8e subunit 
that abolishes PAM interaction. We detected a reduction in short dwell times, but longer dwell times remained 
relatively abundant, indicating that PAM interactions have very short dwell times (Fig. 2F). 
The fraction of very rapid Cascade-DNA interactions is difficult to estimate, due to the limited time resolution 
of the measurements. To investigate to what extent fast DNA probing events take place, we studied their 
diffusional behavior in a DNA-free environment created by addition of cephalexin, that causes cells to elongate, 
forming DNA-free cytoplasmic space between nucleoids (Fig. 2A). We observed a 1.4±0.1 fold enrichment of 
Cascade in the nucleoid containing regions (Fig. 2B), while the labeled subunit Cas8e was more equally 
abundant in both regions (1.1±0.06). This suggests that intact Cascade has an inherent affinity for DNA. In order 
to extract the fraction of DNA binding events of Cascade from its nucleoid enrichment, we simulated Cascade 
complexes diffusing in cephalexin treated cells (see Materials and Methods; Fig. 2C-E). Based on these 
simulations, we estimated that Cascade complexes spend 40% of their time bound to DNA (Redding et al., 
2015).  
 
Figure 2. Cascade DNA interactions in the absence of targets. (A) Elongated cells in the presence of cephalexin 
stained with DAPI (left) and the same image overlaid by Cascade localizations (right). (B) The average number 
of localizations in DNA-containing segments divided by the average number of localizations in DNA-free 
segments (nucleoid enrichment; NE) are plotted per cell (grey dots) and the average is represented by a black 
bar for the Cascade strain (left) and the Cas8e strain (right). (C) Simulation of particles diffusing in an elongated 
cell without endcaps containing a nucleoid free zone. (D) Side view of panel C where the nucleoid free zone (1 
μm width) becomes visible (NE:1.4). (E) The relationship between the time Cascade is bound to DNA (tbound) 
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and the nucleoid enrichment. Analytical solution: NE = 1/(1-Abound) where Abound = tboundACascade (M&M). (F) 
Diffusion states of the Cas8eG160A strain. 
Cascade search in presence of canonical PAM targets 
Next we investigated the diffusion behavior of surveillance complexes in the presence of targets. To make sure 
that all produced Cascades would have a target in the cell, we constructed a plasmid (pTarget) that contained 
target sites for all 18 spacers found in the genomic arrays of E. coli K12 (Fig. 3A). In order to maximize the 
number of binding events, we used a plasmid with a high copy number (pUC ori, ~400), resulting in a total of 
7200 potential target sites per cell outnumbering the copy number of Cascade (~ 600) by more than 10 times. 
We knocked out the nuclease Cas3 that is recruited by the Cascade complex after target recognition (Westra 
et al., 2012) to prevent target degradation and observed that deletion of cas3 and addition of a non-targeted 
control plasmid (pUC19) did not influence Cascade diffusion (Fig. S5 & S6). 
Addition of pTarget drastically decreased the fraction of mobile complexes (D2* = 0.85 μm2/s; 8%) and 
increased two very slow fractions (D1* = 0 μm2/s; 30%; D4* = 0.08 μm2/s; 40%) corresponding to DNA bound 
states (Fig. 3B). As the immobile fractions could consist of Cascade binding to both chromosome and pTarget, 
we estimated the fraction of Cascade complexes not bound to pTarget by the relative abundance of mobile 
Cascade complexes (D2*) in the presence and absence of pTarget (16%). This number allows a rough estimation 
of the in vivo Kd value (40 nM) and an upper limit for the time required for one Cascade complex to find a 
target (30 hours) (M&M). This long search time requires a high enough copy number for physiological relevant 
interference levels. We observed no detectable interference with low Cascade copy numbers (~ 40) in the 
presence of saturating levels of Cas3, but with induced Cascade copy numbers (~ 600), 1% of the transformed 
pTarget plasmids escaped targeting (Fig. 3C). Considering our search time estimate, the induced Cascade strain 
would find its target within three minutes, whereas the WT strain requires 45 minutes, which probably is too 
slow with plasmid replication highlighting the crucial role for target search kinetics in the efficiency of 
interference.  
 
Figure 3. Cascade DNA interactions in the presence of targets. (A) The pTarget plasmid containing 18 targets for 
the 18 spacers found in the two CRISPR arrays of the E. coli K12 genome flanked by a ‘5-CTT-3’ PAM. (B) 
Diffusion states in the presence of pTarget. (C) The relationship between the copy number of Cascade and the 
interference levels as assessed by the relative transformation of pTarget/pGFPuv under different induction 
conditions (error bars: S.E.M. of three biological replicates). 
Influence of CRISPR arrays on target search 
We made a variant of pTarget where the target sites are flanked by a 5’-CGG-3’, identical to the motif found in 
the repeats of genomic CRISPR arrays (pDecoy) (Fig. 4A). Strains carrying pDecoy still showed an increase of 
immobile Cascade complexes albeit to a lesser extent than for pTarget. However, we observed an increase in 
the fraction of monomeric Cas8e subunits (from 27% to 49%; Fig. 4B) suggesting that Cascade complexes still 
bind to these targets but that Cas8e subunits dissociate subsequently upon binding to a repeat-like PAM, 
corroborating recent in vitro studies (Jung et al., 2017). Dissociation of Cas8e after binding to targets within a 
CRISPR array will decrease the number of full complexes and is therefore expected to impair the interference 
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ability of the whole system. To investigate this hypothesis, we constructed a plasmid containing two CRISPR 
arrays, but lacking a transcriptional promoter (pArray). Two origin of replication (ori) variants were made that 
result in different plasmid copy numbers. We found that interference levels of pTarget in the presence of a 
high copy pArray variant was decreased, but not in a low copy variant or a plasmid lacking the CRISPR arrays 
(Fig. 4C). This shows that using high copy variants of the CRISPR system can decrease CRISPR interference in 
the Type I-E system. 
 
Figure 4. Cascade DNA interactions in the presence of CRISPR arrays. (A) The pDecoy plasmid containing 18 
targets for the 18 spacers found in the two CRISPR arrays of the E. coli K12 genome flanked by the 5’-CGG-3’ 
motif also found in CRISPR repeats. (B) Diffusion states in the presence of pDecoy. (C) The relationship between 
the copy number of Cascade and the interference levels as assessed by the relative transformation of 
pTarget/pGFPuv in the presence of different copy numbers of CRISPR arrays (error bars: S.E.M. of three 
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biological replicates). (D) A model of Cascade target search where I) the Cascade complex is formed in presence 
of crRNA, II) probes the DNA via rapid DNA binding events III) it is most likely to find the target as it is directed 
by PAM interactions, which leads to target degradation, IV) but it also has PAM-independent DNA-binding 
modes that could lead to interaction with the chromosomal CRISPR array, upon which the Cas8e subunit is 
expelled and target degradation prevented.  
Conclusions 
Our results provide new insights in the search behavior of RNA-guided CRISPR-Cas complexes in their native 
cellular environment. Aspecific DNA binding of the Cascade complex occurs rapidly, especially during PAM 
probing interactions. The timescales observed here indicate that Cascade requires several hours to scan all 
PAMs, instead of several hundred hours inferred from PAM binding times observed in vitro. Our study more 
closely matches a previously reported in vivo study of non-native dCas9 search (Jones et al., 2017). Differences 
in these observations might result from a limited time resolution of in vitro studies or the influence of specific 
conditions only found in cells. The hour-long search time explains the necessity to express a minimum amount 
of Cascade to overcome phage/plasmid replication speed. We showed that 300-600 Cascade molecules were 
required to defend the majority of cells to an incoming plasmid upon transformation. We still observed 
expression of Cascade molecules in the WT strain, but the level was too low to give a measurable interference 
level. 
Our data shows that Cascade interacts with CRISPR arrays without correct PAM sequence, suggesting the 
presence of a second, PAM-independent DNA-binding mode of Cascade (Blosser et al., 2015; Xue et al., 2016, 
2017). Interestingly, this mode puts the host chromosome in danger, as it does not fully protect the CRISPR 
array from degradation. Perhaps to this end, the system has evolved to expel the Cas8e subunit upon binding 
of a CRISPR array. This mechanism is potentially accommodated by conformational changes in Cas8e (Xue et 
al., 2016). Alternatively, the absence of PAM locking could drive out the Cas8e subunit when the rest of the 
complex changes conformation. The expelling mechanism, however, comes at the cost of decreasing 
concentrations of functional Cascade complexes.  
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Figure S3. Diffusion of Cascade PAmCherry. Relative fractions of the diffusion states for Cascade PAmCherry.; 
D1 represents longer DNA interactions, D2 represents short DNA interactions and D3 represents freely diffusing 
monomeric Cas8e proteins 
 
 
Figure S4. Plasmid copy number determination. A) Calibration curve of dxs and bla primer amplification with 
dilution series of pMS11 (plasmid containing both dxs and bla gene).  The regression of six technical replicates 
was used to make (regression parameters of bla and dxs gene in orange and purple respectively) The 
amplification efficiency was calculated from the formula: Amp.efficiency=〖10〗^(-1/slope)-1. B) The Ct values 
of bla and dxs gene amplifications were calculated from biological triplicates. These Ct values were converted 
to absolute copy numbers (CN; log10 scale) by using the regression values from the calibration curve. The 
plasmid copy number (PCN) was calculated by dividing the copy number of the bla gene by the copy number 
of the dxs gene 
 
Figure S5. Diffusion of Cascade ΔCas3. Relative fractions of the diffusion states for Cascade ΔCas3.; D1 represents 
longer DNA interactions, D2 represents short DNA interactions and D3 represents freely diffusing monomeric 
Cas8e proteins. 
 
 
Figure S6. Diffusion of Cascade in the presence of non-target plasmid pUC19. Relative fractions of the diffusion 
states for Cascade; D1 represents longer DNA interactions, D2 represents short DNA interactions and D3 
represents freely diffusing monomeric Cas8e proteins. 
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ABSTRACT 
We report the whole-genome sequence of a new Escherichia coli temperate phage, Ayreon, comprising a linear 
dsDNA genome of 44,708 bp.  
 
The phage was isolated from pond water samples in Wageningen, The Netherlands (51°58’9.2’’N 
5°40’43.1’’E) using Escherichia coli strain KD471, a derivative of E. coli K12 derivative strain KD263 (Shmakov et 
al., 2014) lacking CRISPR-associated genes Cas1 and Cas2, as the host. Infected cultures were given time to 
allow for lysogeny. Formed lysogens could be induced both using UV exposure and Mitomycin C, demonstrating 
that phage Ayreon is a temperate phage. Transmission electron microscopy revealed icosahedral capsids (±57 
nm) and long flexible tails (±120 nm) which are characteristic of Siphoviridae (Ackermann, 2003).  
Phage DNA was extracted using the SDS-proteinase K protocol previously described (Sambrook and 
Russell, 2001). Library preparation and sequencing were performed by BaseClear (Netherlands) using the 
Illumina HiSeq 2500 platform. About 1,282,954 short reads were generated with a mean 3,478-fold coverage 
of the genome. The resulting sequences were de novo assembled using the CLC Genomics Workbench version 
8.5.1. The contig sequences were corrected with Pilon version 1.11 (Walker et al., 2014), and linked using the 
SSPACE Premium scaffolder version 2.3 (Boetzer et al., 2011). Gapped regions within the scaffolds were 
partially closed in an automated manner using GapFiller version 1.10 (Boetzer and Pirovano, 2012). Annotation 
and identification of open reading frame (ORFs) were performed using the RAST annotation server (Aziz et al., 
2008) followed by manual curation of all predicted proteins against the NCBI protein database using BLASTp 
(Altschul et al., 1990) and Pfam domain searches (Finn et al., 2016). tRNAs were predicted with tRNAscan-SE 
version 1.21 (Schattner et al., 2005), and promoters and terminators were identified using motif search for 
TTGACAN(15,18)TATAAT with a maximum of two mismatches and ARNold (Naville et al., 2011), respectively. 
The genome packaging strategy was predicted by phylogenetic analysis of the large terminase subunit (Merrill 
et al., 2016).  
Phage Ayreon has a linear double-stranded DNA with a genome size of 44,708 bp and a G+C content of 
50.1%, very similar to the G+C content of its bacterial host (50.8%). The phage has 59 predicted ORFs, of which 
25 could not be assigned to a function. Three predicted promoters and 13 predicted Rho-independent 
terminators were identified; no tRNAs could be identified. Phylogenetics analysis of the large terminase subunit 
suggests phage Ayreon uses cohesive end site (cos) packaging; cos sites are expected to be located within ≈1 
kbp upstream of the small terminase subunit (Casjens and Gilcrease, 2009). Considering this, the genome of 
phage Ayreon was opened so that it would begin with the small terminase subunit and end with the expected 
location of the cos site. 
The highest degree of similarity was observed with phage Cdt-1 (accession no. AB285204), a 
cyclomodulin producing prophage (Asakura et al., 2007), with 78% coverage and 96% identity. Phage Cdt-1 
contains a gene cluster associated with virulence, encoding the CdtA, CdtB, and CdtC subunits of the Cdt-1 
holotoxin. Whole-genome alignment of phage Ayreon and Cdt-I prophage demonstrates that the cdtI gene 
cluster is absent from phage Ayreon. Global alignment with the attP integration site of phage Cdt-1 shows 
pairwise identity of >92%, indicating that phage Ayreon integrates into the gene coding for peptide chain 
release factor RF-3 in the host genome (Asakura et al., 2007).  
Accession number. The complete genome sequence of Ayreon has been deposited in GenBank under the 
accession no. MF807953.  
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ABSTRACT  
Prokaryotes encode various host defense systems that provide protection against mobile genetic elements. 
Restriction-modification (R-M) and CRISPR-Cas systems mediate host defense by sequence specific targeting of 
invasive DNA. T-even bacteriophages employ covalent modifications of nucleobases to avoid binding and 
therefore cleavage of their DNA by restriction endonucleases. Here we describe that DNA glucosylation of 
bacteriophage genomes affects interference of some but not all CRISPR-Cas systems. We show that glucosyl 
modification of 5-hydroxymethylated cytosines in the DNA of bacteriophage T4 interferes with type I-E and 
type II-A CRISPR-Cas systems by lowering the affinity of the Cascade and Cas9-crRNA complexes for their target 
DNA. On the contrary, the type V-A nuclease Cas12a (also known as Cpf1) is not impaired in binding and 
cleavage of glucosylated target DNA, likely due to a more open structural architecture of the protein. Our 
results suggest that CRISPR-Cas systems have contributed to the selective pressure on phages to develop more 
generic solutions to escape sequence specific host defense systems. 
INTRODUCTION 
In many environments, bacteria are subject to strong selective pressure by bacteriophages (phages). The 
number of phages exceeds that of their hosts in most ecosystems, outnumbering them up to 150-fold 
(Wigington et al., 2016). In response to this selective pressure, bacteria have developed a diverse palette of 
defense mechanisms including prevention of phage adsorption, blocking of DNA entry, restriction of phage 
DNA, and abortive infection mechanisms (Samson et al., 2013; Stern and Sorek, 2011). Two of these defense 
mechanisms, restriction-modification (R-M) and Clustered Regularly Interspaced Short Palindromic Repeat 
(CRISPR)-CRISPR-associated (Cas) systems, act on the DNA level by selectively degrading invading DNA. 
Distinction between native and foreign DNA by R-M systems is often based on chemical modification (e.g. 
methylation) of adenines and cytosines in host genomic DNA, which protects host DNA from cleavage by 
specific restriction endonucleases. Escherichia coli K-12 harbors the type I restriction enzyme EcoK encoded by 
the hsdR gene that cleaves unmethylated DNA at 5’-AAC(N6)GTGC and 5’-GCAC(N6)GTT sequences and three 
type IV R-M systems encoded by McrA, McrBC, and mrr that cleave methylated DNA (Loenen and Raleigh, 2014; 
Sain and Murray, 1980). Together, these R-M systems limit horizontal gene transfer.  
Recognition of invading DNA by type I, II and V CRISPR-Cas systems is based on base pairing of the invader DNA 
with CRISPR RNAs (crRNAs). These host encoded crRNAs guide effector complexes to complementary target 
DNA (also called protospacer) which is subsequently cleaved by the effector complex or by recruited nucleases 
(Makarova et al., 2015a; Mohanraju et al., 2016). Even though all different types of CRISPR-Cas systems have a 
common role in immunity, they are structurally and mechanistically diverse. Based on this diversity, CRISPR 
systems are divided into two different classes and six different types (Makarova et al., 2015b; Shmakov et al., 
2015). Type I CRISPR systems are the most abundant CRISPR type in nature (Makarova et al., 2015a), and 
comprise a multiprotein crRNA-effector complex (named Cascade) and a nuclease (Cas3) to bind target DNA. 
After target DNA recognition, Cascade recruits Cas3 that mediates target DNA degradation (Jore et al., 2011; 
Westra et al., 2012). The best characterized example of type II CRISPR-Cas systems is the Cas9 nuclease, a single 
effector protein which facilitates both crRNA-mediated DNA binding and DNA cleavage (Makarova et al., 
2015b). Recently, type V-A CRISPR systems were discovered (Zetsche et al., 2015). Like type II systems, type V-
A systems employ a single effector enzyme named Cas12a, which provides an interesting alternative to Cas9 in 
genome editing (Shmakov et al., 2017; Zetsche et al., 2015). 
In response to the selective pressure posed by anti-viral defense systems in bacteria, phages have evolved 
several mechanisms to escape anti-viral defense systems. Phages can evade sequence-specific host defense 
systems by mutating target sequences (Deveau et al., 2008; McGrath et al., 1999; Semenova et al., 2011). While 
this allows for efficient escape from restriction endonucleases, mutations in DNA sequences targeted by 
CRISPR-Cas systems can trigger a process called priming, which leads to an accelerated update of the CRISPR 
memory repertoire (Jackson et al., 2017). Furthermore, phages may use recombination of their genomes to 
get rid of CRISPR target sites (Andersson and Banfield, 2008; Paez-Espino et al., 2015). In addition to mutation 
and recombination of DNA, phages can escape R-M systems by expressing inhibitory proteins. Such proteins 
can inhibit R-M immunity by degradation of R-M cofactors, masking of restriction sites, or modification of phage 
DNA (Samson et al., 2013). Additional strategies include DNA mimicry, as exemplified by the Ocr protein of 
phage T7 that mimics DNA to sequester EcoKI (Krüger and Bickle, 1983; Walkinshaw et al., 2002). Recently, 
phage-encoded proteins that inhibit CRISPR-Cas systems have been characterized (Bondy-Denomy et al., 2013; 
Pawluk et al., 2014, 2016a). Inhibition of CRISPR-Cas systems by anti-CRISPR (ACR) proteins occurs via distinct 
mechanisms. Two Acr proteins (AcrF1 & AcrF2) were found to bind the type I-F Csy complex, inhibiting the 
binding of target DNA, while another Acr protein (AcrF3) binds to Cas3, blocking its interaction with Cascade to 
inhibit target degradation (Bondy-Denomy et al., 2015). Three recently identified families of ACRs are encoded 
by mobile elements in bacteria and are shown to inhibit Neisseria meningitidis Cas9 by direct binding (Pawluk 
et al., 2016b). ACR proteins AcrIIA1-4 encoded by Listeria monocytogenes prophages prevent Cas9 binding and 
can be used to regulate the genome engineering activity of Streptococcus pyogenes Cas9 (Rauch et al., 2017). 
ACR proteins that inhibit SpyCas9 have also been found in virulent bacteriophages (Hynes et al., 2017). 
Another way to escape host defense is found in T-even phages that infect E. coli (Weigele and Raleigh, 2016). 
Phage T4 has evolved a pathway to bypass the R-M systems of E. coli by substitution of its genomic cytosines 
with 5-hydroxymethylcytosines (5-hmC) (Figure 1A and 1B). The dNTP synthesis complex (DSC) which 
comprises both host- and phage-encoded enzymes performs this substitution before DNA synthesis (Kim, 
2005). Degradation of the host genome by T4-derived DenA and DenB nucleases provides an increased pool of 
dCTP, which is converted to dCMP by the phage-encoded dCTPase gp56. Subsequently, dCMP is converted into 
5-hydroxymethyl-dCMP (5-hmdCMP) by phage-encoded Deoxycytidylate 5-hydroxymethyltransferase gp42 
(Mathews et al., 1979). Conversion of 5-hmdCMP to 5-hmdCDP is then catalyzed by the phage-encoded dNMP 
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ACR proteins that inhibit SpyCas9 have also been found in virulent bacteriophages (Hynes et al., 2017). 
Another way to escape host defense is found in T-even phages that infect E. coli (Weigele and Raleigh, 2016). 
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kinase gp1. Host-encoded nucleoside diphosphate kinase Ndk catalyzes the final conversion to 5-hmdCTP, 
which is incorporated by T4 DNA polymerase into the DNA as 5-hmC. To avoid immunity escape by 5-hmC 
modification, E. coli encodes the McrBC system, which specifically degrades 5-hmC modified DNA (Raleigh and 
Wilson, 1986). However, T4 is impervious to this modification dependent system because 5-hmC residues are 
further modified with glucose moieties derived from uridine diphosphate glucose (UPDG). These are covalently 
attached to the 5-hydroxyl group of 5-hmC by phage-encoded alpha- and beta-glucosyl transferases, yielding 
glucosyl-5-hydroxymethylcytosine (5-ghmC) (Lehman and Pratt, 1960) (Figure 1C). As DNA glucosyl-5-
hydroxymethylation provides an effective way to escape immunity by most R-M systems, the question arises 
whether it also protects against certain types of CRISPR-Cas immunity, and what the mechanistic basis for 
protection from CRISPR interference would be.  
 
Figure 1. Modifications of nucleobases in phage T4 DNA. (A) Cytosine present in phage T4(C). (B) 5-
hydroxymethylation of cytosine present in phage T4(hmC). (C) Glucosyl-5-hydroxymethylation present in phage 
T4(ghmC).  
We have tested the effect of DNA glucosylation on the activity of type I-E, type II-A and type V-A CRISPR-Cas 
systems. We demonstrate that T4 with 5-ghmC DNA can escape type I-E and II-A interference by reducing target 
binding affinity of Cascade and Cas9, respectively. Interestingly, 5-ghmC modifications do not lower target 
binding affinity and cleavage efficiency of the type V-A effector nuclease Cas12a. The structural basis for the 
observed differences as well as potential applications for the described results are discussed. 
MATERIAL AND METHODS 
Bacterial strains and plasmid construction 
Cells were made chemically competent using the RuCl method and transformed by applying a heat-shock as 
described in the QIA expressionist handbook (QIAGEN). For the experiments with Type I-E CRISPR-Cas, E. coli 
T7 Express (NEB) was transformed with pWUR400, pWUR797 and pWUR800, pWUR801 or pWUR802 (table 
S1) and used for plaque assays with phage T4. For the in vivo experiments with Type II-A CRISPR-Cas, E. coli T7 
Express was transformed with pWUR805 and pWUR806, pWUR809 or pWUR810 (table S1).  
 
Bacteriophage strains and propagation 
Phage T4(ghmC) (CBS-KNAW Biodiversity Centre, Utrecht, Netherlands) was propagated in E. coli B834 (Su-). 
Phage T4(C) (dCTPase-, denA, denB, alc-) was kindly provided by Prof. Elisabeth Kutter (Evergreen State College) 
and propagated in E. coli B834 or CR63 (Su+). T4(hmC) (α-, β-glucosyltransferase) was kindly provided by Peter 
Weigele (NEB, Ipswich) and propagated in E. coli T7 Express (mcrC-mrr). The phage T4(C) mutant we used in 
our analysis was a quintuple mutant of genes alc, denB, denA and dCTPase. Genes denA and denB encode 
endonuclease II and IV respectively and denA and denB mutations allow the phage to contain C DNA. The alc 
mutation allows for the production of late proteins, enabling bursts of phage.  
 
Plaque assays and efficiency of plating calculation 
E. coli strains were grown at 37 °C in Luria Broth (LB; 5 g/L yeast extract, 10 g/L tryptone, 5 g/L NaCl) at 180 
rpm or on LB-agar plates containing 1.5% (wt/vol) agar. When required, medium was supplemented with the 
following: ampicillin (Amp; 100 μg/L), chloramphenicol (Cam; 25 μg/mL), kanamycin (Kan; 50 μg/mL) or 
streptomycin (Str; 50 μg/mL). Bacterial growth was assessed spectrophotometrically at 600 nm (OD600). To 
induce cas gene expression, IPTG (isopropyl β-D-1 thiogalactopyranoside) was added to the final concentration 
of 1 mM when the bacterial culture reached and OD600 of approximately 0.4. After 30 minutes of Cas protein 
and crRNA production, the cells were used in double agar layer plaque assays with phage T4(ghmC), T4(hmC), 
and T4(C). Plaque assays were performed in triplicate. The sensitivity of the host to phage infection was 
calculated as the efficiency of plaquing, which is the plaque count ratio of a strain containing an anti-T4 CRISPR, 
to that of a strain containing a CRISPR with non-targeting spacers. Anti-T4 spacers were designed by picking a 
PAM-flanked protospacer in two essential T4 genes (gene 19 and gene 22). CRISPR protospacer sequences are 
provided in table S2. A two tailed t-test was performed to calculate whether the differences were significant.  
The presence or absence of modifications of T4 DNA was verified by analysis using restriction enzymes. Isolated 
DNA was incubated with enzymes that are either sensitive or not sensitive to 5-hmC or 5-ghmC. Our analysis 
confirmed that our T4 stock contains 5-ghmC DNA and our T4(C) stock contains C DNA. The presence of 5-hmC 
in phage T4(hmC) was verified by plating on E. coli expressing the McrBC restriction enzyme, which is active on 
5-hmC DNA but not on 5-ghmC DNA. Inability of T4(hmC) to propagate reveals the presence of 5-hmC DNA. 
 
Design and synthesis of modified dsDNA 
All in vitro assays were done using a 98 bp dsDNA target containing the spacer 8 (sp8) sequence (table S2). The 
target was amplified using the primers BG8415 & BG8416 (table S2). PCR products were generated using both 
Q5 high-fidelity DNA polymerase and Taq DNA polymerase (NEB). hm5-dCTP (Bioline) was used in the PCR 
reactions to obtain hydroxymethylated targets. PCR conditions were optimised for each of the modified dNTPs 
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in phage T4(hmC) was verified by plating on E. coli expressing the McrBC restriction enzyme, which is active on 
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used. Typical PCR conditions were as follows: 50 µl PCR reactions with final concentrations dNTPs 200 µM, 
primers 0.5 µM, DNA template 100 ng, 1.25 U Taq polymerase. The following parameters were used: 
denaturation at 95 °C for 30 s followed by 30 cycles of 95 °C for 30 s, 46 °C for 60 s, 68 °C for 60 s with a final 
extension at 68 °C for 3 minutes. For Q5 DNA polymerase (1 U) the following parameters were used; 98 °C 30 
s denaturation, followed by 30 cycles at 98 °C for 30 s 61 °C for 30 s, 72 °C for 20 s with a final extension at 72 
°C for 2 mins. The PCR products were subsequently purified by QIAprep Spin Miniprep Kit (Qiagen) following 
the manufacturer’s instructions. Purified samples were quantified using a NanoDrop 2000C (Thermo Scientific) 
and analysed by native PAGE. 
Three different spacers were designed for the target sequence for Type I-E, Type II-A and Type V CRISPR 
systems. Each of these spacers was designed to have a suitable PAM for the respective CRISPR Type (Leenay et 
al., 2016). The designed spacers can be found in table S2.  
Enzymatic glucosylation of the purified 5-hmC dsDNA was used to synthesize DNA with glucosylated 5-hmC. T4 
Phage β-glucosyltransferase (NEB) 1 U was incubated with approximately 1 µg of 5-hmC dsDNA, 40 µM UDP-
glucose at 37°C for 16 hours. The DNA products were subsequently purified using QIAprep Spin Miniprep Kit 
(Qiagen) and analysed by native PAGE.  
DNA targets containing 5-hmC modifications in the PAM region were produced by annealing oligonucleotides 
BG6508-6510 to BG6506. Oligonucleotides BG6508-6510, containing 5-hydroxymethyldeoxycytidine, were 
purchased from Integrated DNA Technologies (IDT).   
Target DNA was subsequently glucosylated as described above.  
 
  
Radiolabeling of target DNA 
Target DNA containing unmodified cytosine, 5-hmC and 5-ghmC were 5’ radioactively labeled using T4 
Polynucleotide Kinase (PNK) (NEB). Conditions are 1x PNK reaction buffer (NEB), 50 pmol [γ-32P] ATP (Perkin 
Elmer) and 25 pmol target DNA in a 50 µL reaction. The reaction was carried out at 37 °C for 30 minutes and 
subsequently inactivated at 65 °C for 20 minutes. 
 
Preparation of crRNA and sgRNA  
The Cas9 sgRNA was made by in vitro transcription (IVT) of partly overlapping primers. DNA oligonucleotides 
(oligos) used for IVT were PAGE purified (table S3). IVT was performed using the HiScribe™ T7 Quick High Yield 
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Chapter 5
Cas9 cleavage reactions 
For Cas9 Cleavage reactions 33 nM Cas9 (NEB), 120 nM sgRNA and 1x Cas9 buffer (NEB) were pre-incubated 
for 20 minutes at 37 °C. Subsequently 5’ 32P-radiolabeled target DNA was added to a final concentration of 3 
nM and the reaction was incubated for 2 hours at 37 °C. 30 µL 2x formamide loading dye (95% formamide, 
0.125% bromophenol blue) was added and the complete samples were heated to 95 °C for 5 minutes and 
loaded on an 8% acrylamide gel (with 7M Urea and 1x TBE). The gel was run in 1x TBE for approximately 4 hours 
at 15 mA and subsequently exposed for 16-48 hours in a phosphor imaging cassette (Molecular Dynamics) at -
20 °C. The phosphor imaging cassette was scanned using a Personal Molecular Imager (Bio-Rad). 
 
Cas12a protein purification 
A codon optimized Cas12a gene was cloned into a bacterial expression vector [6-His-TEV-Cas12a, a pET-based 
vector that was a gift from Scott Gradia (Addgene plasmid # 29653)]. One liter of LB growth media with 100 
μg/mL ampicillin was inoculated with 10 mL overnight culture Rosetta (DE3) (EMD Millipore) cells containing 
the Cas12a expression construct. Growth media plus inoculant was grown at 37 °C until the cell density reached 
0.5 OD600, then the temperature was decreased to 20°C. Growth was continued until OD600 reached 0.6 when 
a final concentration of 500 μM IPTG was added to induce Cas12a expression. Expression took place for 14-18 
hours before harvesting cells and freezing them at -20 °C until purification. 
Cell paste was suspended in 20 mL of Lysis Buffer (50 mM NaH2PO4 pH 8, 500 mM NaCl, 1 mM 2-
Mercaptoethanol, 10 mM imidazole) supplemented with protease inhibitors (Roche complete, EDTA-free) and 
lysozyme. Once homogenized, cells were lysed by sonication (Bandelin Sonoplus) and then centrifuged at 
16,000g for 1 hour at 4 C to clear the lysate. The lysate was filtered through 0.22 μm filters (Mdi membrane 
technologies) and applied to a nickel column (HisTrap HP, GE lifesciences), washed and then eluted with 
250mM imidazole. Fractions containing protein of the expected size were pooled and dialyzed overnight into 
the dialysis buffer (250mM KCl, 20mM HEPES/KOH, 1mM DTT). After dialysis, sample was diluted 1:1 in 10 mM 
HEPES/KOH pH 8, and loaded on a heparin FF column pre-equilibrated in IEX-A buffer (150mM KCl, 20mM 
HEPES/KOH pH 8). Column was washed with IEX-A and then eluted with a gradient of IEX-C (2 M KCl, 20 mM 
HEPES/KOH pH 8). The sample was concentrated to 700 μL prior to loading on a gel filtration column (HiLoad 
16/600 Superdex 200) via FPLC (AKTA Pure). Fractions from gel filtration were analyzed by SDS-PAGE; fractions 
containing Cas12a were pooled and concentrated to 200 μL (50 mM Tris-HCl pH 8, 2 mM DTT, 5% glycerol, 500 
mM NaCl) and either used directly for biochemical assays or frozen at -80°C for storage. 
Cas12a cleavage reactions 
Cleavage assays were done by pre-incubating 100 nM Cas12a with 400 nM crRNA in 1x Cas9 buffer (NEB) for 
20 minutes at 37 °C. Thereafter 8 nM 5’ 32P radiolabeled target DNA was added in a 30 μL reaction and 
incubation was done at 37 °C for 2 hours. 30 µL 2x formamide loading dye was added and the complete samples 
were heated to 95 °C for 5 minutes and loaded on an 8% acrylamide gel (with 7 M Urea and 1x TBE). The gel 
was run in 1x TBE for approximately 4 hours at 15 mA and subsequently exposed for 16-48 hours in a phosphor 
imaging cassette (Molecular Dynamics) at -20 °C. The phosphor imaging cassette was scanned using a Personal 
Molecular Imager (Biorad). 
 
Cascade Electrophoretic mobility shift assays 
Cascade electrophoretic mobility shift assays were performed based on (Künne et al., 2015). Incubation 
reactions were performed with Cascade-crRNA (sp8) complex concentrations of 0, 1, 3, 10, 30, 100, 300 and 
1000 nM. Dilutions of the Cascade stock solution (2.78 mg/ml) were made in equilibration buffer (20 mM HEPES 
pH=7.5, 75 mM NaCl, 1 mM DTT). 3 nM 5’ 32P radiolabeled target was incubated with Cascade complex in 1x 
Equilibration buffer in a 30 μL reaction. The reaction was incubated for 30 minutes at 37°C. 6 μL 6x loading dye 
(Thermo Scientific) was added and the complete samples were loaded on a native 8% acrylamide gel containing 
1x TBE. The gel was run at 15 mA for 2-3 hours, after which the gel was placed in a phosphor imaging cassette 
and stored for 16-48 hours at -20 °C. The phosphor imaging cassette was scanned using a Personal Molecular 
Imager (Bio-Rad). 
 
dCas9 and dCas12a electrophoretic mobility shift assays 
Electrophoretic mobility shift assays with Cas9 and Cas12a were done using catalytically dead versions of the 
proteins, dCas9 and dCas12a (Jinek et al., 2012; Zetsche et al., 2015). 1 µM dCas9 and dCas12a were incubated 
with 4 µM sgRNA and crRNA respectively in binding buffer (20 mM HEPES, pH 7.5, 250 mM KCl, 2 mM MgCl2, 
0.01% Triton X-100, 0.1 mg/ml bovine serum albumin, 10% glycerol) for 10 minutes at 25 °C as described in 
(Anders et al., 2015). A dilution series was made with 0.1, 0.3, 1, 3, 10, 30, 100 and 300 nM final protein 
concentration using binding buffer. 3 nM 5’ 32P-radiolabeled target DNA was added in a 30 µL reaction and 
incubated for 10 minutes at 37 °C. 10 µL 6x loading dye (Thermo Scientific) was added and the complete 
samples were loaded on a 12% native acrylamide gel containing 1x TBE. The gel was run in 1x TBE at 15 mA for 
2-3 hours. Subsequently, the gel was exposed for 16-48 hours in a phosphor imaging cassette (Molecular 
Dynamics) at -20 °C. The phosphor imaging cassette was scanned using a Personal Molecular Imager (Biorad) 
 
Structural Modeling of modified target DNA binding to Cascade, Cas9 and Cas12a 
Structural coordinates of glucosyl-5-hydroxymethyl modified thymine was isolated from an existing model (PDB 
308D; (Gao et al., 1997)). The modified nucleotide was statically modelled onto target strand (TS) and non-
target strand (NTS) nucleotides in structures of E. coli Cascade (PDB: 5H9F; (Hayes et al., 2016)), S. 
pyogenes Cas9 (PDB: 5F9R;(Jiang et al., 2016)), and F. novicida Cas12a (PDB: 5NFV;(Swarts et al., 2017)) in 
WinCoot 0.8.3 using Least Squares Fit Superpose. Clashes between the DNA modifications and the polypeptide 
chain were identified using the MolProbity (Chen et al., 2010) output of the Comprehensive Validation Tool 
within Phenix (Adams et al., 2010). Identified clashes between the glucosyl-5-hydroxymethyl modification and 
polypeptide residues are schematically indicated in Figure . 
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0.125% bromophenol blue) was added and the complete samples were heated to 95 °C for 5 minutes and 
loaded on an 8% acrylamide gel (with 7M Urea and 1x TBE). The gel was run in 1x TBE for approximately 4 hours 
at 15 mA and subsequently exposed for 16-48 hours in a phosphor imaging cassette (Molecular Dynamics) at -
20 °C. The phosphor imaging cassette was scanned using a Personal Molecular Imager (Bio-Rad). 
 
Cas12a protein purification 
A codon optimized Cas12a gene was cloned into a bacterial expression vector [6-His-TEV-Cas12a, a pET-based 
vector that was a gift from Scott Gradia (Addgene plasmid # 29653)]. One liter of LB growth media with 100 
μg/mL ampicillin was inoculated with 10 mL overnight culture Rosetta (DE3) (EMD Millipore) cells containing 
the Cas12a expression construct. Growth media plus inoculant was grown at 37 °C until the cell density reached 
0.5 OD600, then the temperature was decreased to 20°C. Growth was continued until OD600 reached 0.6 when 
a final concentration of 500 μM IPTG was added to induce Cas12a expression. Expression took place for 14-18 
hours before harvesting cells and freezing them at -20 °C until purification. 
Cell paste was suspended in 20 mL of Lysis Buffer (50 mM NaH2PO4 pH 8, 500 mM NaCl, 1 mM 2-
Mercaptoethanol, 10 mM imidazole) supplemented with protease inhibitors (Roche complete, EDTA-free) and 
lysozyme. Once homogenized, cells were lysed by sonication (Bandelin Sonoplus) and then centrifuged at 
16,000g for 1 hour at 4 C to clear the lysate. The lysate was filtered through 0.22 μm filters (Mdi membrane 
technologies) and applied to a nickel column (HisTrap HP, GE lifesciences), washed and then eluted with 
250mM imidazole. Fractions containing protein of the expected size were pooled and dialyzed overnight into 
the dialysis buffer (250mM KCl, 20mM HEPES/KOH, 1mM DTT). After dialysis, sample was diluted 1:1 in 10 mM 
HEPES/KOH pH 8, and loaded on a heparin FF column pre-equilibrated in IEX-A buffer (150mM KCl, 20mM 
HEPES/KOH pH 8). Column was washed with IEX-A and then eluted with a gradient of IEX-C (2 M KCl, 20 mM 
HEPES/KOH pH 8). The sample was concentrated to 700 μL prior to loading on a gel filtration column (HiLoad 
16/600 Superdex 200) via FPLC (AKTA Pure). Fractions from gel filtration were analyzed by SDS-PAGE; fractions 
containing Cas12a were pooled and concentrated to 200 μL (50 mM Tris-HCl pH 8, 2 mM DTT, 5% glycerol, 500 
mM NaCl) and either used directly for biochemical assays or frozen at -80°C for storage. 
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RESULTS 
Phages escape CRISPR-Cas interference by DNA glucosylation 
The majority of phages that contain 5-ghmC modification in their DNA infect gammaproteobacteria (Warren, 
1980). Hence, anti-viral defense systems that are effective against 5-ghmC DNA-containing phages may be 
expected amongst this class of bacteria. To this end we assessed the ability of the native type I-E CRISPR-Cas 
system of the gammaproteobacterium E. coli to provide resistance against phage T4. Two plasmids expressing 
crRNAs against essential T4 genes were constructed (table S2). The crRNAs target T4 gene 19 (crRNA19), 
encoding a tail tube protein, and T4 gene 22 (crRNA22), encoding the prohead core protein. E. coli cells 
expressing Cascade and Cas3 were transformed with the plasmid encoding the crRNAs and were subsequently 
tested for their sensitivity to infection by a panel of T4 phages. Phage T4(C) contains unmodified cytosine, 
T4(hmC) contains 5-hmC, and T4(ghmC) contains 5-ghmC. Infectivity of the phages was normalized against E. 
coli cells containing a CRISPR array harboring a non-targeting spacer (Figure ). Efficiency of plaquing (EOP) by 
T4(C) was reduced 104-fold by cells expressing targeting Cascade as compared to cells expressing non-targeting 
Cascade. Similarly, EOP by T4(hmC) was reduced 105-fold by cells expressing targeting Cascade. In contrast, 
EOP by T4(ghmC) was lowered only 10-fold by cells expressing targeting Cascade. We therefore conclude that 
CRISPR-Cas type I-E resistance is severely inhibited by 5-ghmC modifications, but not by 5-hmC modifications 
of phage DNA. 
 
Figure 2. Efficiency of plaquing (EOP) assays of T4 phages on E. coli cells expressing CRISPR-Cas systems targeting 
T4 genes 19 or 22. (A) Representation of the circular genome of bacteriophage T4. Positions of protospacer 
sequences and PAMs are shown (indicated by orange bars and purple bars respectively). Glucosyl-5-
hydroxymethylcytosines are indicated in red and nucleotides that base pair with crRNA are indicated by black 
dots. (B) EOP of T4 phages on E. coli cells expressing targeting Cascade complexes normalized to EOP on non-
targeting strains. (C) EOP of T4 phages on E. coli cells expressing targeting Cas9 proteins normalized to EOP on 
non-targeting strains. 
Next, we tested whether the type II-A CRISPR-Cas system of Streptococcus pyogenes mediates immunity against 
T4 phages in E. coli. E. coli cells expressing Cas9 and tracrRNA were transformed with plasmids encoding crRNAs 
targeting T4 genes 19 and 22 and subsequently tested for sensitivity to infection by phages T4(C), T4(hmC), 
and T4(ghmC) (Figure B). Efficiency of plaquing (EOP) by T4(C) and T4(hmC) is decreased 104-fold in cells 
expressing targeting Cas9 compared to non-targeting Cas9. Although both chosen crRNAs mediated efficient 
targeting of T4(hmC), crRNA19 provided lower resistance than crRNA22, indicating spacer-specific interference 
efficiencies on normal DNA. In contrast to EOP of T4(C) and T4(hmC), EOP of T4(ghmC) is similar between cells 
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expressing targeting or non-targeting Cas9. We therefore conclude that, like type I-E systems, type II-A CRISPR-
Cas systems are severely impaired by phage DNA glucosylation. 
Escaping phages carry seed mutations  
We noticed that each of the three T4 phages generated plaques on CRISPR targeting strains, indicating that 
these phages escaped CRISPR-Cas immunity. To determine the nature of this escape, we sequenced the target 
site of the different plaque-forming T4 phages (table S4, S5). The majority (23/34) of T4(C) and T4(hmC) phages 
that escaped from type I-E or type II-A immunity contained a single mutation in the target sequences. Almost 
all mutations (20/23) were located in the seed region of the target sequences. This is a region in the target site 
that is highly intolerant for mismatches during CRISPR mediated immunity (Künne et al., 2014). Surprisingly, for 
both systems none of the mutations were located in the PAM (Protospacer adjacent motif). The PAM is a short 
motif adjacent to the DNA target sequence (PAM) important for efficient target recognition and avoidance of 
self-targeting, and is commonly prone to accumulating escape mutations. 
Thus, several target DNA sequences in T4(C) and T4(hmC) phages escaping type I-E or II-A systems did not 
contain mutations. To ensure these phages were not revertants in which the T4(ghmC) genotype was restored, 
the dCTPase gene of the escape mutants was PCR amplified and sequenced. This confirmed that the T4(C) 
phages still had the dCTPase deficient genotype, which prevents incorporation of 5-ghmC, and suggests the 
mutants escaped CRISPR immunity in another way (Kutter and Wiberg, 1969). In contrast to T4(C) and T4(hmC) 
phages that successfully infected E. coli, none of the T4(ghmC) phages infecting E. coli expressing type I-E and 
type II-A systems had mutations in the DNA targeted by the CRISPR systems. Sequencing of escape mutant 
phages shows that T4(C) and T4(hmC) phages mostly escape CRISPR immunity by mutating the target sequence. 
In contrast, T4(ghmC) infection does not require mutation of DNA for efficient infection. This indicates that the 
5-ghmC modification itself allows efficient escape from type I-E and type II-A CRISPR-Cas systems 
DNA glucosylation inhibits Cascade target binding 
To understand the molecular basis for escape from CRISPR-Cas immunity, we reconstituted CRISPR interference 
with type I-E components in vitro (Figure 3A). After pre-incubation of crRNA-bound Cascade with unmodified, 
5-hmC, or 5-ghmC target DNA, the capacity of Cas3 to degrade these targets was assessed. Cas3, in conjunction 
with Cascade, was able to degrade 5-hmC DNA and the unmethylated control DNA, but no degradation of 5-
ghmC target DNA was observed (Figure 3B). To determine whether this was due to inhibition of Cas3 or rather 
due to inhibition of target binding by Cascade, we performed electrophoretic mobility shift assays (EMSAs) with 
Cascade (Figure 3C). The EMSAs showed that sequence-specific binding of targets containing 5-hmC is 
consistently reduced compared to targets containing unmodified cytosines. In addition, we were unable to 
observe binding of 5-ghmC targets, indicating that phages with glucosylated DNA escape from type I-E CRISPR 
immunity by preventing binding of Cascade to the target DNA. Even though reduced binding affinity of Cascade 
to targets containing 5-ghmC is reduced, thereby allowing escape from CRISPR-Cas interference, inability of 
Cas3 to cleave glucosylated DNA cannot be excluded even when stable binding of target DNA by Cascade would 
occur.  
 
Figure 3. Effect of T4 DNA modifications on type I-E CRISPR-Cas sgRNA mediated DNA targeting. (A) Schematic of 
DNA targeting and R-loop formation by Cascade. Modified cytosine residues are indicated in red. (B) Cleavage 
assay of Cas3 in conjunction with Cascade on 98 bp modified targets, indicated by black arrow. The marker is 
indicated by white arrows. Cascade effector complexes are loaded with either targeting crRNA (T crRNA) or 
non-targeting crRNA (NT crRNA). Restriction products of Cas3 are of undefined length. (C). Electrophoretic 
Mobility Shift Assay (EMSA) of Cascade on target DNA containing C, 5-hmC or 5-ghmC (indicated by black arrow) 
at increasing protein concentrations [nM]. Fraction of bound target is indicated by white arrows, dotted lines 
represent separate gels.  
Glucosylated DNA affects Cas9 binding and prevents target cleavage 
Next, we investigated if DNA modifications can prevent DNA targeting by type II-A Cas9 in vitro (Figure 4A). The 
ability of Cas9 to degrade unmodified, 5-hmC and 5-ghmC targets was assessed by incubation of a reconstituted 
Cas9-sgRNA-loaded complex with target DNAs. As for Cascade/Cas3, Cas9-sgRNA complexes were able to 
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cleave the 5-hmC DNA and the unmodified control DNA, but not the 5-ghmC DNA (Figure 4B). To determine 
the molecular basis for inhibition of 5-ghmC DNA cleavage, EMSAs were conducted using a catalytically inactive 
version of Cas9 (dCas9) (Figure 4C). Surprisingly, the assays showed that the sequence-specific binding of 5-
hmC target DNA is consistently increased compared to binding of unmodified DNA targets. In contrast, the 
binding affinity of 5-ghmC target DNA is consistently decreased compared to targets with unmodified DNA. 
Combined, these results indicate that 5-ghmC partially affects type II-A interference by lowering the binding 
affinity of Cas9-sgRNA complexes to the target DNA. Additionally, glucosylation may affect the ability of Cas9 
to restrict target DNA by protecting the scissile bonds from the catalytic residues, rendering Cas9-sgRNA 
complex-mediated interference even less effective.  
 
Figure 4. Effect of T4 DNA modifications on type II-A CRISPR-Cas sgRNA mediated DNA targeting. (A) Schematic 
of DNA targeting by Cas9. Modified cytosine residues are indicated in red. Cleavage sites are indicated by black 
arrows. (B) Cleavage assay of Cas9 on 98 bp modified targets (indicated by black arrow). Cas9 is loaded with 
either targeting sgRNA (T sgRNA) or non-targeting sgRNA (NT sgRNA). Restriction products of Cas9 are 61 and 
37 bp. (C) EMSA of dCas9 on target DNA containing C, 5-hmC or 5-ghmC (indicated by black arrow) at increasing 
protein concentrations [nM]. Fraction of bound target is indicated by white arrows.  
Glucosyl-5-hydroxymethylation of the PAM does not abolish cleavage by Cas9 
We next investigated whether glucosyl-5-hydroxymethylation of cytosines in the PAM region is sufficient to 
inhibit DNA cleavage by Cas9. Interactions between the target DNA and Cas9 are initiated at the PAM by two 
arginines probing the major groove for the two guanines in the 5’-NGG-3’ PAM (Sternberg et al., 2014). Upon 
PAM recognition, Cas9 sequentially unwinds the protospacer dsDNA and forms an R-loop structure between 
the target DNA strand and the guide RNA. Based on their location in the major groove of the DNA, we 
hypothesized that glucosyl-5-hydroxymethylation of the two cytosines (3’-NCC-5’) complementary to the 
guanines of the PAM could inhibit the PAM recognition process, and could abolish target cleavage. We utilized 
target DNA containing 5-hmC or 5-ghmC modifications either proximal to the protospacer (3’-NhmCC-5’), distal 
to the protospacer (3’-NChmC) or at both cytosine residues in the PAM-complementary region (3’-NhmChmC-5’). 
We found that Cas9-mediated cleavage of target DNA containing 5-hmC or 5-ghmC opposite the guanines in 
the 5’-NGG-3’ PAM was not inhibited by such modifications. Thus, cytosine glucosylating modifications of the 
PAM-complementary sequence are not sufficient and do not contribute to escape from Cas9-mediated 
interference (Figure 5). 
 
Figure 5. Effect of T4 DNA modifications of PAM-complementary cytosines on type II-A CRISPR-Cas sgRNA 
mediated DNA targeting. Cleavage assay of Cas9 on target DNA containing 5-hmC (indicated in red). Cas9 is 
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loaded with either targeting sgRNA (T sgRNA) or non-targeting sgRNA (NT sgRNA). Restriction products of Cas9 
are 57 and 33 bp. The marker is indicated by white arrows. 
DNA cleavage by Cas12a is not inhibited by glucosyl-5-hydroxymethylation 
To investigate the activity of type V-A Cas12a systems to cleave glucosylated DNA, we performed DNA cleavage 
assays using Cas12a from Francisella novicida (FnCas12a; Figure 6A). Strikingly, DNA cleavage assays with 
Cas12a-crRNA complex and various DNA targets reveal Cas12a activity is not affected by 5-hmC or 5-ghmC 
modifications of the target (Figure 6B). Furthermore, EMSAs with catalytically inactive Cas12a containing 
mutations E1006A and R1218A (dCas12a) (Swarts et al., 2017) shows similar binding affinities for unmodified, 
5-hmC, and 5-ghmC target DNA (Figure 6C). These results indicate that DNA targeting by Cas12a-crRNA 
complexes, in contrast to Cascade and Cas9-crRNA effector complexes, is not inhibited by 5-hmC or 5-ghmC 
modifications in the DNA.  
 
Figure 6. Effect of T4 DNA modifications on type V-A CRISPR-Cas sgRNA mediated DNA targeting. (A) Schematic 
of DNA targeting by Cas12a. Modified cytosine residues are indicated in red. Cleavage sites are indicated by 
black arrows. (B) Cleavage assay of Cas12a on 98 bp modified targets (indicated by black arrow). Cas12a is 
loaded with either targeting crRNA (C crRNA) or non-targeting crRNA (NC crRNA). Cleavage products of Cas12a 
are 49 and 44 bp. The marker is indicated by white arrows. (C). Electrophoretic Mobility Shift Assay (EMSA) of 
Cas12a on target DNA containing C, 5-hmC or 5-ghmC (indicated by black arrow) at increasing protein 
concentrations [nM]. Fraction of bound target is indicated by white arrows.  
Structural modelling of modified target DNA into crRNA-effector complexes 
In order to further understand the contrasting effects of DNA glucosylation on CRISPR-Cas effector complexes 
we analysed potential steric clashes of DNA modifications in the target and non-target strand of the DNA at 
each nucleotide position by statically modelling glucosyl-5-hydroxymethyl modified DNA in existing structural 
models of ternary effector complexes (E. coli Cascade (PDB: 5H9F (Hayes et al., 2016)), SpCas9 (PDB: 5F9R 
(Jiang et al., 2016)), and FnCas12a (PDB: 5NFV (Swarts et al., 2017))). As structures of 5-ghmC are not available, 
we used the structure of a 5-ghmT (PDB: 308D), in which the glucosyl-hydroxymethyl modification is also 
positioned on carbon 5 of the base. Static modelling does not take into account potential flexibility of 
polypeptide and nucleic acid chains, but allows for the identification of potential clashes and thereby could 
provide an idea about how effector complexes might accommodate modified DNA substrates. 
 
Figure 7. Potential steric clashes between target nucleotide 5-ghmC modifications and CRISPR effector proteins. 
(A) Multiple clashes (indicated in red) are observed between the polypeptide chains of Cascade and 5-ghmC 
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loaded with either targeting sgRNA (T sgRNA) or non-targeting sgRNA (NT sgRNA). Restriction products of Cas9 
are 57 and 33 bp. The marker is indicated by white arrows. 
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mutations E1006A and R1218A (dCas12a) (Swarts et al., 2017) shows similar binding affinities for unmodified, 
5-hmC, and 5-ghmC target DNA (Figure 6C). These results indicate that DNA targeting by Cas12a-crRNA 
complexes, in contrast to Cascade and Cas9-crRNA effector complexes, is not inhibited by 5-hmC or 5-ghmC 
modifications in the DNA.  
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Cas12a on target DNA containing C, 5-hmC or 5-ghmC (indicated by black arrow) at increasing protein 
concentrations [nM]. Fraction of bound target is indicated by white arrows.  
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each nucleotide position by statically modelling glucosyl-5-hydroxymethyl modified DNA in existing structural 
models of ternary effector complexes (E. coli Cascade (PDB: 5H9F (Hayes et al., 2016)), SpCas9 (PDB: 5F9R 
(Jiang et al., 2016)), and FnCas12a (PDB: 5NFV (Swarts et al., 2017))). As structures of 5-ghmC are not available, 
we used the structure of a 5-ghmT (PDB: 308D), in which the glucosyl-hydroxymethyl modification is also 
positioned on carbon 5 of the base. Static modelling does not take into account potential flexibility of 
polypeptide and nucleic acid chains, but allows for the identification of potential clashes and thereby could 
provide an idea about how effector complexes might accommodate modified DNA substrates. 
 
Figure 7. Potential steric clashes between target nucleotide 5-ghmC modifications and CRISPR effector proteins. 
(A) Multiple clashes (indicated in red) are observed between the polypeptide chains of Cascade and 5-ghmC 
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modifications of nucleotides in the target strand (TS, complementary to the crRNA) and non-target strand 
(NTS). (B) Clashes are mostly observed between the polypeptide chains of Cas9 and 5-ghmC modifications of 
nucleotides in the seed region. (C) No clashes are observed in the seed region for Cas12a. 
In both the Cascade and Cas9 models, multiple clashes are observed between the polypeptide chain and 5-
ghmC modifications of nucleotides in both target DNA strands (Figure A; 7B, table S6). Clashes with Cascade 
are observed for 17 out of 32 target strand nucleotides (TS, complementary to the crRNA) and for 3 out of 7 of 
the non-target strand (NTS) nucleotides of which the position is identified. Clashes with Cas9 are observed for 
3 out of 20 TS nucleotides and for 5 out of 9 of the NTS nucleotides that are structurally defined in the crystal 
structure of Cas9. Several of the modifications in both Cascade and Cas9 that cause steric clashes are located 
in the segment of the DNA that base-pairs with the crRNA seed sequence. Because interactions with the seed 
sequence are essential for R-loop formation and efficient targeting by both Cascade and Cas9 (Künne et al., 
2014), such clashes can explain why DNA targeting by Cascade and Cas9 is inhibited by 5-ghmC modifications 
of the target DNA. In contrast, such clashes are not observed in the Cas12a model, in which 5-ghmC 
modifications can be accommodated at almost all positions within the crRNA-target DNA heteroduplex (Figure 
C).  
It should be noted that for both Cas9 and Cas12a, clashes between the 5-ghmC modifications and the 
polypeptide chain are observed when 5-ghmC modifications are modelled onto the PAM nucleobases (Figure 
B; 7C). However, specifically these PAMs cannot contain cytosines at these positions (Fig. 7) since Cas9 and 
Cas12a recognize 5’-NGG-3’ and 5’-(T)TTN-3’ PAMs, respectively. In line with our biochemical experiments with 
Cas9 (Fig. 5), modifications of the cytosine nucleotides opposite to the 5’-NGG-3’ PAM do not appear to 
introduce clashes with the polypeptide chain of Cas9 in our models. In both models, additional clashes can be 
found upstream the protospacer-PAM segment, and within the PAM-distal protospacer region. Because these 
segments of the DNA are generally not essential for efficient DNA targeting (Cas9: (Fu et al., 
2013)/Cas12a:(Fonfara et al., 2016; Swarts et al., 2017; Zetsche et al., 2016)), we hypothesize that the potential 
clashes between 5-ghmC modifications and the polypeptide chain in our models will have a limited effect on 
DNA targeting. In summary, we conclude that 5-ghmC modifications in the target DNA are likely to result in 
clashes with Cascade and Cas9 and impair their DNA binding activity. However, Cas12a appears to be able to 
accommodate modified nucleobases due to a much more open structure. These models corroborate our 
experiments that demonstrate Cascade and Cas9 activity, but not Cas12a activity, is inhibited by 5-ghmC 
modification of target DNA. 
  
DISCUSSION 
Phages have evolved diverse systems that allow them to counteract bacterial defense mechanisms. Evasion 
from CRISPR-Cas defense can occur by mutation of the protospacer or PAM sequence (Deveau et al., 2008; 
McGrath et al., 1999; Semenova et al., 2011), target site deletion (Pyenson et al., 2017), genome 
recombination(Paez-Espino et al., 2015), or by production of anti-CRISPR proteins (Bondy-Denomy et al., 2015; 
Pawluk et al., 2014, 2016b). Here we show how chemical modifications of DNA nucleotides can render phages 
resistant to interference by specific CRISPR-Cas types. Our results demonstrate that CRISPR-Cas type I-E and 
type II-A interference is severely impaired by glucosyl modification of the cytosine bases (5-ghmC) in T4 phage 
DNA. However, the type V-A effector protein Cas12a remains able to bind and cleave T4 DNA even if it is 
glucosylated, suggesting the possibility that type V systems have evolved to combat covalently modified 
phages.  
Phage encoded DNA modifications are well known antagonists of microbial defense systems, most notably 
restriction-modification systems (Labrie et al., 2010). Apart from the known inhibitory effect of DNA 
modifications on R-M systems, the effect on CRISPR-Cas systems has been studied for some DNA modifications. 
Small modifications such as N6-methylation of adenine in 5’-GATC-3’ sequences do not prevent interference 
by the type II-A CRISPR-Cas system in Streptococcus thermophilus (Dupuis et al., 2013). Later, Yaung and 
colleagues showed that DNA modifications of T4 phages do not protect the phage from Cas9 interference 
(Yaung et al., 2014). By contrast and in line with our results, Bryson and colleagues showed that Cas9 
interference can be inhibited by glucosylation of DNA when using the naturally occurring combination of crRNA 
and trans-activating crRNA (tracRNA), and to a lower extent using the engineered single guide RNA (sgRNA) 
(Bryson et al., 2015). Also, the degree of inhibition is strongly dependent on the selected target DNA sequence, 
and therefore the positions of base modifications. While this manuscript was in preparation, Strotskaya and 
colleagues showed that no interference nor CRISPR array expansion was observed when T4 was targeted by 
the type I-E system in E. coli (Strotskaya et al., 2017).The insensitivity of T4 to CRISPR interference was 
attributed to either DNA modifications or to yet unknown phage mechanisms. Here we demonstrate that the 
insensitivity is a result of DNA modification.  
The inability of Cascade and Cas9 to bind and cleave 5-ghmC DNA is likely due to steric clashes between the 
glucose modifications of the protospacer segment of the target DNA and the polypeptide chain of the effector 
complexes. Our results show that Cas9 can still read the PAM nucleotides if only the PAM-complementary 
cytosines are glucosylated, which is in agreement with structural modeling. The inability of Cas9 to cleave fully 
glucosylated targets suggests that after successful PAM recognition, subsequent recognition of the protospacer 
is hampered. 
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modifications of nucleotides in the target strand (TS, complementary to the crRNA) and non-target strand 
(NTS). (B) Clashes are mostly observed between the polypeptide chains of Cas9 and 5-ghmC modifications of 
nucleotides in the seed region. (C) No clashes are observed in the seed region for Cas12a. 
In both the Cascade and Cas9 models, multiple clashes are observed between the polypeptide chain and 5-
ghmC modifications of nucleotides in both target DNA strands (Figure A; 7B, table S6). Clashes with Cascade 
are observed for 17 out of 32 target strand nucleotides (TS, complementary to the crRNA) and for 3 out of 7 of 
the non-target strand (NTS) nucleotides of which the position is identified. Clashes with Cas9 are observed for 
3 out of 20 TS nucleotides and for 5 out of 9 of the NTS nucleotides that are structurally defined in the crystal 
structure of Cas9. Several of the modifications in both Cascade and Cas9 that cause steric clashes are located 
in the segment of the DNA that base-pairs with the crRNA seed sequence. Because interactions with the seed 
sequence are essential for R-loop formation and efficient targeting by both Cascade and Cas9 (Künne et al., 
2014), such clashes can explain why DNA targeting by Cascade and Cas9 is inhibited by 5-ghmC modifications 
of the target DNA. In contrast, such clashes are not observed in the Cas12a model, in which 5-ghmC 
modifications can be accommodated at almost all positions within the crRNA-target DNA heteroduplex (Figure 
C).  
It should be noted that for both Cas9 and Cas12a, clashes between the 5-ghmC modifications and the 
polypeptide chain are observed when 5-ghmC modifications are modelled onto the PAM nucleobases (Figure 
B; 7C). However, specifically these PAMs cannot contain cytosines at these positions (Fig. 7) since Cas9 and 
Cas12a recognize 5’-NGG-3’ and 5’-(T)TTN-3’ PAMs, respectively. In line with our biochemical experiments with 
Cas9 (Fig. 5), modifications of the cytosine nucleotides opposite to the 5’-NGG-3’ PAM do not appear to 
introduce clashes with the polypeptide chain of Cas9 in our models. In both models, additional clashes can be 
found upstream the protospacer-PAM segment, and within the PAM-distal protospacer region. Because these 
segments of the DNA are generally not essential for efficient DNA targeting (Cas9: (Fu et al., 
2013)/Cas12a:(Fonfara et al., 2016; Swarts et al., 2017; Zetsche et al., 2016)), we hypothesize that the potential 
clashes between 5-ghmC modifications and the polypeptide chain in our models will have a limited effect on 
DNA targeting. In summary, we conclude that 5-ghmC modifications in the target DNA are likely to result in 
clashes with Cascade and Cas9 and impair their DNA binding activity. However, Cas12a appears to be able to 
accommodate modified nucleobases due to a much more open structure. These models corroborate our 
experiments that demonstrate Cascade and Cas9 activity, but not Cas12a activity, is inhibited by 5-ghmC 
modification of target DNA. 
  
DISCUSSION 
Phages have evolved diverse systems that allow them to counteract bacterial defense mechanisms. Evasion 
from CRISPR-Cas defense can occur by mutation of the protospacer or PAM sequence (Deveau et al., 2008; 
McGrath et al., 1999; Semenova et al., 2011), target site deletion (Pyenson et al., 2017), genome 
recombination(Paez-Espino et al., 2015), or by production of anti-CRISPR proteins (Bondy-Denomy et al., 2015; 
Pawluk et al., 2014, 2016b). Here we show how chemical modifications of DNA nucleotides can render phages 
resistant to interference by specific CRISPR-Cas types. Our results demonstrate that CRISPR-Cas type I-E and 
type II-A interference is severely impaired by glucosyl modification of the cytosine bases (5-ghmC) in T4 phage 
DNA. However, the type V-A effector protein Cas12a remains able to bind and cleave T4 DNA even if it is 
glucosylated, suggesting the possibility that type V systems have evolved to combat covalently modified 
phages.  
Phage encoded DNA modifications are well known antagonists of microbial defense systems, most notably 
restriction-modification systems (Labrie et al., 2010). Apart from the known inhibitory effect of DNA 
modifications on R-M systems, the effect on CRISPR-Cas systems has been studied for some DNA modifications. 
Small modifications such as N6-methylation of adenine in 5’-GATC-3’ sequences do not prevent interference 
by the type II-A CRISPR-Cas system in Streptococcus thermophilus (Dupuis et al., 2013). Later, Yaung and 
colleagues showed that DNA modifications of T4 phages do not protect the phage from Cas9 interference 
(Yaung et al., 2014). By contrast and in line with our results, Bryson and colleagues showed that Cas9 
interference can be inhibited by glucosylation of DNA when using the naturally occurring combination of crRNA 
and trans-activating crRNA (tracRNA), and to a lower extent using the engineered single guide RNA (sgRNA) 
(Bryson et al., 2015). Also, the degree of inhibition is strongly dependent on the selected target DNA sequence, 
and therefore the positions of base modifications. While this manuscript was in preparation, Strotskaya and 
colleagues showed that no interference nor CRISPR array expansion was observed when T4 was targeted by 
the type I-E system in E. coli (Strotskaya et al., 2017).The insensitivity of T4 to CRISPR interference was 
attributed to either DNA modifications or to yet unknown phage mechanisms. Here we demonstrate that the 
insensitivity is a result of DNA modification.  
The inability of Cascade and Cas9 to bind and cleave 5-ghmC DNA is likely due to steric clashes between the 
glucose modifications of the protospacer segment of the target DNA and the polypeptide chain of the effector 
complexes. Our results show that Cas9 can still read the PAM nucleotides if only the PAM-complementary 
cytosines are glucosylated, which is in agreement with structural modeling. The inability of Cas9 to cleave fully 
glucosylated targets suggests that after successful PAM recognition, subsequent recognition of the protospacer 
is hampered. 
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The effect of DNA modifications on CRISPR-Cas interference is most likely dependent on the target DNA 
sequence and thereby the degree of DNA modifications. Although Cas9 and Cas12a target roughly the same 
region of our tested target DNA, the chosen target sites are different and result in different degrees of DNA 
modifications in the seed regions of the protospacer (Cong et al., 2013; Jiang et al., 2013; Zetsche et al., 2015). 
However, our structural modeling suggests that Cas12a has an intrinsically more open architecture and we 
predict that it can accommodate and better deal with bulky DNA modifications regardless of their position in 
the protospacer. 
In addition to steric hindrance effects, changes in chemical presentation of nucleobases can result in decreased 
binding affinities. Changes in the chemical signature of the major and minor groove by replacement of guanines 
in the PAM with purine analogs is shown to attenuate binding affinities of the type I-F Csy complex in 
Pseudomonas aeruginosa (Rollins et al., 2015). Similarly, glucosylation of DNA is known to change the chemical 
signature and stability of the DNA duplex. Hydrogen bonds can be formed between the side groups of the 
glucosyl moieties and neighboring bases (Hunter, 1996). These interactions alter the roll, slide, and twist angles 
of base pairs (el Hassan and Calladine, 1996) which could impair R-loop formation and thereby prevent cleavage 
of the modified targets.  
While phage T4 contains 70% α-glucosylated and 30% β-glucosylated DNA, this study only examined the effect 
of β-glucosyl linkages in vitro (Lehman and Pratt, 1960). The effect of α-glucosyl-5-hydroxymethylation on 
CRISPR-Cas interference remains to be determined. Nevertheless, based on a comparable occupation of the 
major groove by α-5-ghmC, we expect there to be little or no differences between the effects of α- or β-coupled 
glucosyls on CRISPR interference. 
Our finding that DNA containing glucosyl-5-hydroxymethylated cytosine bases can be cleaved by a CRISPR-Cas 
type V-A system, but inhibits binding by crRNA-effector complexes from type I-E and II-A systems, has important 
implications that could be exploited for genome engineering applications (Vlot and Brouns, 2017). Firstly, Cas9 
is not inhibited by 5-hmC modifications which allows editing of cells with 5-hmC modified regions such as some 
neuronal cells (Kriaucionis and Heintz, 2009; Münzel et al., 2011). Secondly, the inhibitory effect of 5-ghmC on 
Cas9 targeting could be used to introduce non-cleavable DNA templates for homology directed repair (HDR) 
applications. Lastly, the seemingly robust activity of Cas12a could be harnessed for genome engineering of 
organisms and bacteriophages that contain hypermodified bases such as the pathogen Trypanosoma brucei 
(Gommers-Ampt and Borst, 1995) and phage T4. 
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region of our tested target DNA, the chosen target sites are different and result in different degrees of DNA 
modifications in the seed regions of the protospacer (Cong et al., 2013; Jiang et al., 2013; Zetsche et al., 2015). 
However, our structural modeling suggests that Cas12a has an intrinsically more open architecture and we 
predict that it can accommodate and better deal with bulky DNA modifications regardless of their position in 
the protospacer. 
In addition to steric hindrance effects, changes in chemical presentation of nucleobases can result in decreased 
binding affinities. Changes in the chemical signature of the major and minor groove by replacement of guanines 
in the PAM with purine analogs is shown to attenuate binding affinities of the type I-F Csy complex in 
Pseudomonas aeruginosa (Rollins et al., 2015). Similarly, glucosylation of DNA is known to change the chemical 
signature and stability of the DNA duplex. Hydrogen bonds can be formed between the side groups of the 
glucosyl moieties and neighboring bases (Hunter, 1996). These interactions alter the roll, slide, and twist angles 
of base pairs (el Hassan and Calladine, 1996) which could impair R-loop formation and thereby prevent cleavage 
of the modified targets.  
While phage T4 contains 70% α-glucosylated and 30% β-glucosylated DNA, this study only examined the effect 
of β-glucosyl linkages in vitro (Lehman and Pratt, 1960). The effect of α-glucosyl-5-hydroxymethylation on 
CRISPR-Cas interference remains to be determined. Nevertheless, based on a comparable occupation of the 
major groove by α-5-ghmC, we expect there to be little or no differences between the effects of α- or β-coupled 
glucosyls on CRISPR interference. 
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Cas9 targeting could be used to introduce non-cleavable DNA templates for homology directed repair (HDR) 
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Abstract 
Modified nucleobases can be found in all domains of life and in viruses, and play an important role in gene 
regulation and host defense. A well-studied example of modified nucleobases is the substitution of cytosine by 
glucosyl-5-hydroxymethylcytosine in bacteriophage T4, which provides the phage protection from host 
restriction enzymes. Here we introduced four genes from the DNA modification pathway of bacteriophage T4 
(gp42, gp1, gp56, and β-gt) into Escherichia coli and achieved a modification of approximately 15% of all 
cytosines. By leaving out the β-glucosyltransferase gene, a 5-hydroxymethylcytosine (5-hmC) intermediate is 
produced, which can be exploited for internal plasmid DNA labeling approaches in vitro using click chemistry-
compatible glucosyl groups. Covalent labelling of plasmids with fluorophores enabled single molecule particle 
analysis of plasmid DNA. We suggest that this method can be used for various DNA modification applications 
including plasmid labeling, immobilization and tracking.  
  
Introduction 
Modified bases in DNA have been found in organisms and their viruses across all domains of life (Gommers-
Ampt and Borst, 1995). The covalent chemical modifications of nucleobases range from simple methyl groups 
to amino acids and oligosaccharides. In eukaryotes, methylation of cytosines in CpG islands is used as a silencing 
mechanism (Bonasio et al., 2010; Jones, 2001). Recently, the discovery of low levels of 5-
hydroxymethylcytosine (5-hmC) in eukaryotes has led to new insights into epigenetic and 5-hmC is now 
considered to be the sixth base in higher eukaryotes (Münzel et al., 2011). Although base modifications have 
regained interest due to their role in epigenetic regulation in eukaryotes, they have long been known to be 
highly present in the genomes of bacteria and their viruses (i.e. bacteriophages). Methylation of host genomic 
DNA enables differentiation between foreign and non-foreign DNA by restriction and modification (R-M) 
systems and directs cleavage of non-modified phage DNA, protecting the cell from infection (Wilson and 
Murray, 1991). The role of DNA modifications in host defense was identified when phage λ propagated in E. 
coli strain C was shown to be unable to infect E. coli strain K12 (Arber et al., 1963). Sinuously, phages have 
harnessed DNA modification as a way to evade R-M systems (Labrie et al., 2010). Phage T4 encodes 
endonucleases DenA and DenB, which degrade the host DNA upon infection. De novo generated 5-hmC is 
incorporated in phage DNA and subsequently glucosylated by phage-encoded α- and β-glucosyltransferases 
(Figure ) (Lehman and Pratt, 1960). This glucosylation provides protection from cleavage by modification 
dependent systems (MDS), such as McrBC from E. coli that specifically degrades 5-hmC containing DNA (Raleigh 
and Wilson, 1986). Glucosyl-5-hydroxymethylcytosine (5-ghmC) is also found in the DNA of Trypanosoma 
brucei, the causative agent of sleeping sickness (van Leeuwen et al., 1998). 
 
Figure 1. Modifications of nucleobases in phage T4 DNA. (A) Cytosine base pairing with guanine. (B) 5-
hydroxymethylation of cytosine (5-hmC). (C) β-Glucosyl-5-hydroxymethylcytosine (5-ghmC) present in phage 
T4.  
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Biosynthesis of nucleotide precursors in E. coli is achieved by two metabolic pathways: the pyrimidine and 
purine pathways. The pyrimidine pathway leads to the production of dTTP and dCTP, the purine metabolism 
pathway leads to the production of dGTP and dATP (Fig 2B). T4 encodes a number of enzymes that form the 
dNTP synthase complex (DSC), a protein complex responsible for the efficient synthesis of 5-hmC (Moen et al., 
1988; Reddy et al., 1977; Shen et al., 2004). The DSC consists of at least eight phage-encoded proteins and two 
host encoded proteins (Supplementary table 1). Phage-encoded dCTPase gp56 converts cellular dCDP and dCTP 
to dCMP. Hydroxymethylase gp42 converts dCMP to 5-hydroxymethyl-deoxycytidine-monophosphate (5-
hmCMP), which is further phosphorylated to 5-hmdCTP by gp1 and incorporated in de novo synthesized DNA 
(Fig 2C). Post-replicative glucosylation by β-glucosyltransferase (β-gt) results in 5-ghmC.  
T4 β-glucosyltransferase has recently been applied in the quantification of 5-hmC in eukaryotic DNA (Li et al., 
2012; Nifker et al., 2015; Shahal et al., 2016). In these methods, 5-hmC containing DNA is converted to 6-azide-
β-glucosyl-5-hydroxymethylcytosine (N3-5-ghmC) using uridine-diphosphate-6-azide-glucose (UDP-6-N3-Gluc) 
after which a fluorescent label is linked to the azide group using click chemistry forming fluorescently labeled 
DNA. This possibility to couple functional groups to 5-hmC containing DNA inspired us to transfer the 5-hmC 
synthesis pathway of T4 to E. coli.  
To exploit the ability to couple click-chemistry compatible functional groups to large DNA molecules such as 
plasmids, we engineered the DNA modification pathway of bacteriophage T4 into E. coli by introducing four T4 
genes. 
Results 
Expression of 5-ghmC synthesis operon in E. coli 
To engineer the 5-ghmC synthesis pathway in E. coli, we constructed a plasmid (pGhmC) carrying the following 
genes from bacteriophage T4: gp42, gp1, gp56, and β-gt, encoding a dCMP hydroxymethylase, dNMP kinase, 
dCTPase, and β-glucosyltransferase, respectively. Expression of genes gp42, gp1, and β-gt was controlled by a 
rhamnose-inducible promoter. To control potential cytotoxicity of expression of dCTPase and uncouple it from 
the expression of gp42, gp1 and β-gt, we reversed the orientation of gp56, and transcriptionally isolated the 
gene between two rho-independent transcriptional terminators (Fig 2A). Expression of the four T4 genes 
encoded on pGhmC substitutes the production of cytosine by the production of 5-ghmC (Fig 2B & 2C). E. coli 
cells were transformed with pGhmC and plasmid DNA was isolated and digested with enzymes that are either 
sensitive to or selective for 5-hmC or 5-ghmC DNA (Figure ). AbaSI is a DNA modification-dependent 
endonuclease that recognizes 5-ghmC in double strand DNA. Additionally, AbaSI also recognized 5-hmC DNA, 
but at a lower efficiency than 5-ghmC. When the pGhmC plasmid was incubated with AbaSI, we observed 
almost complete DNA degradation, demonstrating the presence of 5-ghmC. McrBC is an endonuclease that 
cleaves 5-hmC containing DNA. When the pHmC plasmid was incubated with McrBC, we observed DNA 
degradation, demonstrating the presence of 5-hmC.  
 
Figure 2. Metabolic pathway for DNA synthesis in E. coli. (A) Four T4 genes encoded on plasmid pGhmC are 
responsible for the synthesis of 5-ghmC DNA. (B) DNA synthesis pathway in E. coli. (C). DNA synthesis in E. coli 
after introduction of the 5-ghmC synthesis pathway. Three T4 genes are required for the conversion of dCDP 
and dCTP to 5-hydroxymethyl-2’-cytidine. T4 β-glucosyltransferase glucosylates 5-hmC in a post-replicative 
process. 
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Figure 3. Modification-dependent degradation of plasmid DNA. Degradation of pGhmC DNA by AbaSI 
demonstrates the presence of 5-ghmC. Degradation of pHmC DNA by McrBC demonstrates the presence of 5-
hmC. Unmodified DNA of pGG0 is degraded by neither AbaSI nor McrBC.  
To validate that all four genes were essential for the production of 5-ghmC, we constructed plasmids lacking 
either gene gp42, gp1, gp56, or β-gt. Restriction digest analysis indeed showed that all four genes are required 
for efficient production of 5-ghmC (Fig S1). As expected, the deletion of gene β-gt results in 5-hmC DNA. The 
deletion of genes gp1, gp42, and gp56 results in cytosine containing DNA, showing that genes are essential.. 
We observed that when cells containing pGhmC were cultured for a period longer than one day, isolated 
plasmid DNA could not be cleaved by AbaSI, suggesting instability of the expression of the construct. To further 
investigate the toxicity of the expression of the 5-ghmC synthesis operon we performed growth experiments 
in which we monitored the optical density of the cultures. Cells containing pGhmC or pHmC showed a slower 
growth rate in the exponential phase and lower cell density in the stationary phase compared with cells 
containing the control plasmid pMK0 (Fig S2).  
To attempt to further increase the substitution levels of cytosine by 5-hmC or 5-ghmC by increasing the dCMP 
pool we removed the transcriptional terminator upstream the gp56 dCTPase gene. Surprisingly, isolated 
plasmid DNA showed no degradation by AbaSI, indicating the absence of 5-ghmC in the DNA. This suggests that 
the expression levels of dCTPase are too high after removal of the transcriptional terminator, leading to 
cytotoxicity.  
Determination of substitution levels 
To determine the substitution levels of cytosine by 5-hmC or 5-ghmC, we analyzed the plasmid DNA using HPLC-
UV detection. Plasmids pMK0, pHmC, and pGhmC were digested and analyzed using high-performance liquid 
chromatography ultraviolet (HPLC-UV). 5-hmdC levels were calculated by comparing the peak areas of plasmid 
digests with a 5-hmdC standard. pHmC DNA contains a cytosine substitution level of approximately 13-15% 5-
hmdC under the tested circumstances (Figure 47). Enzymatically digested DNA was further analyzed by liquid 
chromatography mass spectrometry (LC-MS) (Fig S4). Using this method we were able to confirm the presence 
of 5-ghmdC by identification of the [M +H]+ ions of 5-ghmdC (m/z 420.2) (Figure ). Identification of [M +H]+ 
ions of 5-ghmC (m/z 304.2) is attributed to the elimination of a 2-deoxyribose moiety from 5-ghmdC caused by 
cleavage of the N-glycosidic linkage.  
 
Figure 47. Quantification of 5-hmC levels of nucleosides from digested plasmid DNA. (A) HLPC analysis of 
nucleoside standards. (B) HPLC analysis of digested pHmC DNA.  
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Figure 47. Quantification of 5-hmC levels of nucleosides from digested plasmid DNA. (A) HLPC analysis of 
nucleoside standards. (B) HPLC analysis of digested pHmC DNA.  
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Figure 5. LC-MS analysis of 5-ghmC levels of nucleosides from digested 5-ghmC DNA. Presence of 5-ghmC in 
plasmid pGhmC was confirmed by identification of the [M +H]+ ions of 5-ghmdC (m/z 420.2). Identification of 
[M +H]+ ions of 5-ghmC (m/z 304.2) is attributed to the elimination of a 2-deoxyribose moiety from 5-ghmdC 
caused by cleavage of the N-glycosidic linkage.  
Coupling of functional groups to 5-hmC containing plasmid DNA 
To label plasmid DNA with a fluorophore, selective tagging by copper-free click chemistry was used (Baskin et 
al., 2007). T4 β-glucosyltransferase was used to catalyze the transfer of an azido-sugar from chemically 
synthesized UDP-6-deoxy-6-azido-glucose (6-N3-UDPG) to the allylic hydroxyl group of 5-hmC. The plasmids 
were then fluorescently labeled with dibenzocyclooctyne-Cy5 (DCBO-Cy5) and Cy5 fluorescence emission at 
670 nm was used to assess the degree of labelling. Based on the relative fluorescence units (RFU) of the 
spectrum between 590 and 720 nm, we concluded that on average there are 4-5 fluorophores per plasmid 
molecule (Fig S3). To assess the functionality of the labeling, we immobilized the plasmid DNA on glass slides 
and imaged the samples using TIRF microscopy. By depositing samples of purified and washed pHmC-Cy5 on 
glass slides, single fluorescent spots could be visualized. By analysing the point-spread function, information 
about the number of fluorophores and their intensities could be compared to pMK0-Cy5 and pGhmC-Cy5 
negative control plasmids (Fig 6). The pHmC-Cy5 sample contained approximately 2.1*102 fluorescent 
molecules per mm2, which is approximately 20 times higher than either the pMK0-Cy5and approximately 9 
times higher than pGhmC-Cy5 samples. This demonstrates successful labelling of the 5-hmC-containing plasmid 
DNA (Fig 6). The low number of localizations when imaging pGhmC-Cy5 plasmids suggests that almost all 5-
hmC nucleobases are glucosylated in vivo by β-glucosyltransferase.  
 
Figure 6. Fluorescence microscopy imaging of plasmids labeled with Cy5. Labeling of plasmid DNA with Cy5 is 
specific to pHmC.  
Single plasmid photobleaching analysis 
Illumination of Cy5 with the excitation laser of 642 nm causes photobleaching and switching to the non-
fluorescent OFF-state of the fluorophores. Time traces of individual fluorescent spots show the step-wise 
decrease or increase of fluorescence intensity (Fig 7). The number of steps corresponds to the number of 
fluorophores labeled in the plasmid. To confirm that the image signal originates from Cy5, we used recovery to 
the fluorescent ON-state using a 405 nm laser. Fluorescence of the spots was recovered indicating the presence 
of Cy5.  
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Figure 7. Step-wise photobleaching and recovery of Cy5 fluorophores labeled to pHmC DNA of two individual 
time traces. Recovery and bleaching of individual Cy5 fluorophores is indicated by the red lines.  
Discussion 
In this work we present the introduction the of 5-hmC and 5-ghmC synthesis pathway from T4 into E. coli and 
we demonstrate its utility proof of concept by covalent coupling of functional groups to plasmid DNA. The 
introduction of 5-hmC and 5-ghmC synthesis pathway from T4 may provide insights into the effect of 5-hmC 
and 5-ghmC on regulatory processes in E. coli. The relatively modest levels of incorporation are beneficial when 
only low levels of labels are desirable, for example when immobilizing a plasmid on a surface. The levels of 
substitution of cytosine by 5-hmC can potentially be increased by increasing the expression levels of the 
introduced T4 genes. While this work was in progress, Mehta and colleagues published a similar approach of 
introducing the 5-ghmC synthesis pathway in E. coli (Mehta et al., 2016). Achieved substitution levels in plasmid 
DNA were approximately 71% and 45% for 5-hmC and 5-ghmC, respectively. The higher substitution levels, 
compared to our results, can likely be attributed to the use of codon-optimized T4 genes and higher plasmid 
copy numbers.  
Labeling of DNA with fluorophores is commonly used to visualize DNA molecules, however available methods 
are often restricted to short oligonucleotides. In contrast our method can be used for labeling DNA molecules 
of any size, including genomic DNA. Further steps are also easy to implement, making our design a generally 
applicable method for DNA labeling. In addition, covalent coupling of azide groups to DNA molecules allows 
labeling of any click-chemistry compatible functional group. Labeling of 5-hmC-azide with biotin could be used 
as a method to immobilize DNA. Alternatively, DNA may be labeled with peptides, non-fluorescent dyes, 
magnetic beads, or gold particles. This work creates a modular method for functionalization of DNA and opens 
up new DNA-labeling approaches.  
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labeling of any click-chemistry compatible functional group. Labeling of 5-hmC-azide with biotin could be used 
as a method to immobilize DNA. Alternatively, DNA may be labeled with peptides, non-fluorescent dyes, 
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Materials and Methods 
Strains and constructs 
E. coli strain cloni 10G (Lucigen) (relevant genotype: endA1 recA1 mcrA Δ(mrr-hsdRMS-mcrBC) galU galK) was 
used for all analytical experiments. E. coli 10G was made chemically competent using the RuCl method and 
transformed with plasmid DNA by applying a heat-shock as described in the QIAexpressionist handbook 
(QIAGEN). Cells were grown in Luria Broth (LB; 10 g·L−1 NaCl, 5 g·L−1yeast extract, and 10 g·L−1 tryptone) at 
180 rpm or on LB-agar plates containing 1.5% (wt·vol−1) agar. To repress expression of the construct, 0.2% 
glucose was supplemented to the medium. 0.2% Rhamnose was used for induction of protein expression. When 
required, medium was supplemented with kanamycin (Km; 50 μg·mL−1). Bacterial growth was measured at 
600 nm (OD600).  
Sequences of genes 42, 1, B-gt, and 56 were selected from phage T4 (GenBank: AF158101.6) and unwanted 
restriction sites were deleted. The operon was assembled from synthetic oligonucleotides and/or PCR products 
and cloned into pMK-RQ (kanR) by GeneArt (Life Technologies). E. coli K12 was transformed with the synthetic 
construct and cells were grown followed by plasmid isolation. All subsequent experiments were performed in 
E. cloni 10G.  
To create the constructs that lack one of the 5-ghmC operon genes, pGhmC was restricted using the enzymes 
listed in (Supplementary table 2). Following restriction, plasmids were re-ligated using T4 DNA ligase and used 
to transform E. coli 10G.  
Molecular Biology and DNA Sequencing.  
All strains and plasmids were confirmed by PCR and sequencing (GATC-Biotech). Plasmids were prepared using 
GeneJET Plasmid Miniprep Kits (Thermo Scientific) and DNA from PCR and agarose gels was purified using the 
Thermo Scientific GeneJET PCR Purification and Gel Extraction Kits. 
Restriction analysis of DNA  
DNA was restricted using 10U of enzyme in the recommended buffers and conditions. The products were 
visualized on a 1% agarose gel that was stained after running the gel.  
HPLC analysis of nucleosides 
In order to unambiguously confirm that modified dNTPs are incorporated into the PCR products of dsDNA, we 
digested the DNA products and identified the presence of the modified nucleosides based on their retention 
times using HPLC with a UV analysis. Nucleoside standards were generated from dNTPs (10 mM) with 1U shrimp 
alkaline phosphatase (NEB) at 37°C for 60 minutes and purified using 3K Nanosep Centrifugal Devices (PALL Life 
Sciences), centrifuged at 5000 g for 6-15 minutes. The dsDNA PCR products were digested using 5U DNA 
Degradase (Zymo Research) at 37°C for 120 minutes and  3 U shrimp alkaline phosphatase (NEB), at 37°C for 
60 minutes and purified by Nanosep Centrifugal Devices (3K). Analysis of the nucleosides was performed using 
Dionex UltiMate 3000 (Thermo Scientific) using a 50 X 2.1 mm Accucore C30 column (Thermo Scientific). Buffer 
A 5% ammonium acetate (HPLC grade, Sigma-Aldrich), buffer B was 40% acetonitrile (Thermo Scientific). The 
temperature for column compartment was 30°C, flow rate was 0.2 ml/min. Absorbance was recorded at 260 
nm. 
LC-MS analysis 
The online LC part coupled to the MS analysis used was an UltiMate 3000 capillary LC system (Dionex), with 
different columns used for nucleosides separation. For Pursuit 3u C18 column (150*4.6mm, VARIAN) and 
AccucoreTM C30 (50 × 2.1 mm, 2.6 µm particle size, Thermo Scientific) column, the chromatograph was 
performed using buffer A (5 mM ammonium acetate, pH 4.5, Sigma) and buffer B (40% acetonitrile (v/v), Fisher 
Scientific), with linear gradients of buffer B increase form 3% to 20% in 17 minutes, then to 80% in 1 minute, 
at a constant flow rate of 5 µl/min. For HypercarbTM porous graphitic carbon column (100 × 2.1 mm, 3 µm 
particle size, Thermo Scientific) A gradient elution was performed using buffer A (10 mM ammonium acetate, 
pH 4.5, Sigma) and buffer B (40% acetonitrile (v/v), Fisher Scientific, and 10 mM ammonium acetate, pH 4.5, 
Sigma), with linear gradients of buffer B increase form 20% to 80% in 15 minutes, then switched to 100% buffer 
C (95% methanol (v/v), Fisher Scientific) for 3 minutes, then back to 20% B and 80% A in 1.1 minutes, at a 
constant flow rate of 200 µl/min. MS analysis was conducted on MaXis UHR TOF mass spectrometer (Bruker) 
equipped with an ESI nano sprayer source, Electrospray needle voltage was set to 4500V. Scan range of MS1 
profile was set to m/z 100-800 in positive ion mode. Spectra data were analyzed using a Compass DataAnalysis 
software (version 4.1.359.0).   
Microscopy setup 
Imaging was performed on a home-built microscope similar to one described elsewhere [Farooq and Hohlbein, 
PCCP 17, 27862, 2015]. In short, laser light of 405 nm at and/or 642 nm from a fibre-coupled laser engine 
(Omicron, Germany) is directed towards an 100x 1.49 NA HP SR TIRF objective (Nikon, Japan) via a set of 
collimation and focusing lenses (Thorlabs, Germany), in total internal reflection fluorescence (TIRF) or highly 
inclined illumination (HiLo) mode. Emission light is separated from the excitation light via a dichroic mirror 
(Chroma, USA), spectrally filtered between 663-738 nm and falls on an Andor Zyla 4.2 plus sCMOS camera 
(Andor, Northern-Ireland). Only the centre of the chip was used, where a homogeneous excitation laser power 
was applied. 
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Thermo Scientific GeneJET PCR Purification and Gel Extraction Kits. 
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DNA was restricted using 10U of enzyme in the recommended buffers and conditions. The products were 
visualized on a 1% agarose gel that was stained after running the gel.  
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In order to unambiguously confirm that modified dNTPs are incorporated into the PCR products of dsDNA, we 
digested the DNA products and identified the presence of the modified nucleosides based on their retention 
times using HPLC with a UV analysis. Nucleoside standards were generated from dNTPs (10 mM) with 1U shrimp 
alkaline phosphatase (NEB) at 37°C for 60 minutes and purified using 3K Nanosep Centrifugal Devices (PALL Life 
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The online LC part coupled to the MS analysis used was an UltiMate 3000 capillary LC system (Dionex), with 
different columns used for nucleosides separation. For Pursuit 3u C18 column (150*4.6mm, VARIAN) and 
AccucoreTM C30 (50 × 2.1 mm, 2.6 µm particle size, Thermo Scientific) column, the chromatograph was 
performed using buffer A (5 mM ammonium acetate, pH 4.5, Sigma) and buffer B (40% acetonitrile (v/v), Fisher 
Scientific), with linear gradients of buffer B increase form 3% to 20% in 17 minutes, then to 80% in 1 minute, 
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constant flow rate of 200 µl/min. MS analysis was conducted on MaXis UHR TOF mass spectrometer (Bruker) 
equipped with an ESI nano sprayer source, Electrospray needle voltage was set to 4500V. Scan range of MS1 
profile was set to m/z 100-800 in positive ion mode. Spectra data were analyzed using a Compass DataAnalysis 
software (version 4.1.359.0).   
Microscopy setup 
Imaging was performed on a home-built microscope similar to one described elsewhere [Farooq and Hohlbein, 
PCCP 17, 27862, 2015]. In short, laser light of 405 nm at and/or 642 nm from a fibre-coupled laser engine 
(Omicron, Germany) is directed towards an 100x 1.49 NA HP SR TIRF objective (Nikon, Japan) via a set of 
collimation and focusing lenses (Thorlabs, Germany), in total internal reflection fluorescence (TIRF) or highly 
inclined illumination (HiLo) mode. Emission light is separated from the excitation light via a dichroic mirror 
(Chroma, USA), spectrally filtered between 663-738 nm and falls on an Andor Zyla 4.2 plus sCMOS camera 
(Andor, Northern-Ireland). Only the centre of the chip was used, where a homogeneous excitation laser power 
was applied. 
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Preparation of Cy5 labeled DNA 
Plasmids were labeled using a copper-free click reaction, described by Song and colleagues (2011) with a few 
adjustments. A stock solution of 250 ng/μL DNA was prepared for the reaction. 20 μL of DNA (5 μg total) was 
mixed with 2 μL of Uridine 5′-diphospho-6-azide-glucose (UDPG-N3) (150 μM final concentration), 1 μL of T4-
β-glycosyl transferase (β-GT) (10 units), 3 μL cut-smart buffer (CS) and 4 μL of MQ, giving a total reaction volume 
of 30 μL. The samples were incubated at 37 ˚C overnight. The following day the excess UDPG-N3 was removed 
using the DNA cleaner & concentrator (5) kit from Zymo. 60 μL binding buffer was added to the reaction mixture 
(2:1) and loaded on a silica column. The DNA was washed two times with 250 μL washing buffer and eluted in 
30 μL of MQ. 5 μL of PBS buffer (10 mM final concentration) and 5 μL of DBCO-Cy5 (0.5 mM final concentration) 
was added to the DNA. Incubation was performed at 37 ˚C overnight. The excess DBCO-Cy5 was removed using 
the DNA clean & concentrator (5) kit from Zymo and eluted in 30 μL MQ. The final DNA concentration was 
determined using the Qubit DNA quantification kit and the presence of Cy5 in the sample was confirmed and 
the quantity approximated using the basic fluorometer-app on a DeNovix DS 11 spectrophotometer.  
Imaging of fluorescently labeled plasmids using TIRF microscopy  
Glass cover slides were first cleaned by burning at 500 °C for 20 minutes, and were coated with Vectabond 
(Vector Labs, Burlingame, Ca, USA) by immersing them for 5 minutes in a 2% Vectabond solution in acetone. 
Afterwards, 10 µl of a purified and washed 10 pg/µl DNA solution was placed on the treated glass slides, 
incubated for 1 minute, and washed with phosphate-buffered saline solution. During measurements, fresh 
gloxy solution (Nahidiazar et al., 2016) was deposited on the glass slides to minimize bleaching effects.  
For the acquisition HiLo illumination with 3.7 W/cm2 642 nm laser intensity and 2.1 mW/cm2 405 nm laser 
intensity were used. The density of fluorophores detected after bleaching the sample for 50 seconds with the 
642 nm laser and re-activation with the 405 nm laser is reported for the samples. The acquisition rate of the 
camera was set to 10 ms. The mean counts of at least three different positions of the sample is presented as 
data. 
Data analysis 
The position, intensity, and number of fluorescent particles detected in different conditions was determined 
by using ThunderSTORM (Ovesny et al., 2014) with the pSMLM plug-in (Martens et al., 2018). The default 
ThunderSTORM settings were used, but using a local maximum detection equal to 1.5 times the standard 
deviation of F1 of the wavelet filter and a pSMLM sub-pixel analysis with a radius of 4 pixels. Only fluorescent 
spots with an intensity count larger than three times the average intensity of non-pHmC-Cy5 were considered 
in the analysis. Analysis was confined to the last 500 frames of every measurement. Further analysis was 
performed using custom-written MATLAB (The MathWorks) scripts. 
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642 nm laser and re-activation with the 405 nm laser is reported for the samples. The acquisition rate of the 
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data. 
Data analysis 
The position, intensity, and number of fluorescent particles detected in different conditions was determined 
by using ThunderSTORM (Ovesny et al., 2014) with the pSMLM plug-in (Martens et al., 2018). The default 
ThunderSTORM settings were used, but using a local maximum detection equal to 1.5 times the standard 
deviation of F1 of the wavelet filter and a pSMLM sub-pixel analysis with a radius of 4 pixels. Only fluorescent 
spots with an intensity count larger than three times the average intensity of non-pHmC-Cy5 were considered 
in the analysis. Analysis was confined to the last 500 frames of every measurement. Further analysis was 
performed using custom-written MATLAB (The MathWorks) scripts. 
 
  
References 
Arber, W., Hattman, S., and Dussoix, D. (1963). On the Host-Controlled of Bacteriophage Lambda. Virology 35, 
30–35. 
Baskin, J.M., Prescher, J.A., Laughlin, S.T., Agard, N.J., Chang, P. V., Miller, I.A., Lo, A., Codelli, J.A., and Bertozzi, 
C.R. (2007). Copper-free click chemistry for dynamic in vivo imaging. Proc. Natl. Acad. Sci. 104, 16793–
16797. 
Bonasio, R., Tu, S., and Reinberg, D. (2010). Molecular Signals of Epigenetic States. Science (80-. ). 330, 612–
616. 
Farooq, S., and Hohlbein, J. (2015). Camera-based single-molecule FRET detection with improved time 
resolution. Phys. Chem. Chem. Phys. 17, 27862–27872. 
Gommers-Ampt, J.H., and Borst, P. (1995). Hypermodified bases in DNA. FASEB J. 9, 1034–1042. 
Jones, P.A. (2001). The Role of DNA Methylation in Mammalian Epigenetics. Science (80-. ). 293, 1068–1070. 
Labrie, S.J., Samson, J.E., and Moineau, S. (2010). Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 
8, 317–327. 
van Leeuwen, F., Taylor, M.C., Mondragon, A., Moreau, H., Gibson, W., Kieft, R., and Borst, P. (1998). beta-D-
glucosyl-hydroxymethyluracil is a conserved DNA modification in kinetoplastid protozoans and is abundant 
in their telomeres. Proc. Natl. Acad. Sci. U. S. A. 95, 2366–2371. 
Lehman, I.R., and Pratt, E. a. (1960). On the structure of the glucosylated hydroxymethylcytosine nucleotides 
of coliphages T2, T4, and T6. J. Biol. Chem. 235, 3254–3259. 
Li, Y., Song, C.-X., He, C., and Jin, P. (2012). Selective Capture of 5-hydroxymethylcytosine from Genomic DNA. 
J. Vis. Exp. 3–6. 
Martens, K.J.A., Bader, A.N., Baas, S., Rieger, B., and Hohlbein, J. (2018). Phasor based single-molecule 
localization microscopy in 3D (pSMLM-3D): An algorithm for MHz localization rates using standard CPUs. 
J. Chem. Phys. 148. 
Mehta, A.P., Li, H., Reed, S.A., Supekova, L., Javahishvili, T., and Schultz, P.G. (2016). Replacement of 2′-
Deoxycytidine by 2′-Deoxycytidine Analogues in the E. coli Genome. J. Am. Chem. Soc. jacs.6b09661. 
Moen, L.K., Howell, M.L., Lasser, G.W., and Mathews, C.K. (1988). T4 phage deoxyribonucleoside triphosphate 
synthetase: purification of an enzyme complex and identification of gene products required for integrity. 
J. Mol. Recognit. 1, 48–57. 
Münzel, M., Globisch, D., and Carell, T. (2011). 5-Hydroxymethylcytosine, the Sixth Base of the Genome. Angew. 
Chemie - Int. Ed. 50, 6460–6468. 
Nahidiazar, L., Agronskaia, A. V., Broertjes, J., Van Broek, B. Den, and Jalink, K. (2016). Optimizing imaging 
conditions for demanding multi-color super resolution localization microscopy. PLoS One 11, 1–18. 
Nifker, G., Levy-Sakin, M., Berkov-Zrihen, Y., Shahal, T., Gabrieli, T., Fridman, M., and Ebenstein, Y. (2015). One-
Pot Chemoenzymatic Cascade for Labeling of the Epigenetic Marker 5-Hydroxymethylcytosine. 
ChemBioChem 16, 1857–1860. 
Ovesny, M., Krizek, P., Borkovec, J., Svindrych, Z., and Hagen, G.M. (2014). ThunderSTORM: a comprehensive 
ImageJ plug-in for PALM and STORM data analysis and super-resolution imaging. Bioinformatics 30, 2389–
2390. 
Raleigh, E.A., and Wilson, G. (1986). Escherichia coli K-12 restricts DNA containing 5-methylcytosine. Proc. Natl. 
Acad. Sci. U. S. A. 83, 9070–9074. 
Reddy, G.P., Singh, A., Stafford, M.E., and Mathews, C.K. (1977). Enzyme associations in T4 phage DNA 
precursor synthesis. Proc. Natl. Acad. Sci. U. S. A. 74, 3152–3156. 
Shahal, T., Green, O., Hananel, U., Michaeli, Y., Shabat, D., and Ebenstein, Y. (2016). Simple and cost-effective 
fluorescent labeling of 5-hydroxymethylcytosine. Methods Appl. Fluoresc. 4, 44003. 
Shen, R., Olcott, M.C., Kim, J., Rajagopal, I., and Mathews, C.K. (2004). Escherichia coli nucleoside diphosphate 
kinase interactions with T4 phage proteins of deoxyribonucleotide synthesis and possible regulatory 
functions. J. Biol. Chem. 279, 32225–32232. 
Wilson, G.G., and Murray, N.E. (1991). Restriction and modification systems. Annu. Rev. Genet. 25, 585–627. 
 
 
  
128
Chapter 6
Supplementary data 
 
 
Supplementary figure 1. Restriction analysis of plasmids lacking individual T4 genes. Inability of AbaSI to degrade 
plasmid DNA demonstrates the absence of 5-ghmC. The minor degradation of the plasmid lacking β-
glucosyltransferase (Δβ-gt) indicates the presence of 5-hmC. 
 
Supplementary figure 2. Growth curves of E. coli cells harboring plasmid pGhmC, pHmC or negative control 
plasmid pMK0 or pGhmC lacking gene 42 (pGhmCΔH).  
 
Supplementary figure 3. Absorption spectra of DCBO-Cy5 (top) and plasmid pHmC labeled with Cy5 (bottom). 
Peaks at 666 nm show emission by Cy5 molecules. 
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Supplementary figure 4. LC-MS analysis of 5-ghmC levels of nucleosides from digested 5-ghmC DNA. Presence of 
5-ghmC in PCR products was confirmed by identification of the [M +H]+ ions of 5-ghmdC (m/z 420.2). 
Identification of [M +H]+ ions of 5-ghmC (m/z 304.2) is attributed to the elimination of a 2-deoxyribose moiety 
from 5-ghmdC caused by cleavage of the N-glycosidic linkage.  
  
Supplementary table 1. Enzymes of the DSC. 
Name Encoded by Gene EC number 
dCMP Hmase T4 42 2.1.2.8 
dTMP synthase T4 td 2.1.1.45 
Ribonucleotide reductase T4 nrdA & nrdB 1.17.4.1 
dCTPase T4 56 3.6.1.12 
Dihydrofolate reductase T4 frd 1.5.1.3 
dNMP kinase T4 1 2.7.4.13 
dCMP deaminase T4 cd 3.5.4.12 
Thymidine kinase T4 tk 2.7.1.21 
NDP kinase E. coli ndk 2.7.4.6 
dAMP kinase E. coli adk 2.7.4.3 
 
Supplementary table 2. Enzymes used for construction of plasmids lacking one gene of the ghmC operon. 
Construct 
name 
Deleted gene Enzymes used Phenotype   
pGhmC - - ghmC   
pΔ56 dCTPase MfeI & EcoRI ghmC   
pHmC B-glucosyltransferase PvuI & PacI hmC   
p Δ1 dNMP kinase AscI & MluI C   
p Δ42  dCMP hydroxymethylase XmaI & BspEI C   
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Chapter 7
Summary 
This thesis is about molecular studies on CRISPR-Cas systems, the isolation and characterization of a 
bacteriophage, and the engineering of a pathway in E. coli that results in the synthesis of modified nucleotides. 
Admitted, these topics do initially not seem to have much in common, besides all being interesting subjects of 
research in the field of molecular microbiology. However, the careful reader will realize that these topics are 
actually interconnected by a common denominator: bacteriophage-host interactions. Below I will summarize 
our findings in our efforts to elucidate the mechanisms involved in anti-viral defense systems and explain how 
this led to the introduction of a nucleotide modification pathway in E. coli.  
 
In chapter 1, we describe that bacteria and archaea are under constant threat by their viruses, bacteriophages 
(phages). In response to this selective pressure, prokaryotes have developed multiple strategies to protect from 
phage infection. Mechanisms that protect prokaryotes from phage infection include inhibition of phage 
adsorption, superinfection exclusion, restriction-modification, BREX, DISARM, toxin-antitoxin systems, and 
CRISPR-Cas systems. Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated 
(Cas) systems were the first adaptive and heritable immunity systems found in prokaryotes and provide 
prokaryotes with resistance against mobile genetic elements. CRISPR-Cas systems function in three stages; 
adaptation, expression, and interference. In the adaptation process, invader DNA sequences are incorporated 
into a CRISPR array. In the expression stage CRISPR arrays are transcribed into pre-CRISPR RNA (pre-crRNA) and 
further processed into CRISPR RNAs (crRNAs). In the interference stage, CRISPR-Cas effector complexes loaded 
with crRNA bind their cognate foreign DNA targets (termed “protospacers”) when flanked by a protospacer-
adjacent motif (PAM) followed by degradation of target DNA.  
We also discuss several mechanisms by which bacteriophages can evade antiviral defense systems. One 
common way to evade these systems by phages is by modifying their nucleic acids. Phage DNA can be modified 
either in the same way as the host DNA, making differentiation between host DNA and phage DNA impossible, 
or in such a way that the phage DNA is not recognized at all. Besides their role in host defense systems, DNA 
modification can play a role in regulation of gene expression and other regulatory processes.  
Chapter 2, 3, and 6, describe research that makes use of single-molecule microscopy. Considering that these 
techniques might not be familiar to all readers, we provide a short introduction to these techniques in chapter 
1.  
 
In chapter 2, we investigate the interaction of the CRISPR-Cas complex Cascade from E. coli with bona fide and 
mutated target DNA. Target binding by Cascade is determined by complementarity of the crRNA and the 
protospacer, with the additional requirement of an immediately neighboring trinucleotide protospacer 
adjacent motif (PAM). Upon successful recognition of the PAM and the first 8 nucleotides of the target DNA, a 
so-called R-loop is formed. We developed a single-molecule FRET assay to monitor the recognition of target 
DNA and the formation of the R-loop in real-time. We identified two different modes of binding exhibited by 
Cascade that are dependent on the target DNA. A long-lived binding event can be detected when a target has 
a correct PAM and is fully complementary to the crRNA. However, when the target DNA is mutated or does not 
have a correct PAM, target binding by Cascade takes place as a short-lived event. We propose a model in which 
the R-loop formation will be “locked” upon successful recognition of a bona fide target. This locked state 
recruits the CRISPR-associated nuclease-helicase Cas3 which leads to subsequent target degradation. 
In case of partial recognition of a mutated target, the R-loop cannot be propagated over the full length of the 
protospacer and subsequent locking of the R-loop will not occur. This unlocked state is a signal for primed 
spacer acquisition, in which new spacers are rapidly integrated in the CRISPR array. Using in vivo experiments, 
we validated that these two different binding modes guide the functional outcome of target binding by 
Cascade.  
 
While experiments such as those described in chapter 2 can be extremely helpful in identifying interactions 
between Cascade and DNA targets in vitro, there are still many unanswered questions regarding the target 
search inside the cell. In chapter 3, we describe how we visualized Cascade in its native environment by tracking 
single crRNA-surveillance complexes in live E. coli cells. Tracking of the Cas8e subunit of the Cascade complex 
allowed us to demonstrate that crRNAs are required for assembly of Cascade complexes. We also demonstrate 
that Cascade spends approximately 40% of its time bound to DNA. By tracking Cascade complexes in which 
important residues involved in PAM recognition are mutated, we show that the transient DNA-binding behavior 
of Cascade is largely due to PAM interactions. Furthermore, we demonstrate the underlying mechanism of 
protection from cell death by cleavage of the genomic CRISPR array using our single-molecule setup. We show 
that Cascade can still bind to the CRISPR array based on full complementarity of the array to the crRNA, but 
that recognition of the repeat-PAM leads to dissociation of the Cas8e subunit from the Cascade complex. 
Dissociation of the Cas8e subunit prevents the recruitment of Cas3, thereby preventing cleavage of the CRISPR 
array. These results provide new insights in the dynamics of the search behavior of CRISPR-Cas complexes in 
the molecular crowded environment in the cell.  
 
Bacteriophages have developed diverse strategies to escape bacterial defense systems. One of these strategies 
is the production of phage-encoded proteins that inhibit CRISPR-interference, called anti-CRISPRs (ACRs). In an 
effort to identify novel anti-CRISPR proteins we isolated a large number of E. coli phages and screened them 
for ACR activity. Even though ACR activity could not be confirmed, we characterized some of the isolated 
phages in order to provide an addition to the body of knowledge about bacteriophage biology. In chapter 4 we 
describe the isolation and genome sequencing of one of the screened phages, phage Ayreon. Phage Ayreon is 
a lysogenic phage that is highly similar to phage cdtl, but lacks the gene cluster responsible for cdtl holotoxin 
production in phage cdtl.  
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The production of ACRs is not the only strategy employed by phages to evade host-defense systems. One of 
the alternative escape mechanisms is the modification of nucleobases of the phage DNA by methylation. In 
chapter 5, we studied the effect of extensive bacteriophage DNA modifications on CRISPR-Cas interference. We 
show that glucosyl-5-hydroxymethylation of cytosine in the DNA of bacteriophage T4 inhibits interference by 
both type I-E and type II-A CRISPR systems. However, CRISPR-Cas interference of a type V system is not affected 
by glucosyl-5-hydroxymethylation of DNA. We demonstrate that this inhibition of CRISPR-Cas interference is 
caused by the decreased binding affinity of Cascade and Cas9 to modified DNA targets. Using structural 
modelling of DNA modifications, we predict which positions of DNA modifications will cause molecular clashes 
between the protein and the target, thereby identifying key positions of DNA modifications that inhibit 
interference. Our results also suggest that CRISPR-Cas systems have contributed to the selective pressure on 
phages to develop more generic solutions to escape sequence specific host defense systems. 
 
In chapter 6, we further explore the potential of glucosyl-5-hydroxymethylcytosine (5-ghmC), as found in 
bacteriophage T4. We engineered four genes from the DNA modification pathway of bacteriophage T4 into 
Escherichia coli. Heterologous expression of these genes resulted in the production of 5-ghmC DNA in E. coli. 
Removal of the gene encoding the T4 β-glucosyltransferase resulted in the production of 5-
hydroxymethylcytosine (5-hmC). This 5-hmC containing DNA can further be labeled with click-chemistry 
compatible functional groups, such as fluorophores. As a proof of concept, we labeled 5-hmC containing 
plasmid DNA with Cy5 fluorophores and studied electro-transformation of E. coli cells with these plasmids. 
Furthermore, we used single-molecule particle tracking to study plasmid uptake and stability after 
transformation. We propose that this method can be used to identify bottlenecks in efforts to establish genetic 
transformation protocols for new microbial species 
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Chapter 8
How bacteriophages shape the ecology in the biosphere 
Viruses are the most abundant biological entities in the biosphere and are ubiquitous components in every 
environment. Our understanding of the biology of viruses continues to expand, making it ever more clear that 
they play a major role in almost every ecosystem on our planet. The areas influenced by viruses include 
biogeochemical and ecological processes such as nutrient cycling, bacterial and algal biodiversity distribution, 
algal bloom control, and genetic transfer, and microbial evolution (Fuhrman, 1999). Interestingly, until around 
a decade ago, viruses were ignored in studies on microbial loops in marine food webs. Later, studies reported 
on the significance of viruses on the control of bacteria and phytoplankton (Bergh et al., 1989; Proctor and 
Fuhrman, 1990; Thingstad, 1990).  
Quantitative enumeration of viruses is commonly performed using transmission electron microscopy (TEM), 
revealing an enormous diversity of morphotypes. Most common morphologies include viruses with contractile 
tails (such as myoviruses), long non-contractile tails (such as siphoviruses), and short non-contractile tails (such 
as podoviruses). Lesser known morphologies include bottle-shaped, spindle-shaped, two-tailed, coil-shaped, 
and turreted icosahedral morphologies, mostly found for archaeal viruses (Prangishvili, 2013). Besides the large 
diversity in morphologies, viruses are also a reservoir of the greatest genetic diversity on Earth (Suttle, 2005). 
The remarkable genetic diversity of viruses combined with the absence of conserved evolutionary markers, 
such as ribosomal genes, makes it difficult to classify viruses (Breitbart et al., 2002; Rohwer and Edwards, 2002).  
How anti-viral defense systems shape Life Sciences 
Research on bacteriophage biology and anti-viral defense systems have arguably had the largest impact on the 
field of biology as a whole. The study of several model bacteriophages has led to the elucidation of 
fundamentals of biology that we take for granted today. Breakthroughs in molecular biology involving 
bacteriophages include sequencing of the first gene, sequencing of the first RNA genome, and sequencing of 
the first DNA genome. Some of the most important early discoveries are summarized in Table 1. Another 
application of phages that has hugely impacted life sciences is phage display, in which peptides are fused to 
phage particles and enable screening of biological relevant peptides in a high-throughput manner (Smith and 
Petrenko, 1997). The discovery of restriction-modification systems enabled molecular cloning and 
manipulation of DNA. Manipulation of specific locations of cellular DNA became available by harnessing the 
Cre-Lox recombination system from coliphage P1. The Cre-Lox system uses the P1-encoded Cre protein that 
efficiently promotes recombination of DNA occurring at specific sites, called lox, and can be used to create 
deletions, insertions, translocations and inversions (Sauer, 1987; Sauer and Henderson, 1988). Multiple other 
phage encoded proteins, including T4 ligase and T7 RNA polymerase, were harnessed to advance molecular 
cloning and heterologous expression of proteins (Sgaramella et al., 1970; Studier and Moffatt, 1986). Efficiency 
and simplicity of genetic modification of bacterial genomes increased even more when the λ RED system was 
harnessed to use PCR products or synthetic oligonucleotides for homologous recombination (Casjens and 
Hendrix, 2015; Court et al., 2002). Most recently, the discovery of CRISPR-Cas systems has revolutionized the 
field of genetic engineering (Wang and Qi, 2016). The type II-A CRISPR-Cas effector protein Cas9 from S. 
pyogenes is nowadays extensively used as a tool to accomplish genome engineering. The CRISPR toolkit for 
RNA-guided genome engineering has been expanded with Cas9 proteins from various hosts, such as 
Streptococcus thermophilus, Neisseria meningitidis, and Staphylococcus aureus (Gasiunas et al., 2012; Ran et 
al., 2015; Zhang et al., 2013). Besides genome engineering, CRISPR-Cas proteins have been developed into tools 
to accomplish transcriptional regulation and epigenetic regulation (Gilbert et al., 2015, 2013; Konermann et al., 
2015). Recent developments even allow the engineering of RNA in the cell (Cox et al., 2017). In conclusion, 
research on bacteriophages and defense systems that protect prokaryotes from infection shaped to a great 
extent the way we do science today and continues to do so. Undoubtedly, many more  phenomena, pathways, 
and mechanisms lie in store, waiting to be discovered. Fortunately, with the increasing advance in our 
knowledge about biology, so do our research technologies and methodologies also advance. In the following 
paragraphs, I will discuss how advanced microscopy technologies can unveil the mechanisms of anti-phage 
defense systems.  
Table 1 Major early scientific discoveries involving bacteriophages, table adapted from (Keen and Gables, 2016) 
Reference Finding 
(Luria and Delbrück, 1943) Mutation is a spontaneous and random process 
(Hershey and Chase, 1952) DNA is unambiguously the hereditary material of life 
(Luria and Human, 1952) Viruses’ ability to infect other hosts is greatly diminished due to DNA 
cleavage by restriction enzymes 
(Hall and Spiegelman, 1961) Complementary DNA and RNA can hybridize 
(Crick et al., 1961) Nucleotide triplets are read as codons to form proteins 
(Brenner et al., 1961) mRNA is the intermediate between DNA and protein; mRNA is 
translated into protein by ribosomes 
(Goulian et al., 1967) DNA can be synthesized from its precursors in vitro 
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Reference Finding 
(Luria and Delbrück, 1943) Mutation is a spontaneous and random process 
(Hershey and Chase, 1952) DNA is unambiguously the hereditary material of life 
(Luria and Human, 1952) Viruses’ ability to infect other hosts is greatly diminished due to DNA 
cleavage by restriction enzymes 
(Hall and Spiegelman, 1961) Complementary DNA and RNA can hybridize 
(Crick et al., 1961) Nucleotide triplets are read as codons to form proteins 
(Brenner et al., 1961) mRNA is the intermediate between DNA and protein; mRNA is 
translated into protein by ribosomes 
(Goulian et al., 1967) DNA can be synthesized from its precursors in vitro 
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Single-molecule approaches shed light on CRISPR mechanisms 
Adaptive immune systems, such as CRISPR-Cas systems, provide protection from pathogens based on highly 
specific mechanisms to distinguish self from non-self. This high specificity brings a downside that it can be 
readily overcome by mutations of rapidly evolving pathogens. However, CRISPR-Cas responds more rapidly and 
efficiently to a mutated invader by a so-called primed response (Datsenko et al., 2012). This primed response 
has been studied quite extensively with regards to the genetic processes involved (Fineran et al., 2014; Jackson 
et al., 2017; Richter et al., 2014; Savitskaya et al., 2013). However, the underlying molecular mechanism of 
primed spacer acquisition remained enigmatic. Below, I will discuss how single-molecule approaches, including 
those described in chapter 2 and 3, have provided some of the answers to questions regarding the molecular 
mechanisms of CRISPR-Cas systems.  
Single-molecule methods are well-suited for the investigation of the molecular details of DNA binding and DNA 
cleavage by CRISPR-Cas systems since they allow detection of transient interactions and intermediate states 
(Joo et al., 2008; Singh and Ha, 2018). One of the first single-molecule approaches to study DNA interrogation 
and target binding by Cas9 was performed by Sternberg et al (2014). The authors visualized the target search 
of Cas9, labeled with quantum dots, on λ DNA that was immobilized on a flow cell by total internal reflection 
fluorescence (TIRF) imaging. This setup is commonly referred to as ‘’DNA curtains’’. The authors demonstrated 
that DNA binding is initiated only after detection of the PAM and that DNA strand separation and RNA-DNA 
heteroduplex formation initiate at the PAM and proceed directionally towards the PAM distal end of the target. 
Furthermore, they showed that Cas9 samples DNA by 3D diffusion and not by 1D diffusion along the DNA. Next 
to Cas9, also the DNA interrogation patterns and target search behavior of Cascade was studied using the DNA 
curtains setup (Redding et al., 2015). In contrast to Cas9, Cascade does bind to protospacers in the absence of 
an interference PAM, albeit that this recognition is much less efficient than recognition of protospacers with 
an interference PAM.  
Conformational control of CRISPR-Cas-mediated immune responses 
The approach taken by Sternberg et al and Redding et al resulted in valuable data that allowed for refinement 
of our understanding of DNA interrogation by CRISPR proteins. However, the resolution limit (± 250 bp) of the 
used technique does not allow identification of the interactions between proteins and nucleic acids that occur 
on a smaller scale. Dynamic interactions can be observed at a much higher resolution using techniques such as 
single-molecule Förster resonance energy transfer (smFRET). Typically, two molecules are labeled with a 
different fluorophore and intermolecular interactions are visualized through FRET between the fluorophores 
(Joo et al., 2008; Rahul et al., 2008). Differences in FRET can be interpreted as conformational changes of the 
labeled molecules. In chapter 2, we describe how we studied the target binding by Cascade using smFRET. In 
short, biotinylated Cascade complexes were immobilized on a surface and dsDNA targets, labeled with a FRET 
pair on opposite strands, was added. Changes in FRET could be attributed to binding of Cascade to the target 
and unwinding of DNA strands. Our single-molecule data demonstrate that high-fidelity target-DNA binding is 
a multistep process that is initiated at the PAM and continues by DNA unwinding in a PAM-distal direction. 
When the pairing of the DNA with the crRNA is completed over the full length of the protospacer the complex 
is stabilized into a “locked” state. This locked state allows destruction of the target DNA by Cas3. However, 
when Cascade encounters a target with mismatches, the initial recognition complex will be formed but Cascade 
will not switch into the locked state. By remaining in the “unlocked” state, the complex can disassemble using 
thermal energy and therefore is usually a short-lived interaction.  
Previous research already established that Cse1 subunit adopts an open conformation upon binding of ssDNA 
(Jackson et al., 2014; Mulepati et al., 2014). This is in contrast with the locked conformation upon binding of 
dsDNA, in which the C-terminal domain is closer to the N-terminal domain, thereby causing the relocation of 
the C-terminal domain into the locked position. Our proposed model, describing how different binding modes 
lead to different functional outcomes, was further explored using smFRET studies (Xue et al., 2016). The authors 
developed a FRET system that enables measurement of conformational changes of the Cse1 subunit upon 
binding of the protospacer. Their results demonstrated that targets containing mutations cause conformational 
changes of Cse1 into the open conformation, thereby exposing the L1 domain. The L1 domain is formed by 
residues 125-131 of Cse1 and forms a loop that participates in PAM recognition (Van Erp et al., 2015). The L1 
domain is critical for controlling Cse1 conformation and L1 mutants can still bind bona fide targets but block 
recruitment of Cas3 (Xue et al., 2016). Cas1-Cas2 increases the recruitment of Cas3 to bona fide targets and is 
correlated with primed spacer acquisition (Redding et al., 2015). This suggests that the open Cse1 conformation 
promotes interference-independent priming (Kunne et al., 2016; Redding et al., 2015; Xue et al., 2016). 
Together, these results demonstrate a mechanism that guides the direction of the CRISPR-Cas-mediated 
immune response, resulting in interference and/or priming, depending on target characteristics.  
Vires in numeris, strength in numbers 
One crucial requirement of anti-viral defense systems is that they must inactivate the invading phage DNA 
shortly after entry into the cell. The life cycle of many bacteriophages is less than 30 minutes, but even long 
before completion of the life cycle the phage has overtaken most, if not all, metabolic activities in the cell 
(Hadas et al., 1994). This provides only a window of mere minutes for the CRISPR-Cas complexes to find and 
inactivate invading DNA. Our studies, described in chapter 3, show that the concept of “vires in numeris” 
(strength in numbers) clearly applies to CRISPR-mediated immunity. It would take several hours for a single 
Cascade complex to find its target in the cell. However, we show that 300-600 Cascade complexes are enough 
to provide protection against plasmid invasion. Obviously, continuous expression of CRISPR-Cas systems comes 
at a fitness cost. Due to this cost, the availability of resources is a determining factor in the evolution of 
constitutive defense systems, including CRISPR-Cas, or inducible defences, including cellular surface 
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modification (Westra et al., 2015). While CRISPR-Cas expression in E. coli is naturally repressed by Histone-Like 
Nucleoid Structuring Protein (H-NS), we show that Cascade is functionally expressed, albeit at levels that are 
too low to provide interference (Westra et al., 2010). Because of the repression of CRISPR-Cas systems by H-
NS, and additionally the slow evolution of the CRISPR arrays, it is suspected that the CRISPR-Cas system in E. 
coli fulfils an unknown alternative role (Westra et al., 2014). However, injection and subsequent replication and 
multiplication of phage DNA will cause redistribution and dilution of H-NS that is bound to the host DNA (Ali et 
al., 2012; Navarre et al., 2007; Rosen et al., 2006). This redistribution of H-NS might result in decreased 
repression of the CRISPR locus, thereby allowing functional expression and establishing CRISPR-mediated 
immunity. Such de-repressing conditions might become even more pronounced by the presence of phage-
encoded DNA mimicking proteins such as bacteriophage T4 protein Arn or bacteriophage T7 protein Ocr (Ho 
et al., 2014).  
  
What can be expected for the next decade of molecular biology? 
CRISPR-Cas technology has proven itself as a versatile tool that has revolutionized the field of molecular biology 
and promises to continue to do so. Over the next decade, CRISPR-Cas derived technologies will expand the 
toolbox of the molecular biologists and allow many biological questions to be answered. Below, I will discuss 
the development of several CRISPR-based technologies  
Genome Imaging using CRISPR-Cas-based technologies 
The spatiotemporal organization of the genome plays an important role in transcriptional regulation and 
visualizing the dynamic processes that the genome undergoes has the potential to improve our understanding 
of regulatory processes of living cells. The specificity at which CRISPR proteins are able to target certain 
sequences makes them excellent tools to study the spatial and temporal behaviour of the genome in live cells. 
Previously, localization of genomic loci was performed on static organization of the genome using imaging 
technologies such as fluorescence in situ hybridization (FISH) (Lichter et al., 1990). The first study using CRISPR 
proteins to aid visualization of genome dynamics made use of a fusion of catalytically inactive Cas9 (dCas9) 
from S. pyogenes with EGFP (Chen et al., 2013). Robust imaging of repetitive elements in living cells was 
demonstrated and even visualization non-repetitive genomic sequences was achieved by using an array of 
spacers targeting different regions of a target locus. This approach was also used to design a multicolour 
visualization technique where three Cas9 orthologs from different species were fused to GFP, RFP, or BFP (Ma 
et al., 2015). Efficient targeting by these fusion proteins of different genomic loci allow to determine the 
intranuclear distance between loci, thereby revealing the state of DNA compaction in living cells.  
CRISPR-Cas-mediated in situ localization of nucleic acids is not restricted to DNA. When sgRNA-guided Cas9 
protein is stabilized with a PAMmer oligonucleotide, it can be directed to bind cellular mRNA (O’Connell et al., 
2014). This feature has been harnessed in a recent study where a dCas9-GFP fusion protein was used to target 
mRNA in live cells (Nelles et al., 2016). This novel technology enables the tracking of RNA in livings cells in a 
programmable manner.  
The advances in methods of tracking cellular components in live cells and in real time opens up a wide range 
of potential applications. Considering the recent developments in technologies of tracking either proteins or 
mRNA transcripts, it can soon be expected that both techniques will be employed simultaneously in order to 
study regulatory processes by imaging of both RNA and proteins associated with the translation machinery. 
The initial applications of RNA-guided CRISPR proteins were primarily focussed on site-directed DNA cleavage. 
However, CRISPR-based targeting was quickly adapted for purposes like imaging, targeted methylation, and 
transcription modulation. It can be expected that similar developments will occur for the RNA-guided RNA 
targeting described above and potential applications include modulation of RNA-processing.  
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CRISPR-Cas-mediated genetic engineering and gene therapy 
CRISPR-Cas-mediated genetic engineering has had enormous impact on the field of molecular biology, including 
gene therapy research (Dai et al., 2016; Savić and Schwank, 2016). Notable breakthroughs in gene therapy 
technology include correction of a gene mutation in mouse models of Duchenne muscular dystrophy, thereby 
rescuing the disease phenotype (Nelson et al., 2017; Tabebordbar et al., 2016). Despite recent advances in 
CRISPR-mediated gene therapy there are a number of challenges to be addressed before the technology can 
be used for application in humans. One of the most prevalent concerns raised regarding gene therapy is the 
fact that the sequence specificity of the RNA-guided CRISPR proteins might not be high enough to prevent off-
targeting. Even though there does not seem to be a general consent on the actual prevalence and functional 
consequences of off-targeting among scientists much effort has been focused on reducing such effects (Chen 
et al., 2016; Kleinstiver et al., 2016; Shin et al., 2017; Slaymaker et al., 2016).  
Double stranded DNA repair mechanisms  
The application of CRISPR-Cas proteins in genome engineering relies on highly specific and efficient cleavage 
of DNA followed by repair of the DNA break, introducing genomic alterations. CRISPR-Cas-mediated DNA 
cleavage will result in a stop of cell-cycle momentum, triggering the DNA damage repair signaling cascade and 
the activation of endogenous DNA repair mechanisms (Heyer et al., 2010). The repair of a double stranded 
break can be accomplished by either non-homologous end joining (NHEJ) or homology-directed repair (HDR) 
(Fig. 1). NHEJ is a mechanism in which the two DNA strands are recoupled by ligation, which will frequently 
result in the introduction of non-specific insertions and deletions (indels). Indels usually disrupt the targeted 
gene by a shift in open reading frame (ORF). Due to these error-prone properties, the NHEJ pathway is desirable 
for creating knockouts, but a less desirable tool for precise genome engineering and gene therapy (Chrenek et 
al., 2016; Cong et al., 2013; Heyer et al., 2010; Renkawitz et al., 2014; Yang et al., 2013). 
Homology-directed repair (HDR), in contrary to NHEJ, uses a homologous sequence as a template for the repair 
of damaged DNA (Chrenek et al., 2016; Renkawitz et al., 2014). The homologous sequence can be either a sister 
chromatid or an introduced DNA fragment, but must be in relative close proximity of the double-stranded break 
(DSB) to promote HDR by establishing DNA base pairing between the desired homologous sequence and the 
damaged DNA strand. HDR is the most desirable repair mechanism for gene therapy due to its ability to 
promote highly specific genetic exchange. A drawback of HDR is its relatively low efficiency, especially when 
compared to NHEJ. This is partly due to the fact that HDR can only occur in the S and the G2 phase of the cell 
cycle and therefore not active in the post mitotic tissue, whereas NHEJ can occur throughout the complete 
cellular cycle (Oude Blenke et al., 2016; Richardson et al., 2016; Wright et al., 2016). 
 
Figure 1. Double-stranded DNA breaks induce endogenous DNA repair mechanisms. Non-homologous end 
joining (NHEJ) often results in deleterious insertions or deletions. Homologous-directed repair (HDR) makes use 
of a exogenously introduced homologous template and results in high-fidelity DNA repair. Figure adapted from 
(Wu et al., 2018)  
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The mechanism of HDR 
The HDR pathway can be divided into three stages: the presynapsis, synapsis and postsynapsis (Heyer et al., 
2010; Renkawitz et al., 2014). In the presynapsis stage, species-specific protein complexes will bind to the blunt-
end DSB, forming a DNA-protein complex and initiate 5` to 3` resection. DNA-end-resection is a process in 
which the 5`-end of the dsDNA is cleaved away by exonucleases and forms an extended section of ssDNA. To 
prevent the formation of secondary structures and to facilitate the binding of recombinase proteins, the ssDNA 
is coated with a ssDNA-binding protein, replication protein A (RPA). A stable structure is formed by RPA 
together with the recombinase protein, which is able to perform homology searches by DNA-strand invasion 
and base pairing with homologous template DNA. In the synapsis stage, homology searching proteins are 
actively searching for a complementary DNA strand that is homologous to the damaged DNA strand. When the 
homologous templates has been found, the ssDNA-protein complex invades the template, creating an opening 
between the two DNA strands of the homologous template and forms the displacement loop (D-loop). In the 
last stage of HDR, the postsynapsis, previously bound recombinase proteins are disassociated from the now 
stably paired DNA-DNA complex and the DNA is repaired. The postsynapsis stage of HDR is divided into multiple 
sub-pathways, which either create crossover or non-crossover products. Consequently, when a non-crossover 
sub-pathway proceeds, the DNA will be transcribed from the template, in contrast to the crossover sub-
pathway in which the homologous DNA template is (partially) incorporated into the desired target DNA strand.  
 
Possible solutions for increased efficiency of HDR by Cas9 and potential obstacles 
The CRISPR-Cas9 system and the endogenous HDR system are desirable genome engineering mechanisms, 
which have been extensively used in research settings and gene therapy, but there are still obstacles to be 
overcome in order to increase the desired HDR efficiency over NHEJ efficiency (Wright et al., 2016). 
One potential solution for increasing HDR efficiencies is to chemically induce cells to inhibit the NHEJ pathway 
by inhibiting key proteins of the NHEJ pathway (Maruyama et al., 2015). The NHEJ inhibitor promotes the 
frequency of HDR by inhibiting the NHEJ pathway and therefore favoring incorporation of the desired DNA 
repair template. However, interfering with NHEJ can be undesirable in gene therapy due to the possible 
alterations made to the cellular mechanisms and the potential inhibition of other unintentional genomic 
damages. Alternative strategies to increase HDR efficiencies include engineering the Cas9 proteins, the sgRNA, 
or the DNA repair template.  
The type of DNA template used in genome editing has a drastic impact on HDR efficiency. DNA templates can 
be either complementary to the target strand or to the non-target strand, have short or long overhangs, and 
be either double stranded or single stranded. The use of DNA templates that are complementary to the non-
target strand demonstrate a higher HDR efficiency, up to 2.6 times the efficiencies when DNA templates that 
are complementary to the target strand are used (Richardson et al., 2016). Even more so, the use of ssDNA 
templates demonstrate a 4 times higher HDR efficiency then when dsDNA templates are used.  
 
Glucosyl-hydroxymethylcytosine as a way to improve HDR efficiencies 
Even when a sequence specific DSB is repaired via the HDR pathway, potential re-cleavage of that site could 
nullify the successful gene editing. Re-cleavage of a repaired gene could occur because CRISPR proteins allow 
a certain degree of imperfect matching with their target. Generally, no mismatches are tolerated in the PAM 
region and only very few are allowed in the seed region. However, some sgRNA-target DNA mismatches are 
allowed at the PAM-distal end of the target. When the result of successful gene editing is a single point 
mutation, the DNA could potentially be cleaved again, creating a cleave-repair loop. 
Yet another factor limiting the effectiveness of CRISPR-mediated gene editing is the short lifetime of the 
recombination template DNA. ssDNA templates that are introduced in the cell are anticipated to be subject to 
various cellular exonucleases. Even though the impact of this degradation is largely unknown, protection of 
template DNA by phosphorothioate linkages is shown to increase their half-life and to increase the probability 
of incorporation (Mosberg et al., 2010, 2012).  
As described in chapter 5 of this thesis, glucosyl-hydroxymethylation of cytosine (5-ghmC) renders DNA 
protected against cleavage by various nucleases, including Cas9. This property of 5-ghmC DNA could potentially 
be harnessed in order to improve gene editing efficiencies (Vlot and Brouns, 2017). In short, modified template 
DNA can be created by PCR using 5-hydroxymethyldeoxycytidine, resulting in 5-hydroxymethylcytosine (5-
hmC) containing DNA. 5-hmC DNA can be further glucosylated to 5-ghmC by T4 β-glucosyltransferase and used 
as repair template in HDR-mediated gene editing (Figure 2). Current efforts in our laboratory are directed 
towards improving HDR efficiencies in a RPE65rd12 mouse model by using 5-ghmC template DNA.  
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Figure 2. Generation of a double-strand break by Cas9, followed by repair via the Homology Directed Repair 
pathway. Glucosyl-hydroxymethylation of repair template DNA increases its life span and prevents re-cleavage 
of the DNA after succesfull repair.  
Concerns regarding CRISPR-mediated genome engineering 
A somewhat discouraging study demonstrated that antibodies against Staphylococcus aureus Cas9 (SaCas9) 
and Streptococcus pyogenes Cas9 (SpCas9) were found in human serum (Charlesworth et al., 2018). Upon 
further investigation, even anti-SaCas9 T-cells were identified in peripheral blood of almost half of the donors. 
These findings were explained by the fact that both S. aureus and S pyogenes are common human commensals 
that cause infections in humans at a high frequency, resulting in pre-existing adaptive immune responses. Pre-
existing adaptive immunity against Cas9 likely will limit the effectiveness of Cas9-based gene therapy. As SaCas9 
T-cells are able to induce CTL-mediated clearance of cells presenting Cas9 peptides, thereby eliminating edited 
cells and rendering the therapy ineffective (Kuwano et al., 1993; Mingozzi et al., 2007). Furthermore, this 
matter raises serious safety concerns because anti-Cas9 CTLs could potentially induce a systemic inflammation. 
It is clear that findings like these described above raise serious concerns about the efficacy and safety of CRISPR-
based gene therapies. However, research into genetic engineering using CRISPR-Cas technologies opens up a 
wide range of possibilities and should not be discouraged by such concerns, but rather exploit these as stimuli 
to overcome current limitations.  
Bacteriophages with DNA modifications and CRISPR-Cas 
Bacteriophages have evolved diverse systems that allow them to counteract bacterial defense mechanisms. 
Evasion from CRISPR-Cas defense can occur by mutation of the protospacer or PAM sequence (Deveau et al., 
2008; McGrath et al., 1999; Semenova et al., 2011), target site deletion (Pyenson et al., 2017), genome 
recombination (Paez-Espino et al., 2015), or by production of anti-CRISPR proteins (Bondy-Denomy et al., 2015; 
Pawluk et al., 2014, 2016). Besides the aforementioned escape strategies, phage-encoded DNA modifications, 
such as methylations, are well-known antagonists of microbial defense systems (Labrie et al., 2010). In chapter 
5, we describe that phage-encoded DNA modifications, in this case glucosyl-hydroxymethylation of cytosines, 
provides a way to escape CRISPR-mediated immunity. We demonstrate that escape from CRISPR-mediated 
immunity is facilitated by the decreased binding affinity of CRISPR-effector complexes to glucosyl-
hydroxymethylated DNA. Notably, this inhibitory effect of DNA modifications is not effective on all CRISPR 
systems, exemplified by the absence of inhibition on binding of the type V-A Cas12a effector protein. The fact 
that Cas12a DNA binding is not inhibited by glucosyl-hydroxymethylation of cytosines might raise the question 
whether there are bacteriophages that infect bacteria that harbor type V-A CRISPR-Cas systems. Phages that 
potentially contain modifications similar to those studied in chapter 5 (5’-hmC and 5’-ghmC) would at least 
require a dCMP-hydroxymethylase homolog for the synthesis of dhmCMP. Such homologs are mainly found in 
phages that infect enterobacteria and a few other families (Weigele and Raleigh, 2016). We have compared a 
list of phages that potentially contain cytosine modifications with a list of organisms that are currently known 
to harbor type V-A CRISPR-Cas systems (Zetsche et al., 2015). Unfortunately no match was found. Moreover 
we could not match any of the spacers to known phages. This might suggest that the prevalence of cytosine 
modifications of bacteriophage genomes is not high, and that phages that do have these modifications do not 
infect hosts that have type V-A CRISPR-Cas systems. Therefore the effect of these modifications on the 
evolution of CRISPR-Cas systems might be very limited. 
Even though it is not yet clear if, and if so; how, the evolution of CRISPR-Cas systems and glucosyl-
hydroxymethylation pathways are connected, it is worth noting that CRISPR-Cas systems might accelerate 
phage evolution (Tao et al., 2018). While phage T4 DNA is poorly cleaved by Cas9 and infection rates of T4 on 
cells expressing Cas9 are virtually unaffected, a remarkable difference in mutation frequencies can be detected 
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(Tao et al., 2018). Mutation frequencies of phage genomes that escape the inefficient cleavage by Cas9 are 
about six orders of magnitude higher than the spontaneous mutation frequency. While high mutation rates 
allow fast adaptation, and can thus be considered beneficial, they are not necessarily advantageous once 
adaptation is achieved (Elena et al., 2005; Giraud et al., 2001; Regoes et al., 2012). Considering that CRISPR-
Cas systems exhibit strong selective pressure on adaptation speed, these systems are a driving force for phage 
evolution.  
Bacteriophages with DNA modifications: practical applications 
Bacteriophages with DNA modifications in fermentation processes 
One of the main industries that has a key interest in studying anti-phage defense systems is the dairy industry. 
Bacteriophage infection of fermentation cultures, especially phage infection of starter cultures followed by 
slow fermentation or culture collapse, poses a large problem in this industry. Researchers in the dairy industry 
played a key role in the discovery of CRISPR-Cas systems and a better understanding of phage-host interactions 
is expected to contribute to the development of more effective anti-phage measures (Barrangou et al., 2007; 
Horvath and Barrangou, 2010). Our findings that bacteriophages that have extensively modified nucleobases 
can inhibit CRISPR-Cas interference should also be taken into account regarding the engineering of phage 
resistant cultures in the fermentation industry. First of all, it would be highly interesting to study the prevalence 
of bacteriophage DNA modifications among phages that infect fermentation cultures. If this would be the case, 
DNA modification insensitive CRISPR-Cas systems, such as Cas12a, could be introduced into the bacteria that 
are used for these industrial applications, in order to combat these infections.  
Bacteriophages with DNA modifications in phage therapy 
While bacteriophages that have DNA modifications can pose difficulties in fermentation processes, they might 
be favorable in applications where phage resistance is undesirable. One of such applications is bacteriophage 
therapy. Bacteriophage therapy is a promising solution to treat patients that are infected with antibiotic-
resistant bacteria. The emergence of antibiotic-resistant bacteria is becoming an increasingly threatening 
problem. A recent report estimates that by 2050, every year ten million people will die due to antibiotic-
resistant bacteria if no global effort to fight this problem is undertaken (O’Neill, 2014). Even though this 
estimate may be inaccurate due to the difficulty in determining reliable assumptions, it should be evident that 
there is a large clinical and public health burden associated with antibiotic resistance (de Kraker et al., 2016). 
The problem of antibiotic resistance becomes even more worrisome when considering that the number of 
newly discovered antibiotics is in decline.  
Already proposed by the discoverer of bacteriophages, Félix d’Hérelle, bacteriophage therapy involves the 
infection and killing of bacteria by bacteriophages. The premise of such therapy has been explored in East 
European countries for the last hundred years and is well accepted and received by physicians and patients. 
Until now, phage therapy has been used in only a small number of cases in Western countries. Even though a 
growing number of patients would potentially benefit from phage therapy, it is still rarely used, mostly because 
of a missing regulatory framework for the approval of therapeutic use of phages (Pirnay et al., 2015; Verbeken 
et al., 2014). While Western countries lag behind Eastern European countries regarding phage therapy, several 
phage-based products have been developed by Western countries. For example: the biotechnology company 
Intralytix has developed ListShieldTM, a phage preparation for controlling the foodborne bacterial pathogen 
Listeria monocytogenes, designed for treating foods that have a high risk for L. monocytogenes contamination. 
One of the disadvantages of bacteriophage therapy over the use of conventional antibiotics is that phage 
resistance can emerge extremely rapidly (Örmälä and Jalasvuori, 2013). Phage resistance can be evolved by 
mutation of phage receptors, or by evolving more elaborate defense systems, such as CRISPR-Cas systems. The 
type of phage resistance that is likely to occur is higly dependent on the availability of resources (Westra et al., 
2015). Phage cocktails, which contain several types of phages that infect the same species of bacteria, can be 
used to prevent the emergence of phage resistance (Salman et al., 2014; Nale et al., 2016). Another strategy 
would be to use phages against which the development of phage resistance would be more difficult. This is 
where phages that have DNA modifications come into play. As described in this thesis, DNA modifications can 
protect against two major defense systems employed by bacteria, namely restriction-modification systems and 
CRISPR-Cas systems. The genomes of phages that have DNA modifications are poorly cleaved by crRNA-effector 
proteins and acquisition of new spacers from such phages has never been reported (Strotskaya et al., 2017; 
Tao et al., 2018; Vlot et al., 2017). This suggests that such phages would be a good choice regarding the use of 
natural phages in phage therapy. Alternatively, DNA modification pathways could be introduced in 
bacteriophages using genetic engineering. We have demonstrated that such a pathway can be engineered in 
E. coli, and it would be likely that introduction of such a pathway into other phages would be possible.  
The lytic nature of phages used in phage therapy, ironically, can promote the spreading of antibiotic resistance 
genes by horizontal gene transfer (Keen et al., 2017). Upon phage-induced cell lysis substantial amounts of DNA 
are released, including intact plasmids that encode antibiotic resistance genes. These plasmids can be taken up 
by naturally competent species, thereby increasing the spread of antibiotic resistance. However, many phages 
actively degrade the host DNA, including plasmid DNA, using hydrolytic endonucleases. Degradation of phage 
DNA is often prevented by nucleobase modifications. In the case of phage T4 the host DNA is degraded by 
endonucleases denA and denB while T4 DNA is protected from this degradation by glucosyl-
hydroxymethylation of the phage DNA. Based on these features it becomes clear that phages that degrade the 
host genome are more suitable for use in medicine than their non-degrading counterparts.  
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What needs to happen to make phage therapy a success?  
The interest in phage therapy in Western countries is mainly fuelled by several success stories, where patients, 
whose bacterial infection did not respond to antibiotics, were saved by experimental phage therapy. In some 
cases the notion “experimental’’ has to be taken literal. This is exemplified in the successful case of Tom 
Patterson, who was cured from a Acinetobacter baumannii infection using a combination therapy of antibiotics 
and phages. When asked how the team that prepared the phage cocktail knew what dose to prepare, the 
answer was: “We didn’t know, we are making this up as we go along” (Strathdee, 2017). This directly addresses 
one of the most relevant issues that requires ongoing thought on how to improve phage therapy. Renowned 
phage researcher Stephen T. Abedon wrote a report in which he stresses the importance of a more rational 
approach towards phage preclinical development (Abedon, 2018). Primarily the establishment of phage 
concentrations that are high enough to achieve adequate killing of bacteria needs attention. Therefore, a 
proper understanding of Poisson distributions, adsorption kinetics, and actual in situ multiplicity of infection 
(MOI) is required. For one, it is crucial to realize that high ratios of phages to bacteria do not necessarily result 
in eradication of the bacterial population. Even more so, initial in situ phage densities after applications of a 
particular dose of phages will hardly ever result in the killing of 100% of bacteria. This emphasizes that 
successful bacterial clearing strictly depends on the ability of the phages to replicate in the infection-causing 
host.  
Despite a century of practical application of phages in Eastern Europe and aforementioned success stories of 
recent cases in the Western world, bacteriophage therapy is often met with scepticism by physicians, in some 
regards rightfully so. The lack of randomized double-blind placebo controlled clinical studies puts question 
marks at some of the claimed successes of phage therapy. However, that should be no reason to not pursue 
further development of experimental and clinical practices of this promising therapy. Fortunately several 
initiatives have been started, including a Phage Directory. The Phage Directory is a network of phage 
researchers that facilitate exchange of bacteriophages for emergence treatments (2017). Also a number of 
clinical test have been started or are about to start.  
Perhaps more important than the practical side of phage therapy is the regulatory framework, or rather the 
lack thereof, for the approval of clinical use of phage therapy (Huys et al., 2013; Verbeken et al., 2014). 
Currently, bacteriophages do not have legal approval for therapeutic use and therefore cannot be used except 
as a last resort according to Article 37 of the Declaration of Helsinki (2013). One of the fundamental challenges 
that needs to be overcome is the classification of bacteriophages used for therapeutic purposes. Currently, 
bacteriophages are categorized as a human medicinal product (Art. 1 of Directive 2011/83/EC) due to the 
extreme broad definition of medicinal products. Despite the poor fit with this classification this results in the 
need for large clinical studies to demonstrate safety and efficacy, which would require approximately ten years 
and millions of euros for each phage to be approved. While such a trajectory to achieve legal approval would 
be possible, it would be necessary for every individual bacteriophage product. One of the most notable 
advantages of bacteriophages over antibiotics is their specificity for bacterial species or even strains. This 
feature can only be fully exploited through a patient-specific approach. To enable the therapeutic use of phages 
to their full potential, a panel of phage researchers is advocating the adaptation of the regulatory framework. 
The proposed adaptation includes that phage therapeutics would be considered as advanced-therapy 
medicinal products (ATMPs). This would enable the use of patient-tailored phage preparations in hospital 
settings (Huys et al., 2013; Pirnay et al., 2018).  
Phage therapy clearly has advantages over antibiotics, making them logical partners for our human immune 
defenses. While there is an evident need for alternatives to antibiotics, it is important to improve our scientific 
understanding of phage treatments and put in place a regulatory framework that is necessary to make it a 
successful endeavor. Further development will also require significantly larger investments than have been 
made so far, an investment that surely will be worth it. 
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and millions of euros for each phage to be approved. While such a trajectory to achieve legal approval would 
be possible, it would be necessary for every individual bacteriophage product. One of the most notable 
advantages of bacteriophages over antibiotics is their specificity for bacterial species or even strains. This 
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made so far, an investment that surely will be worth it. 
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Ongoing Research 
Prokaryotic defense systems that protect against mobile genetic elements are mostly clustered in defense 
islands (Doron et al., 2018; Makarova et al., 2011). Recently, a new restriction and modification (R-M)-like 
defense systems was discovered and named Defense Island Systems Associated with Restriction and 
Modification (DISARM) (Ofir et al., 2017). This defense system is widespread in bacteria and archaea and is 
composed of five genes, including a DNA methyltransferase. DISARM systems can be divided in two types (type 
I and II). The DISARM type II system found in Bacillus paralicheniformis protects against infection by several 
families of DNA phages. Functionality of a type I DISARM system has not been demonstrated and is the main 
focus of our ongoing research. Some results of these studies are presented below. As the experiments 
described here are still in progress, they should be treated as preliminary results.  
Discovery of the novel DISARM bacterial defense systems 
The newly discovered DISARM gene cassette was initially discovered by analyzing the protein domain DUF1998 
(pfam09369). DUF1998 is a protein of unknown function and is thought to be participating in anti-phage 
defense as it was previously found enriched in defense islands (Makarova et al., 2011). In an attempt  to 
characterize the genetic context in which DUF1998 genes are found, 35,893 genomes in the Integrated 
Microbial Genomes (IMG) database were scanned. DUF1998 was found in 1,274 of 35,893 scanned microbial 
genomes. Next, neighboring genes of DUF1998 were analyzed. Results showed that in 1,095 of the 1,370 
DUF1998-gene containing cases, DUF1998 was preceded by a large gene that contained a pfam00271 domain. 
This pfam00271 domain was previously found to be part of the catalytic core of DExx-box helicases, involved 
in a broad spectrum of activities such as rearranging of ribonucleoprotein complexes and pre-mRNA processing 
(Staley and Guthrie, 1998; Wang et al., 2006). Furthermore, upstream of DUF1998, a gene with a phospholipase 
D (PLD) domain (pfam13091) was found abundantly in 370 of the 1,370 cases. This PLD domain was previously 
found to be associated with enzymes manipulating phosphoester bonds like phospholipases, kinases and 
endonucleases (Selvy et al., 2011). This triplet of genes, pfam00271, DUF1998 and pfam13091, was defined as 
the core genes of the defense system, present in 351 of the 35,893 scanned genomes. These core genes were 
associated with a gene containing a methyltransferase domain in 324 of the 351 cases, suggesting that the 
systems resemble a novel type of R-M-like bacterial defense systems. This new defense system was therefore 
named Defense Island System Associated with Restriction Modification (DISARM). The DISARM defense system 
was divided in two types: type I, the common type, and type II, the rare type. Type I contains next to the triplet 
core genes a DNA adenine N6 methyltransferase gene (pfam13569), which is annotated as Type IIG RM gene 
in the restriction enzyme database REBASE, and a COG0553 SNF2 family helicase, which contains domains of 
SNF2-like ATPase (pfam00176) and of helicase C-terminal (pfam00271). Type II DISARM contains a DNA 5-
cytosine methyltransferase (pfam00145), and in most cases a protein of unknown function (Figure 3).  
 
Figure 3. Two types of DISARM systems occur in bacteria and archaea. 
The anti-viral activity of a type II DISARM system was demonstrated after Ofir et al. cloned the DISARM locus 
of B. paralicheniformis 9945a into B. subtilis BEST7300, an organism that naturally lacks a DISARM system. The 
engineered Bacillus strain was then challenged with phages from various morphological families; Siphophages, 
Myophages, and Podophages. Their results clearly demonstrate the anti-phage protection, manifested by a 
delay or absence of culture collapse upon phage infection (Ofir et al., 2017). Further experiments demonstrate 
that the DISARM-containing strain does allow phage adsorption and DNA injection but phage DNA replication 
is inhibited. The obvious similarities of the DISARM system with classical R-M systems suggested that 
methylation of self-DNA plays a role to allow discrimination between self- and non-self DNA. Cloning and 
expression of drmMII revealed that the DISARM system methylates CCWGG motifs in genomic DNA. However, 
replication inhibition of phages containing CCWGG methylation demonstrated that methylation alone is not 
sufficient to protect from the DISARM and the system probably uses an additional mechanism to discriminate 
self and non-self DNA. Sequencing of both bacterial and phage DNA after infection indicated that phage DNA 
was rapidly depleted in cells containing a functional DISARM system. Furthermore, it was found that phi3T 
could not form lysogens, suggesting that the DISARM system effectively forms immunity against phage-
infections at an early stage.  
In short, Type II DISARM showed phage resistance against several phages. After creating DISARM gene 
knockouts it was found that drmA, drmB and drmE were essential for the defense system. The drmMII gene 
was important for the survivability of the host, as it methylates the self-genome. These results suggest that 
DISARM to some extend resembles common R-M systems, however, its restriction modules consisting of 
multiple components appears to work differently. 
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Investigation of anti-phage activity by a type I DISARM system 
To further study and unravel the mechanism of DISARM anti-phage systems we focused on a type I DISARM 
system. We hypothesize that the functionality of type I systems will be similar to that of type II systems. 
However, we anticipate that potential differences in activity of both systems might help in unraveling of the 
molecular mechanism of DISARM systems. To exploit the availability of genetic engineering systems for E. coli, 
we searched for type I DISARM systems present in organisms closely related to E. coli. Type I DISARM systems 
are found in 278 different organisms, of which 8 are classified as Enterobacteriaceae. We selected Serratia sp. 
SCBI (South African Caenorhabditis Briggsae Isolate) and analyzed the gene organization of the DISARM more 
closely. 
This DISARM gene cassette comprises a cytosine methyltransferase (MT) gene, a drmD gene, a hypothetical 
gene, a drmMI gene, a drmA gene, a drmB gene and a drmC gene. Interestingly, the gene annotated as drmC 
(IMG Gene_OID: 2518347322) encodes a peptide of 89 amino acids, significantly shorter than the 
approximately 330 amino acid long homologs in 14 selected organisms containing a type I system. Careful 
analysis showed that the ORF of drmC was incorrectly annotated, and that the gene from bp 549,360-550,121 
corresponds to the drmC homolog.  
 
Figure 4. Schematic representation of the three compatible plasmids that contain the DISARM genes. 
To investigate the functionality of the type I DISARM system from Serratia SCBI we cloned the 17 kbp gene 
cassette unto a set of three compatible plasmids. We transformed E. coli BL21-AI with the three plasmids 
encoding the full type I DISARM system (Figure 4). Cultures of DISARM-containing cells and cells containing 
empty plasmids were challenged with phage λ. It is important to note that phage λ was propagated in E. coli 
strain SCS110, which lacks both the dcm and dam methylase genes, resulting in a unmethylated phage stock. 
Infections were performed at a range of multiple orders of magnitude of multiplicity of infection (MOI). The 
optical density of the cultures was monitored for 16 hours and measured every ten minutes. The DISARM-
containing cultures consistently showed a reduced rate of culture collapse (Figure 5). To quantify the level of 
protection provided by the DISARM system we calculated the rate of culture collapse after the maximum optical 
density was reached as the difference in OD600 per minute [ΔOD600 min-1]. Although the MOI influences the 
time at which the maximum OD600 is reached after which the optical density decreases due to cell lysis, the 
rate of culture collapse is not influenced by the MOI (Figure ).  
 
Figure 5. DISARM provides protection agains infection by phage λ. (A) Infection of WT E. coli by phage λ results 
in culture collapse indicated by a decrease in optical density. (B) Infection of E. coli containing DISARM by phage 
λ results in a delayed culture collapse indicated by a decrease in optical density.  
 
Figure 6. Rate of culture collapse by infection by phage λ. (A) Rate of culture collapse in WT E. coli. (B) Rate of 
culture collapse of E. coli containing DISARM.  
DISARM systems are associated with restriction enzymes and methyltransferases. Until now it is not clear if 
these associated methyltransferases are essential for functionality of these DISARM systems. The type I DISARM 
system from Serratia sp. SCBI contains a methyltransferase upstream of drmD which we considered to be 
required for functionality of the system. When we transformed E. coli with the plasmid containing drmABC 
followed by the plasmid containing drmD and drmMI, the plasmids were heavily mutated. This suggests toxicity 
of the drmABC in the absence of drmD and/or drmMI. To prevent toxicity effects we cloned the 
methyltransferase (MT) and used this plasmid to transform E. coli prior to transformation with drmABC and 
drmD-MI. This resulted in a stable plasmid-based DISARM system, able to protect cells from phage infection. 
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The question still remains if the methyltransferase (MT) is essential, a question that can be answered by 
analysing DISARM functionality of a strain containing only drmA-D and drmMI. Furthermore, knockouts of all 
of the five DISARM individual genes, drmA, drmB, drmC, drmMI and drmD, need to be created in order to 
identify which genes are essential. 
Recent studies have shown that a fusion between DUF1998 and DEAD/H-helicase, named dpdJ, are involved in 
the Dpd system, a new R-M system consisting of at least 12 genes that modifies DNA with 7-deazaguanin 
derivatives (Thiaville et al., 2016). Just like in the DISARM systems, dpdJ is followed by a PLD-containing gene 
named dpdK. Based on the similarity of the protein domains and the genetic organization thereof, we 
hypothesize that these proteins fulfill similar roles in the DNA restriction module of the Dpd system and the 
DISARM system (Figure 7).  
 
Figure 7. Gene clusters of the type I DISARM system in B. paralicheniformis and the Dpd system in S. montevideo 
and K. radiotolerans. Similar colors represent homologs.  
Coevolution between bacteria and bacteriophages remains a highly interesting topic. There is a great variety in 
bacterial defense mechanisms, and anti-defense systems developed by bacteriophages. In recent years, more 
and more defense systems have been discovered suggesting that we only know the tip of the iceberg (Doron 
et al., 2018; Makarova et al., 2011). DISARM represents a new kind of R-M system with a different recognition 
and restriction module. The discovery of DISARM represents one of the many more defense systems that might 
be discovered in the future. Studying the arms race between bacteria and bacteriophages will give us a better 
understanding of the major evolutionary driving force shaping prokaryotic genomes.  
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understanding of the major evolutionary driving force shaping prokaryotic genomes.  
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 Techniques for Writing and Presenting Scientific Papers, WGS/language services. 
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 Essential Skills for Data Intensive Research, SURF eScience. Utrecht (NL), 2016 
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 Presenting with Impact, VLAG. Wageningen (NL), 2016 
 
Optionals 
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